Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRP,Agouti-related protein,29786,0.191405215010626,0.00331457288552539,0.184908652154996,0.197901777866255,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APCS,Serum amyloid P-component,24726,0.110960076995506,0.00219538657388061,0.1066571193107,0.115263034680312,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOC1,Apolipoprotein C-I,24914,0.106325205926935,0.0023959883191137,0.101629068821472,0.111021343032398,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOM,Apolipoprotein M,29545,0.0935481767942218,0.00175301423438034,0.0901122688948364,0.0969840846936073,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCHE,Cholinesterase,24528,0.0776058343498384,0.00179667557859607,0.0740843502157901,0.0811273184838867,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL23,C-C motif chemokine 23,29581,0.10517609393572,0.00267874818103885,0.0999257475008837,0.110426440370556,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL27,C-C motif chemokine 27,29478,0.17804002057335,0.00391692200145417,0.1703628534505,0.1857171876962,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN1,CCN family member 1,29301,0.282995241352462,0.00471270874428722,0.273758332213659,0.292232150491265,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFP,Properdin,24966,0.0668854181153767,0.00147131513138811,0.064001640457856,0.0697691957728974,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.0580776488937559,0.00124346902754039,0.0556404495997768,0.0605148481877351,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F7,Coagulation factor VII,29544,0.0972112950481119,0.00194518764234995,0.093398727269106,0.101023862827118,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.148395424920331,0.00199100161635062,0.144493061752283,0.152297788088378,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0948761664754294,0.00237331949695184,0.0902244602614038,0.099527872689455,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHR,Growth hormone receptor,24381,0.0798922907717898,0.00183858526668201,0.0762886636490931,0.0834959178944866,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.216943697174388,0.00487232209129706,0.207393945875446,0.22649344847333,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0762243446143946,0.00192031914355038,0.0724605190930359,0.0799881701357534,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLKB1,Plasma kallikrein,24454,0.0671234500577091,0.00161538765208102,0.0639572902596303,0.0702896098557879,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0834616371254669,0.00137745696865018,0.0807618214669125,0.0861614527840213,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLR,Low-density lipoprotein receptor,29500,0.339255168081567,0.00287411790591862,0.333621896985967,0.344888439177168,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFGE8,Lactadherin,29443,0.128688052039962,0.00280109205036697,0.123197911621243,0.134178192458682,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPY,Pro-neuropeptide Y,29725,0.255064305301141,0.00409273325908002,0.247042548113344,0.263086062488938,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAMR1,Inactive serine protease PAMR1,29443,0.0777084317689346,0.00176712177657651,0.0742448730868446,0.0811719904510245,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.190272183357407,0.00374521345626063,-0.197612801731678,-0.182931564983136,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.204751270027478,0.00173474025457533,0.201351179128511,0.208151360926446,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROC,Vitamin K-dependent protein C,29545,0.0960436596889917,0.00161679195517564,0.0928747474568475,0.0992125719211359,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROS1,Vitamin K-dependent protein S,24966,0.0673758175740363,0.00164096903202556,0.0641595182712662,0.0705921168768064,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,29628,0.120190962759087,0.00304255968365636,0.114227545779121,0.126154379739054,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA5,Plasma serine protease inhibitor,24644,0.0814601206310816,0.00205147186887455,0.0774392357680875,0.0854810054940757,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF2,Alpha-2-antiplasmin,24515,0.0355001163260437,0.000877209449124791,0.0337807858057591,0.0372194468463283,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.0915598604257309,0.00210467288470729,0.0874347015717046,0.0956850192797571,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.13030316894233,0.00270774426134681,0.12499599019009,0.13561034769457,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI,Tissue factor pathway inhibitor,29435,0.13529936132735,0.00194031799840798,0.13149633805047,0.13910238460423,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.0777180139273544,0.00166055458517625,0.074463326940409,0.0809727009142999,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTR,Transthyretin,24707,0.0675838789921095,0.00162998880111131,0.0643891009419314,0.0707786570422877,0
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.284660229076282,0.00736727850202027,0.270220363212322,0.299100094940241,1.11253692931617e-308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA4,Kallistatin,24557,0.0593122024309861,0.0015403373638207,0.0562931411978975,0.0623312636640747,1.11253718746861e-308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FURIN,Furin,29566,0.0830197195278243,0.00216247276060941,0.0787812729170299,0.0872581661386188,1.1125374349175e-308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP1,Neuropilin-1,29628,-0.0681576542356134,0.00179561486080041,-0.0716770593627822,-0.0646382491084446,6.92070110397115e-308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,P4HB,Protein disulfide-isomerase,29313,0.0939072634839183,0.00250219151395689,0.0890029681165628,0.0988115588512738,4.06908300441706e-301
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,29566,0.0612478271854363,0.00164053061048886,0.0580323871888781,0.0644632671819944,3.90986814510148e-298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.198040356549316,0.00530506728045453,0.187642424679625,0.208438288419007,6.75335979805949e-298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH,Parathyroid hormone,24195,0.195533069453446,0.00522943193765295,0.185283382855646,0.205782756051246,1.60084828824458e-297
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFH,Complement factor H,23693,0.0561873861813798,0.00150961592492386,0.053228538968529,0.0591462333942306,9.97807780207754e-295
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRN,"Attractin, Isoform 2",24966,0.0399421073433393,0.00107507312093583,0.0378349640263051,0.0420492506603736,4.01302471564424e-294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN3,Contactin-3,29443,0.0770948521993509,0.00208573556429298,0.0730068104933367,0.0811828939053652,2.21617357005188e-292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0464065305665784,0.00126948142959425,0.0439183469645736,0.0488947141685831,5.66199279364509e-286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0585292802311668,0.00160476729444185,0.0553839363340608,0.0616746241282728,6.43764524107036e-285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.204142816330469,0.00562348654569095,0.193120782700914,0.215164849960023,2.69855857332442e-282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB2,Carboxypeptidase B2,24914,0.0531624004575547,0.0014635299723623,0.0502938817117246,0.0560309192033848,1.45483640621258e-281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0917835626925521,0.0025671488621092,-0.0968151744622861,-0.0867519509228181,4.30548222040074e-274
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCA,Alpha-synuclein,24381,0.268058578050921,0.00750056786487082,0.253357465035774,0.282759691066068,1.08568639600069e-272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYAP1,Synapse-associated protein 1,24381,0.133075574818982,0.00372416089545267,0.125776219463895,0.140374930174069,1.30445412917773e-272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES1,Liver carboxylesterase 1,29489,0.185579717969174,0.00523056852879954,0.175327803652727,0.195831632285622,4.87202232169525e-270
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F10,Coagulation factor X,24951,0.0627142414425713,0.00178448272903197,0.0592166552936687,0.066211827591474,3.93302607942559e-264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL6,C-X-C motif chemokine 6,29786,0.174389660141978,0.00497832620245846,0.164632140785159,0.184147179498797,1.7887002555005e-263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,29518,0.0802024173200971,0.00230996495059828,0.0756748860169245,0.0847299486232697,6.41150174977617e-259
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFI,Complement factor I,24966,0.0447394121172957,0.00129296827785148,0.0422051942927068,0.0472736299418846,2.66868288656996e-256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.236798438101068,0.00685968163941091,0.223353462087823,0.250243414114313,5.31708839157926e-256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP6,Charged multivesicular body protein 6,24922,0.126362499255267,0.00366256992010353,0.119183862211864,0.13354113629867,7.67020733572872e-255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.0759620248912699,0.00221896301064028,0.0716128573904149,0.0803111923921248,6.16317332584965e-252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FN1,Fibronectin,24966,0.0593381827621857,0.00173826205897577,0.0559311891265932,0.0627451763977782,1.1679554225229e-249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.175066549309324,0.00516253363720254,0.164947983380407,0.185185115238241,2.75623806982758e-247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A5,Zinc transporter ZIP5,29434,0.115010682101623,0.00346320532909595,0.108222799656595,0.121798564546651,1.92815647446398e-237
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPL,Lipoprotein lipase,29478,-0.101154430206693,0.00305162610785828,-0.107135617378095,-0.0951732430352904,1.36520631697709e-236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN2,Ficolin-2,29381,0.0880083938735319,0.00266564159270053,0.0827837363518389,0.0932330513952249,9.49493523581583e-235
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.043687933634801,0.00133182539735098,0.0410775558559931,0.0462983114136089,7.31926475557362e-232
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR5,Cadherin-related family member 5,29478,0.0820701654283965,0.00252765224544284,0.0771159670273285,0.0870243638294644,2.98245414958157e-227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAT,Tissue-type plasminogen activator,29736,0.105978451706799,0.00326544253446175,0.0995781843392538,0.112378719074344,4.33142552159683e-227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBC,Inhibin beta C chain,29443,0.0867642558296208,0.00268384543934269,0.0815039187685091,0.0920245928907325,2.46130908437736e-225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.3094037097481,0.00957804435977721,0.290630742802936,0.328176676693263,6.06568473089938e-225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0452970058064896,0.00142316568505555,0.0425076010637807,0.0480864105491985,7.54741663154676e-218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD4,T-cell surface glycoprotein CD4,29383,0.0616782274032857,0.00194353586593657,0.0578688971060501,0.0654875577005214,2.40626400375627e-217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,28797,0.226309578006206,0.00715849817434265,0.212278921584494,0.240340234427917,1.15808579160925e-215
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPIND1,Heparin cofactor 2,24914,0.0577400774108093,0.00183777181570504,0.0541380446520274,0.0613421101695912,1.58979616411623e-212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORT1,Sortilin,29433,0.0758994860509516,0.00242169744643401,0.071152959055941,0.0806460130459623,3.94010564296391e-212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0412800890682203,0.00132414926771352,0.0386847565035018,0.0438754216329388,6.26296261775738e-210
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0529521281575868,0.00169919702675111,0.0496217019851546,0.0562825543300189,4.51079198456543e-209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F13B,Coagulation factor XIII B chain,24833,0.052464675443019,0.00168515445598246,0.0491617727092934,0.0557675781767446,8.78275550221686e-209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.28284085758602,0.00911147350938721,0.264982369507621,0.300699345664419,1.36177243256266e-207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.210778591235071,0.0068004880110149,-0.224107547736661,-0.197449634733482,1.37915676346823e-207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOST,Sclerostin,29433,0.0776567846446026,0.00251888223002574,0.0727197754737522,0.0825937938154531,1.94656652414754e-205
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAPIN,SNARE-associated protein Snapin,24867,0.116139300190032,0.00377169289352658,0.10874678211872,0.123531818261344,2.28700846631188e-204
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFM,Afamin,24966,0.0390257540675231,0.00127052816602653,0.0365355188621111,0.0415159892729351,2.11773161099014e-203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG2,Desmoglein-2,29443,-0.0538064328003965,0.00175797813350792,-0.0572520699420721,-0.050360795658721,1.48599049797082e-202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.166625930962977,0.00544844226006605,0.155946984133247,0.177304877792706,3.52253998334958e-202
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTD,Biotinidase,24966,0.0411895434403321,0.00135045845838553,0.0385426448618965,0.0438364420187678,1.23881829405909e-200
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO3,Beta-enolase,24240,0.119424387674857,0.00392229421025546,0.111736691022756,0.127112084326957,7.49418689102213e-200
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.134389518989579,0.00443383142391933,0.125699209398697,0.143079828580461,9.86422123256541e-199
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0441955695212017,0.0014585307257206,0.0413368492987893,0.0470542897436141,1.37378560473063e-198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.145211741490513,0.00479902554638127,0.135805651419606,0.15461783156142,4.61414918866925e-198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINC1,Antithrombin-III,24914,0.0291560218062794,0.000965036705300209,0.027264549863891,0.0310474937486678,5.84444638308076e-197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAB2,Stabilin-2,24938,0.0553314752535188,0.00183677050281067,0.0517314050680099,0.0589315454390278,7.53702659050905e-196
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.13567633340144,0.00452050347702987,0.126816146586461,0.144536520216418,1.97036715987694e-194
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.101840495905009,0.00339997580442402,0.0951765433283377,0.10850444848168,3.11592358633888e-194
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCS1,Neuronal calcium sensor 1,29725,0.0556622675927378,0.00186375774370658,0.0520093024150729,0.0593152327704027,3.95896142650512e-193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUMB,Protein numb homolog,24229,0.162151822015093,0.00545916105271412,0.151451866351773,0.172851777678412,1.84353258549627e-190
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,29491,0.0768072294599131,0.00259347876061962,0.0717240110890987,0.0818904478307276,5.747151990629e-190
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,24229,0.164998460605694,0.00557457576178196,0.154072292112601,0.175924629098787,3.65833388159451e-189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA80,N-alpha-acetyltransferase 80,24195,0.233355349037003,0.00788651689950587,0.217897775913972,0.248812922160035,4.81505533389814e-189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYNU,Kynureninase,29786,0.0869265617939295,0.00295689043948553,0.0811310565325379,0.0927220670553211,2.78097182234959e-187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT2,Linker for activation of T-cells family member 2,29349,0.237863108069284,0.00809441549910626,0.221998053691036,0.253728162447533,4.27488728582384e-187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFR,Epidermal growth factor receptor,29820,0.0314220527496401,0.00106998249922674,0.0293248870511557,0.0335192184481245,6.7155866813463e-187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0544297763079754,0.00186808167585472,0.0507683362233001,0.0580912163926506,4.73868553025612e-184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0487805451775963,0.00168615821821073,0.0454756750699032,0.0520854152852893,1.79635318982532e-181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUSB,Beta-glucuronidase,29604,0.112299659026023,0.00389450012286696,0.104666438785204,0.119932879266842,2.41824381949759e-180
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR3,Anterior gradient protein 3,28764,0.111835789336166,0.00387879813595014,0.104233344989704,0.119438233682629,3.08972169332687e-180
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIP2,Cysteine-rich protein 2,29218,0.0678715998637065,0.00236878038838534,0.0632287903024712,0.0725144094249418,4.35442627998276e-178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP4,Dipeptidyl peptidase 4,28990,0.0561128010451056,0.00195850555350744,0.052274130160231,0.0599514719299802,4.7739013499808e-178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRP,Gastrin-releasing peptide,24240,0.101022133040808,0.00352426810719221,0.0941145675507112,0.107929698530905,9.72477989945411e-178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL22,C-C motif chemokine 22,29169,0.0961263573854355,0.00336676625931062,0.0895274955171867,0.102725219253684,7.32790699196466e-177
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2,Prothrombin,24966,0.0276293464208158,0.000968673290875349,0.0257307467707001,0.0295279460709315,4.08302968092833e-176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0548956239505699,0.00192886241630619,0.0511150536146098,0.0586761942865301,2.33875405510185e-175
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.115129040070853,0.00406080740011833,-0.123088222575085,-0.107169857566621,1.69704695912914e-174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTYMK,Thymidylate kinase,24922,0.126530580911306,0.00447070850029292,0.117767992250732,0.13529316957188,1.80903664087058e-173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR2,Cadherin-related family member 2,29349,0.13360606991547,0.00473566340368738,0.124324169644243,0.142887970186697,8.31289302880163e-173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.124527914561097,0.00442274443389628,0.11585933547066,0.133196493651533,4.33512248812076e-172
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F9,Coagulation factor IX,29545,0.0330361912388688,0.00118679642266591,0.0307100702504436,0.035362312227294,2.35322929391207e-168
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA3,Glutathione S-transferase A3,28797,0.138897416867154,0.00499631733934895,0.12910463488203,0.148690198852278,7.19435995278952e-168
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPM,Carboxypeptidase M,29584,0.0618412483052926,0.00223744851451751,0.0574558492168383,0.0662266473937469,4.87371381219973e-166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP29,Synaptosomal-associated protein 29,29566,0.164795080887554,0.00596340000072352,0.153106816886135,0.176483344888972,5.55852906659646e-166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11,Coagulation factor XI,24606,0.0561784051552654,0.00203086446820589,0.0521979107975818,0.0601588995129489,6.87147800478009e-166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0733456819409449,0.00266118325653266,0.0681297627581409,0.078561601123749,9.76769742147726e-165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.142822301918432,0.00520072838527406,0.132628874283294,0.153015729553569,1.4059521411868e-163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC5,Glypican-5,29218,0.10082481257719,0.00367601922121531,0.0936198149036081,0.108029810250772,1.51976517423406e-163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EEF1D,Elongation factor 1-delta,24922,0.16354464272708,0.0059688566596867,0.151845683674094,0.175243601780065,7.19696491504873e-163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0482495416911993,0.00176415495699964,0.04479179797548,0.0517072854069186,1.18864896677702e-162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THPO,Thrombopoietin,28916,0.0688786619755589,0.0025225823550904,0.0639344005595817,0.0738229233915361,4.25292634907432e-162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJAP1,Tight junction-associated protein 1,29566,0.14754277104863,0.00540798497316635,0.136943120501224,0.158142421596036,6.97958161887011e-162
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.108717691200376,0.00399013219715009,0.100897032093962,0.11653835030679,1.84571659170819e-161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1S,Complement C1s subcomponent,24966,0.0372006183629289,0.00136991432169208,0.0345155862924124,0.0398856504334453,4.63636063220479e-160
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP10,Stromelysin-2,29439,-0.104510981991853,0.00385802820399895,-0.112072717271691,-0.096949246712015,1.20274381215557e-159
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YES1,Tyrosine-protein kinase Yes,29349,0.200613622102535,0.00743501126235992,0.18604100002831,0.215186244176761,2.05487938616375e-158
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON2,Spondin-2,29311,-0.0611444121081116,0.00227912468071538,-0.0656114964823137,-0.0566773277339095,1.19333026817603e-156
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,29163,0.0412771692005895,0.001544741660827,0.0382494755453686,0.0443048628558105,2.00256402191985e-155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH9,Myosin-9,24938,0.196853771664357,0.00738550196388005,0.182378187815152,0.211329355513562,2.3406454378016e-154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLN,Promotilin,29434,0.154835160319784,0.00581641064575727,0.1434349954541,0.166235325185468,2.66010546084366e-154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YTHDF3,YTH domain-containing family protein 3,28931,0.14808466924124,0.00556611501969803,0.137175083802632,0.158994254679848,4.30375311773599e-154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRL,Appetite-regulating hormone,29478,0.140348546334249,0.00528041102863049,0.129998940718134,0.150698151950365,7.74111052532414e-154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.102699315217701,0.00386613461295087,0.0951216913763177,0.110276939059085,1.2686027718555e-153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FYB1,FYN-binding protein 1,29400,0.159393784764623,0.00600595616322387,0.147622110684705,0.171165458844542,2.20089815459767e-153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHBP1,EH domain-binding protein 1,24922,0.129690565827887,0.00488832421642863,0.120109450363687,0.139271681292087,5.73408420510918e-153
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5E,5'-nucleotidase,29566,0.0970751867241288,0.00367064173030934,0.0898807289327225,0.104269644515535,2.38901268583029e-152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SARG,Specifically androgen-regulated gene protein,24820,0.188664100815512,0.00714643047960839,0.174657097075479,0.202671104555544,1.70797641502487e-151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,29434,0.0738284735658034,0.00280593523169552,0.0683288405116802,0.0793281066199266,7.89406364202525e-151
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL17,C-C motif chemokine 17,29414,0.15626787594373,0.00594185213069801,0.144621845767562,0.167913906119898,1.07840195382384e-150
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0563932429430222,0.00214570770462802,0.0521876558419513,0.0605988300440931,1.70671520342375e-150
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF9,Protein turtle homolog A,24922,0.142458856832345,0.00542476460911925,0.131826318198471,0.153091395466219,5.91498762230219e-150
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC3B,Tetranectin,24381,0.0367952013242302,0.00140322512108269,0.0340448800869081,0.0395455225615522,1.77350275182272e-149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTA1,Glutathione S-transferase A1,29426,0.143898640431395,0.0055011107955532,0.133116463272111,0.154680817590679,4.05905186575972e-149
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,24381,0.129141003189069,0.00495316739819737,0.119432795088602,0.138849211289536,7.9846314746246e-148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.165704868929739,0.00637150357204453,0.153216721928532,0.178193015930946,1.91139544161035e-147
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.151626260102212,0.00584782657300596,0.14016452001912,0.163088000185303,1.45614977679524e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL5,C-X-C motif chemokine 5,29384,0.192674997025338,0.00743713327195956,0.178098215812297,0.207251778238379,2.4438756320201e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.182093761528513,0.00702490861428585,0.168324940644512,0.195862582412513,3.3420093482503e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPD52L2,Tumor protein D54,24381,0.183976913608798,0.00709826762816816,0.170064309057588,0.197889518160008,3.93297215119136e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL17,C-X-C motif chemokine 17,29786,0.07104759579023,0.00274553998593567,0.0656663374177961,0.0764288541626639,4.93525588296797e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,29349,0.114555270440678,0.00442988605577393,0.105872693771361,0.123237847109995,8.18464735716276e-146
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAB2,Disabled homolog 2,29725,0.186655742688206,0.00722418729281459,0.172496335594289,0.200815149782122,1.36412501843861e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR37,Prosaposin receptor GPR37,28916,0.111950398644716,0.00433241353446977,0.103458868117155,0.120441929172276,1.41537724962154e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH1,Somatotropin,29433,-0.299674778655679,0.0116046207061412,-0.322419835239716,-0.276929722071643,2.00867761880168e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINF1,Pigment epithelium-derived factor,24579,0.044276956764103,0.00171462825395908,0.0409162853863432,0.0476376281418628,4.21830870938899e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEG1,Protein HEG homolog 1,24381,0.0461205189433803,0.00178641161219061,0.0426191521834867,0.0496218857032739,5.03988079714785e-145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC4,Syndecan-4,29478,0.0780564275748944,0.0030311128401523,0.0721154464081959,0.083997408741593,1.23109378325146e-144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.0506096540870247,0.00196417577022381,0.046759869577386,0.0544594385966634,1.68806621204193e-144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C4BPB,C4b-binding protein beta chain,29566,0.0675504607554216,0.00262558705993392,0.0624043101179511,0.0726966113928921,2.22955697149675e-144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.057398835646401,0.00223114353731036,-0.0617718769795293,-0.0530257943132727,2.24867483366144e-144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0675593477299897,0.00263429539992928,-0.0727225667138511,-0.0623961287461284,1.76721328249551e-143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.188903681938585,0.00737977601377958,0.174439320951577,0.203368042925593,1.23519491597938e-142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0661963041788822,0.0025926540500578,0.0611147022407689,0.0712779061169955,3.10088958015126e-142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0485193365269924,0.00190713164629326,0.0447813585002576,0.0522573145537272,2.86625925497737e-141
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZN,Kazrin,24805,0.173502323932006,0.00682961846407298,0.160116271742423,0.186888376121589,1.41859194346316e-140
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADIPOQ,Adiponectin,24966,-0.112518756894803,0.00442955049880413,-0.121200675872459,-0.103836837917147,1.47199765923093e-140
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL16,Pro-interleukin-16,29786,0.0683338907696137,0.0027036435627625,0.0630347493865992,0.0736330321526282,1.79497671584173e-139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.161771086191082,0.0063952056500741,0.149236483116937,0.174305689265227,2.06991955303311e-139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINK1,Misshapen-like kinase 1,24845,0.153371396044152,0.00608487052286605,0.141445049819335,0.16529774226897,1.925787467051e-138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,29566,0.0363569765817433,0.00144452381158922,0.0335257099110284,0.0391882432524581,2.52517824567405e-138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFC,Platelet-derived growth factor C,28797,0.047621387451054,0.00189230987463604,0.0439124600967674,0.0513303148053407,2.97682717228482e-138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0439010989016282,0.0017483217840445,0.040474388204901,0.0473278095983554,1.0739091926432e-137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.177047427554186,0.0070812540396683,0.163168169636436,0.190926685471936,2.80201937924783e-136
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,28774,0.128816348947299,0.00516870268130007,0.118685691691951,0.138947006202648,1.17370765137205e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.133246800227187,0.00535456810728857,0.122751846736901,0.143741753717472,2.65999580798292e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFC,Vascular endothelial growth factor C,29566,0.0905958227066098,0.00364209772501692,0.0834573111655766,0.0977343342476429,3.45150265320734e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.172711221860698,0.00694362003067868,0.159101726600567,0.186320717120828,3.60994699246536e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXIN1,Axin-1,29434,0.154768037544844,0.00622358500668216,0.142569810931747,0.166966264157941,4.11637016774959e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCG,Pro-glucagon,28797,0.202307693375214,0.00814175816445136,0.18634984737289,0.218265539377539,7.15982703721449e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,29581,0.2032843602138,0.00818638745781298,0.187239040796487,0.219329679631114,9.74412396105507e-135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.117829166964409,0.00475219689786426,0.108514861044595,0.127143472884223,2.4047768356069e-134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS1,Protein MTSS 1,24805,0.180690748432009,0.0072803182951179,0.166421324573578,0.19496017229044,2.43663119299008e-134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPOCK1,Testican-1,29218,0.0418207279762474,0.00168817364237403,0.0385119076371943,0.0451295483153005,4.28123730858257e-134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK1,Dickkopf-related protein 1,29694,0.0960940862420048,0.00388143727095259,0.0884864691909377,0.103701703293072,5.92088996718289e-134
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.0865837193884852,0.00350313140082573,0.0797175818428668,0.0934498569341036,1.69454287322672e-133
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN1,Perilipin-1,28774,0.0562759355034552,0.0022826295257934,0.0518019816329001,0.0607498893740103,7.99709904423262e-133
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELN,Elastin,24922,0.0567352826947052,0.00230332876936118,0.0522207583067573,0.0612498070826531,2.21061618782832e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.0703972969811734,0.00286072744107871,0.0647902711966591,0.0760043227656877,2.27608766586642e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNA4,Plexin-A4,29434,0.131414043376123,0.00534062525675675,0.12094641787288,0.141881668879367,2.3501064187517e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.13406737387544,0.00544578202779262,0.123393641100966,0.144741106649913,3.29653860659647e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOMO1,Nodal modulator 1,29443,0.0378409082014749,0.00153974004644764,0.0348230177104375,0.0408587986925122,4.88131322283329e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL3,C-X-C motif chemokine 3,29453,0.151329552153431,0.00615799234839174,0.139259887150584,0.163399217156279,5.07695586584594e-132
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0722497487540521,0.00294718792731853,-0.0780262370915965,-0.0664732604165078,3.71168966255244e-131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.130786787979422,0.00533702839207523,0.120326212330954,0.141247363627889,4.67569871201339e-131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.135176541536694,0.00551994728113345,0.124357444865672,0.145995638207716,6.93266513960103e-131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF2,Growth/differentiation factor 2,29478,0.0570945216101761,0.00233567942906207,0.0525165899292144,0.0616724532911378,1.15551592523693e-130
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.061001921700478,0.00249681774629923,-0.0658956844832245,-0.0561081589177316,1.54666092198244e-130
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS15,Enteropeptidase,29349,0.14407767523643,0.0059195987786571,0.132475261630262,0.155680088842598,1.46107461029394e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.050043104059423,0.00205644355805771,0.0460124746856299,0.0540737334332161,1.57160583731145e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,24805,0.153096582773401,0.0062877643211239,0.140772564703999,0.165420600842804,2.00051628156453e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.106115897799316,0.00436551938214199,0.0975594798103177,0.114672315788314,3.26680380306235e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTSS2,Protein MTSS 2,24793,0.158285229575731,0.00650784766423694,0.145529848153827,0.171040610997635,3.73232766714295e-129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTBDN,Retbindin,29349,0.0470528045113445,0.00194373827541886,0.0432430774915235,0.0508625315311655,3.37420627482437e-128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPING1,Plasma protease C1 inhibitor,24914,0.0299021618806814,0.00123457546690197,0.0274823939655535,0.0323219297958092,4.09990715231712e-128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP20,Centrosomal protein 20,28797,0.117722802157542,0.0048649321298313,0.108187535183073,0.127258069132011,4.4284630828402e-128
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0518736314582614,0.00214742924090602,0.0476646701460856,0.0560825927704372,1.11142705413404e-127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.133807754047044,0.0055453003329097,0.122938965394541,0.144676542699547,3.84089229799999e-127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0437754632636397,0.00181870784250685,0.0402107958923263,0.0473401306349532,8.78822286999877e-127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,24867,0.180135584129498,0.00748305701272924,0.165468792384549,0.194802375874447,1.36790347907134e-126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHBG,Sex hormone-binding globulin,24951,-0.0813599419439774,0.00338727666911376,-0.0879990042154404,-0.0747208796725145,4.73108589387184e-126
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXLNA,Alpha-taxilin,29218,0.138983171409758,0.00580627554166416,0.127602871348096,0.150363471471419,2.0560739922402e-125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.152634025511785,0.00638059412632861,0.14012806102418,0.165139989999389,2.89771869443611e-125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD63,CD63 antigen,29169,0.0803346902434911,0.00336385604116936,0.0737415324027992,0.086927848084183,7.51684598653037e-125
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG16L1,Autophagy-related protein 16-1,24805,0.133653701048756,0.00560029778482016,0.122677117390508,0.144630284707003,1.77506976549992e-124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARF6,ADP-ribosylation factor 6,24805,0.167363843992301,0.00701552561840557,0.153613413780226,0.181114274204376,2.20357132716831e-124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS6,Growth arrest-specific protein 6,29639,-0.0397941584176007,0.00166970355774245,-0.0430667773907759,-0.0365215394444255,2.25298680326471e-124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AAMDC,Mth938 domain-containing protein,24240,0.0835634425821159,0.00350368318234644,0.0766962235447169,0.090430661619515,2.73240839982418e-124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCTN3,Tectonic-3,24922,0.0465281629904642,0.00195513024136998,0.042696107717379,0.0503602182635494,8.44754167410596e-124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORD,Sorbitol dehydrogenase,29595,0.105981293494244,0.00445834258097615,0.0972429420355303,0.114719644952957,9.56108027632317e-124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES3,Carboxylesterase 3,29349,0.108587610314632,0.00457379136173018,0.0996229792456407,0.117552241383623,1.97801978610395e-123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMIP,C-Maf-inducing protein,24793,0.128998792654581,0.00544004527895617,0.118336303907827,0.139661281401335,6.22959123775224e-123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD7B,OTU domain-containing protein 7B,24867,0.0982822468626339,0.00414795906353467,0.090152247098106,0.106412246627162,9.52720113901189e-123
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.159627933369545,0.00674100475760923,0.146415564044631,0.172840302694459,1.42723874878645e-122
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.160098097597742,0.00679818344339672,0.146773658048684,0.173422537146799,1.66948583418483e-121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,29478,0.0469780242096534,0.00199552019417893,0.0430668046290627,0.0508892437902441,2.01949327916821e-121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0311639244546756,0.00132535663027205,0.0285662254593424,0.0337616234500088,3.90776971626509e-121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99L2,CD99 antigen-like protein 2,29443,0.0371786099232248,0.00158716321830815,0.0340677700153408,0.0402894498311087,3.03208103745087e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0628226811400623,0.00268550824966087,0.057559084970727,0.0680862773093976,6.40813191825537e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,29694,0.146857451338713,0.00628249747239729,0.134543756292815,0.159171146384612,9.15280483326311e-120
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCXR,L-xylulose reductase,29566,0.0820203560355523,0.00351531028889891,0.0751303478693105,0.0889103642017942,2.50286601574005e-119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.1111140923829,0.00476152352442072,0.101781506275036,0.120446678490765,3.95826120715771e-119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP5,Retinol-binding protein 5,29349,0.0857847953573027,0.00368031922176188,0.0785713696826494,0.0929982210319559,4.3454621782965e-119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,24845,0.135433828967747,0.00580732992529745,0.124051462314165,0.14681619562133,5.14463368312813e-119
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBIN,Erbin,29349,0.155832217630021,0.00671537608192405,0.14267008050945,0.168994354750592,4.66836406205029e-118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.170537331274967,0.00735676893541124,0.156118064161561,0.184956598388373,8.06680476821964e-118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0610296281102557,0.00263199409082278,0.0558709196922431,0.0661883365282684,1.08679135353335e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.0783533961025981,0.00338599824027695,0.0717168395516553,0.0849899526535409,2.14917424442663e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCK2,Cytoplasmic protein NCK2,29581,0.159930008208815,0.00691456512437445,0.146377460565041,0.173482555852589,2.58124439845286e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.160736205987396,0.00694597326978344,0.147122098378621,0.174350313596172,3.27130907916155e-117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R9B,Neurabin-2,29786,0.142138563884968,0.00617688676895988,0.130031865817807,0.15424526195213,3.70854881109597e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,24381,0.125038231807271,0.00542865502728503,0.114398067953792,0.13567839566075,3.79158342455499e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD6,T-cell differentiation antigen CD6,29760,0.0793705513962983,0.00345075751984326,0.0726070666574055,0.0861340361351911,4.70858139376217e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK2,Docking protein 2,29478,0.183306064301959,0.00797366387453496,0.167677683107871,0.198934445496048,6.31124401446795e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.0995981888209276,0.00432894474393987,0.0911134571228055,0.10808292051905,6.34447149306532e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFP,Alpha-fetoprotein,29132,0.102647134374101,0.00446568841929074,0.0938943850722912,0.111399883675911,6.97523953258965e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREG1,Protein CREG1,29079,0.0573980679229441,0.00249726523306658,0.0525034280661336,0.0622927077797546,7.2249688071182e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CES2,Cocaine esterase,29349,0.0824177946402119,0.00358672460934995,0.0753878144058859,0.0894477748745378,8.061656689861e-116
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILPL2,RILP-like protein 2,24922,0.147767305741593,0.00642851799714884,0.135167410467181,0.160367201016004,1.02546174305814e-115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK10,Kallikrein-10,29466,0.0602217012602424,0.00262313461905593,0.0550803574068928,0.065363045113592,1.27401875463968e-115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.107476128239951,0.00468141516426401,0.0983005545179932,0.116651701961908,1.3404551702544e-115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELP,P-selectin,29594,0.0852473300882208,0.00372367452187321,0.0779489280253494,0.0925457321510923,5.41734079964932e-115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.142636174987761,0.00623569988008785,0.130414203222789,0.154858146752733,8.36912911715954e-115
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.163055768081506,0.00712916595285544,0.149082602813909,0.177028933349102,1.36716173627792e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.136150541531241,0.00595811415842345,0.124472637780731,0.147828445281751,2.15888108063489e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0665533854618874,0.00291283179014621,0.0608442351532008,0.0722625357705739,2.32489192082063e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCR,Breakpoint cluster region protein,29434,0.136922743185261,0.00600215697341109,0.125158515517375,0.148686970853147,3.39886205576052e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKB,Creatine kinase B-type,24938,-0.088721554823193,0.00388893083029114,-0.0963438592505636,-0.0810992503958223,4.9214196922066e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.0864939140502711,0.00379498581569119,0.0790557418515163,0.0939320862490258,5.49094319938251e-114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A4,Protein S100-A4,29566,0.0848284296065844,0.00373617803166089,0.0775055206645291,0.0921513385486398,3.7557207052569e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.126648624691751,0.00557287333844022,0.115725792948408,0.137571456435094,3.81824087609562e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.111139517083164,0.00489198940209159,0.101551217855064,0.120727816311263,4.45180117591722e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB3,Plexin-B3,29383,0.0704396695617134,0.00310386300546574,0.0643560980710006,0.0765232410524263,4.8047998805253e-113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY1,Aminoacylase-1,29478,0.0915367125938642,0.00404079110294984,0.0836167620320825,0.0994566631556459,1.19239102443767e-112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLA,Alpha-galactosidase A,24329,0.0560061623796636,0.00247184249385551,0.0511613510917068,0.0608509736676204,1.71460592331207e-112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.108047022773894,0.00477540122446307,0.0986872363739465,0.117406809173842,2.24981679242326e-112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.0743492892350448,0.00329746184439097,0.0678862640200385,0.0808123144500511,1.26283405576969e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.102635396781678,0.0045533187946221,0.0937108919442187,0.111559901619137,1.51441528799883e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL16,C-C motif chemokine 16,29820,0.077243169689228,0.00342814496034496,0.0705240055669519,0.0839623338115042,1.72201857409922e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLA2,Src-like-adapter 2,24867,0.155135383090064,0.00687944292302332,0.141651674960938,0.16861909121919,1.7432135266824e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6A,Ras-related protein Rab-6A,29434,0.068407427686292,0.00303919240331275,0.062450610575799,0.074364244796785,2.99118248897718e-111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBP2,Poly(rC)-binding protein 2,24867,0.106818197947205,0.004753504206963,0.0975013297015574,0.116135066192852,1.00183001600157e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP85,Centrosomal protein of 85 kDa,28797,0.0939641548227446,0.00419073657910811,0.0857503111276927,0.102177998517796,2.12784128437781e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGL1,Fibrinogen-like protein 1,24951,-0.0940975444988278,0.00419474475174591,-0.10231924421225,-0.0858758447854058,2.35882671569701e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USO1,General vesicular transport factor p115,29349,0.132016222356399,0.00589501907317349,0.120461984972979,0.143570459739819,3.73581346347225e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,29349,0.201841621947729,0.00901441229462558,0.184173373850262,0.219509870045195,4.03980259421138e-110
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BECN1,Beclin-1,24240,0.0885611750757488,0.00396065740231329,0.0807982865672148,0.0963240635842829,1.23599909206725e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.16017475406517,0.0071702377193037,0.146121088135334,0.174228419995005,1.87826307680959e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,24845,0.0694049755183823,0.00310957637867784,0.0633102058161738,0.0754997452205909,2.8248955967758e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFX1,Transcriptional repressor NF-X1,24111,0.0994105032268937,0.00445373890436015,0.0906811749743478,0.10813983147944,2.98150593171948e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPB1,Beta-ureidopropionase,24922,0.134080117928953,0.00601038552787019,0.122299762294328,0.145860473563579,3.62170274568446e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0355499447167196,0.0015951826425629,0.0324233867372963,0.0386765026961429,4.06249195108558e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPY30,Protein dpy-30 homolog,29604,0.0873166782616188,0.00392001571497182,0.079633447460274,0.0949999090629635,5.14187391695865e-109
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN1,Dynactin subunit 1,29725,0.0946276682495567,0.00425548014926601,0.0862869271569953,0.102968409342118,1.17130673941813e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLTP,Phospholipid transfer protein,29702,-0.0523384086026158,0.00235507580898872,-0.0569543571882337,-0.0477224600169979,1.55969763668272e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,24922,0.132316794758293,0.00595087953534926,0.120653070869008,0.143980518647577,1.79848431124576e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEC31A,Protein transport protein Sec31A,24240,0.112296659981201,0.00505326580377199,0.102392259005808,0.122201060956594,2.51335963708391e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,24951,0.0392872166628964,0.00176829325794685,0.0358213618773205,0.0427530714484722,2.61332191805723e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,29434,0.0483505669960152,0.00218173861980347,0.0440743593012004,0.05262677469083,6.18895827818679e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKBKG,NF-kappa-B essential modulator,29434,0.133131424295902,0.00600831808950776,0.121355120840467,0.144907727751337,6.69994984891144e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGCC,Regulator of cell cycle RGCC,24867,0.110189230621278,0.00496994785913336,0.100448132817376,0.119930328425179,7.26046900577057e-108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0571017489538324,0.00258124273871049,0.0520425131859599,0.062160984721705,1.52328703717549e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F11R,Junctional adhesion molecule A,29443,0.0814233001900847,0.0036830672406202,0.0742044883984691,0.0886421119817003,2.00963900599856e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP23,Synaptosomal-associated protein 23,29478,0.125994530107594,0.00569941394232065,0.114823678780646,0.137165381434543,2.04432548776381e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAEP,Glycodelin,29218,-0.191213006957176,0.00865803898274609,-0.208182763363359,-0.174243250550994,3.32713476962192e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.0886525016366016,0.00401569836960182,0.080781732832182,0.0965232704410212,4.1321873980394e-107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAP1,Proline-rich acidic protein 1,24938,0.0591459855688502,0.00268486246317464,0.0538836551410279,0.0644083159966725,1.56463010742198e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.168061071872682,0.007636072943124,0.153094368904159,0.183027774841205,1.72693400542356e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THOP1,Thimet oligopeptidase,29343,0.0445250370824226,0.00202381119571808,0.0405583671388152,0.0484917070260301,2.06605436626238e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEFTY2,Left-right determination factor 2,29674,0.0748887701323823,0.00340547240238282,0.068214044223712,0.0815634960410526,2.50399385900689e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL10,C-X-C motif chemokine 10,29581,0.0962850772356118,0.00438137734891067,0.0876975776317469,0.104872576839477,3.46687278663037e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APPL2,DCC-interacting protein 13-beta,24381,0.162198265896517,0.00737531271023972,0.147742652984447,0.176653878808587,3.70161027315317e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN2,CCN family member 2,29478,0.0822226736409287,0.00374226561113333,0.0748878330431074,0.08955751423875,3.85798475790444e-106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.0983633374127202,0.00448678227997076,0.0895692441439775,0.107157430681463,1.68862145524035e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.147954099482574,0.00675963306229034,0.134705218680485,0.161202980284663,2.32569220072689e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD1,Sushi domain-containing protein 1,28916,0.0702021402700586,0.00321484965380952,0.063901034948592,0.0765032455915253,7.31507896393998e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLG,Plasminogen,24421,0.031852469167078,0.00145829593008955,0.0289942091441025,0.0347107291900536,9.2888524006548e-105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,24229,0.139827529111674,0.00640715218505229,0.127269510828971,0.152385547394376,1.409450083119e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA5,Integrin alpha-5,29443,0.0357966493690304,0.00164259437996055,0.0325771643843078,0.0390161343537531,1.82413295789363e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL13,C-C motif chemokine 13,29732,0.0986205844931037,0.00452686049953337,0.0897479379140182,0.107493231072189,2.08642387228508e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.14696645998437,0.00674339861611834,0.133749398696778,0.160183521271962,2.51775563295405e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.163189030277812,0.00749592582936514,0.148497015652256,0.177881044903368,4.19262489964997e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL5,C-C motif chemokine 5,29594,0.143269138128818,0.00658686998713394,0.130358872954036,0.156179403303601,4.45537314207885e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.0364208489710056,0.00167486903105188,0.033138105670144,0.0397035922718673,5.05111468284151e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAP,Prolyl endopeptidase FAP,29820,0.0392290685929687,0.0018046770637694,0.0356919015479807,0.0427662356379567,5.83960072338361e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOL1,Apolipoprotein L1,24951,0.0859320773023288,0.00395102991377784,0.0781880586713243,0.0936760959333334,6.4903843337001e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHK,Ketohexokinase,24240,0.0916099287409762,0.00421385793475111,0.0833507671888641,0.0998690902930884,8.41405796203856e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.106434297885279,0.00489730627950452,0.0968355775774498,0.116033018193108,9.87378052916626e-104
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO1,Forkhead box protein O1,29434,0.121366764814131,0.00560735656513931,0.110376345946458,0.132357183681804,4.39781700530511e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.056025497221171,0.00259146448713816,0.0509462268263802,0.0611047676159618,7.31626484060822e-103
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM20A,Pseudokinase FAM20A,24922,0.0402508275369876,0.0018643992101601,0.0365966050850738,0.0439050499889014,1.97457981890231e-102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0389110681216284,0.00181114284861335,0.0353612281383463,0.0424609081049106,1.84123862686145e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D23,TBC1 domain family member 23,29349,0.126498059266617,0.00589586062647714,0.114942172438722,0.138053946094512,2.44748930947281e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCLY,Selenocysteine lyase,29632,0.0680879576052071,0.00317811734699183,0.0618588476051031,0.0743170676053111,4.6770613219898e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IST1,IST1 homolog,24636,0.140096314609267,0.00653597877506216,0.127285796210145,0.152906833008389,5.32592643098957e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.127382435241533,0.00594526463755342,0.115729716551928,0.139035153931138,6.29547135534388e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPL,N-acetylneuraminate lyase,24922,0.0631712182405278,0.00295018888045204,0.0573888480348418,0.0689535884462138,8.27268375608744e-101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0446353406146133,0.00208770735625593,0.0405434341963517,0.0487272470328749,1.2025083610223e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,28916,0.0487362486638104,0.00227975470405644,0.0442679294438598,0.0532045678837611,1.29387452691799e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0591755150253801,0.00276686824247903,0.0537524532701212,0.0645985767806389,1.42817625117114e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.156703284686368,0.00733320616597635,0.142330200601055,0.171076368771682,1.5359789321967e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY4,Protein canopy homolog 4,29349,0.105126403952849,0.00492251478018568,0.095478274983685,0.114774532922013,1.98779953614682e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0280908623906557,0.0013173018251634,0.0255089508133354,0.0306727739679759,5.30361636374135e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,24867,0.165968367442474,0.00778821319130878,0.150703469587509,0.181233265297439,7.1539895247772e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BID,BH3-interacting domain death agonist,29434,0.0930800438572119,0.00437373858445927,0.0845075162316718,0.101652571482752,9.51602854699639e-100
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBPL,FK506-binding protein-like,24805,0.0828798857013244,0.0038931136464491,0.0752493829542842,0.0905103884483646,1.12505553704583e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.119345711203402,0.00560632289386652,0.108357318331423,0.13033410407538,1.15245856750847e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,24111,0.0874238890876287,0.0041101202732191,0.0793680533521193,0.0954797248231381,1.75494764404581e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.118109410160311,0.0055658568469873,0.107200330740216,0.129018489580407,3.56880762598088e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBP,Protein AMBP,29683,0.0279498739922101,0.00131985843915901,0.0253629514514584,0.0305367965329617,8.49789179869441e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.149233922398461,0.00704387500727786,0.135427927384196,0.163039917412726,9.54127152476711e-99
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLK1,Protein delta homolog 1,29820,0.077333540302246,0.00365796972362613,0.0701639196439387,0.0845031609605532,1.76335633704183e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0325356152110757,0.00153989900592143,0.0295174131594697,0.0355538172626816,2.34755028502287e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.137135210929534,0.00649109020060035,0.124412674136357,0.149857747722711,2.38725914497321e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0685430031996484,0.00324571140424379,0.0621814088473305,0.0749045975519662,3.02620784470313e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPK2,SRSF protein kinase 2,29434,0.116137597619737,0.00550013199912556,0.10535733890145,0.126917856338023,3.07937651954313e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLSCR3,Phospholipid scramblase 3,24804,0.0818285611212445,0.00387293355715854,0.0742376113492138,0.0894195108932752,3.21113372006962e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.139951287554857,0.00663066047428571,0.126955193025257,0.152947382084457,3.69399028824545e-98
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REN,Renin,29478,-0.105170203498751,0.004996807129804,-0.114963945473167,-0.0953764615243349,1.26337749427329e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.0725323777989027,0.00344824509979055,0.0657738174033132,0.0792909381944922,2.24920491679134e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB1,BPI fold-containing family B member 1,29333,-0.0869586199965959,0.00413797891049847,-0.0950690586611729,-0.0788481813320189,2.51287007441956e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAN,Aggrecan core protein,29192,0.0390762051635939,0.00186004918061784,0.0354305087695829,0.0427219015576048,2.90446535301243e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.0997634720007752,0.00475066487280155,0.0904521688500842,0.109074775151466,3.37630176786638e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.0952174025812074,0.00454203176188935,-0.10411978483451,-0.0863150203279043,7.24617932199331e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.143207757864277,0.00683535315413911,0.129810465682164,0.15660505004639,9.28137898521837e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCC,Tubulin-specific chaperone C,29218,0.111227565204742,0.0053093470657125,0.100821244955946,0.121633885453539,9.79777728041054e-97
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.122708910769444,0.00585722954737327,0.111228740856592,0.134189080682295,1.29126764124156e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.11442381324666,0.00546470274188848,0.103712995872559,0.125134630620762,1.63117609081825e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINH1,Serpin H1,24445,0.177161596743164,0.00846072987548279,0.160578566187218,0.19374462729911,1.65631415195807e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.043587565587931,0.00208274625812452,0.0395053829220069,0.0476697482538551,2.12732073475039e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0782686003482976,0.00374260595634316,0.070933092673865,0.0856041080227302,2.90859021799384e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPHN1,Oligophrenin-1,24845,0.147900929851673,0.0070745300999741,0.134034850855723,0.161767008847622,3.18029047212877e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA11,Annexin A11,29373,0.0913936918062229,0.00438475101115168,0.0827995798243656,0.0999878037880802,8.63278938424077e-96
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,29820,0.0304684442772276,0.00146293787588855,0.0276010860404861,0.0333358025139692,1.18741370080509e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.127727667715359,0.00613997023480753,0.115693326055136,0.139762009375582,2.05148621525922e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MITD1,MIT domain-containing protein 1,29218,0.131896320950371,0.00634381292295108,0.119462447621387,0.144330194279355,2.54618279159487e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.0981551142650224,0.00471935293207097,0.0889051825181633,0.107405046011881,3.00876727833754e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX2,Heme oxygenase 2,28774,0.0636836532051429,0.00306642275485015,0.0576734646056366,0.0696938418046492,4.20570542934526e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.0862387295786595,0.00415327045144236,0.0780983194938325,0.0943791396634866,4.56008242321756e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.125009616797974,0.00602380481185594,0.113202959366737,0.136816274229212,5.57196774121481e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,29581,0.116597544120513,0.00562004945250052,0.105582247193612,0.127612841047414,6.23859221889966e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBNL,Drebrin-like protein,29581,0.125828053081105,0.00606812423240016,0.113934529585601,0.13772157657661,7.78479062965674e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.149621327656165,0.00721748736658115,0.135475052417666,0.163767602894664,8.71596893643261e-95
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2B3,SH2B adapter protein 3,28797,0.133144469033938,0.00643284090642484,0.120536100857345,0.14575283721053,1.77703339793527e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.074734248131288,0.00361241645060646,0.0676539118880993,0.0818145843744767,2.14201181699793e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3F,Semaphorin-3F,29478,0.0357772485245078,0.00172999060125189,0.0323864669460541,0.0391680301029615,2.42636219848463e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.105450900993163,0.0050969307767926,0.0954609166706495,0.115440885315677,2.70887272715637e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.128557958240887,0.0062208400960024,0.116365111652722,0.140750804829051,3.33525400697543e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.0779672542399823,0.00377142439355389,0.0705752624286166,0.0853592460513479,3.92767274814314e-94
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR,GMP reductase 1,29786,0.0670472953547413,0.00325850211715888,0.0606606312051099,0.0734339595043727,2.0099498991301e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTPBP2,GTP-binding protein 2,24195,0.109642196724748,0.00532430881578465,0.09920655144581,0.120077842003686,2.01968030705794e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSHB,Follitropin subunit beta,24240,0.0875994812431766,0.0042611911060024,0.0792475466754119,0.0959514158109413,4.11223240634587e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R2,Interleukin-1 receptor type 2,29404,0.0268192600287755,0.00130684162370856,0.0242578504463068,0.0293806696112443,6.12358683657499e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.0860082911376649,0.00419129267411909,0.0777933574963915,0.0942232247789384,8.24386317874853e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,24381,0.105476655040023,0.00514021401031298,0.0954018355798093,0.115551474500236,8.71199736955661e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.0935768086554884,0.0045617559194509,0.0846357670533647,0.102517850257612,9.62214321089058e-93
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0531883304147298,0.00259719059000019,0.0480978368583294,0.0582788239711301,1.49960109898295e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0612354178100631,0.00299002071416971,0.0553749772102904,0.0670958584098357,1.97332973965899e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0856237704780531,0.00418237304012825,0.0774263193194018,0.0938212216367045,2.2674981721423e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRKL,Crk-like protein,29491,0.142083275857024,0.00695991876676715,0.12844183507416,0.155724716639887,5.38578721585439e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN1,Pantetheinase,24951,0.097823894577591,0.00479097310836771,0.0884335872851903,0.107214201869992,6.48693856261243e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUCB2,Nucleobindin-2,29652,0.0499370855930175,0.002447485182856,0.0451400146346197,0.0547341565514153,6.6812111909963e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0510966201359533,0.00250439636059659,0.0461880032691839,0.0560052370027226,6.87206386981319e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0715466972064467,0.00350521422198899,0.0646764773313483,0.0784169170815451,7.71773687735127e-92
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EZR,Ezrin,29694,0.0321329977930036,0.00157763309721109,0.0290408369224699,0.0352251586635374,1.36559421159324e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDHD2,Phospholipase DDHD2,24867,0.0888260754130805,0.00436299615076691,0.0802746029575774,0.0973775478685836,2.15393421205797e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP3B1,AP-3 complex subunit beta-1,24805,0.102706888412639,0.0050452618920751,0.092818175104172,0.112595601721106,2.24561245179138e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.102664724960249,0.00504671246787867,0.092773168523207,0.112556281397291,2.28520177111009e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0741510078082883,0.00365059204016842,0.0669958474095582,0.0813061682070184,4.17587306499895e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.0880625662611716,0.00433319655914564,0.0795695010052461,0.096555631517097,4.45099804845807e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,24229,0.118210362178056,0.00581815107503971,0.106806786070978,0.129613938285133,5.17002448229333e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.162638216646471,0.0080145390442266,0.146929720119787,0.178346713173155,6.52234314219739e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,24381,0.167996511294363,0.00827410889200232,0.151779257866038,0.184213764722687,6.71975371799246e-91
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK11,Serine/threonine-protein kinase STK11,28916,0.0969859840881522,0.00479405033666183,0.0875896454282951,0.106382322748009,2.23286110697197e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL13,C-X-C motif chemokine 13,29694,0.0807078417033701,0.00399336954621536,0.072880837392788,0.0885348460139522,3.20995749142149e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM1,Isthmin-1,29434,0.0521385747728182,0.00258159173343476,0.047078654975286,0.0571984945703503,4.31285402683636e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,24867,0.10113045451687,0.00500476667441505,0.0913211118350162,0.110939797198723,4.51567732977209e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOK1,Docking protein 1,24845,0.181711981235586,0.00899687504373098,0.164078106149874,0.199345856321299,5.47485953974878e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX15,Sorting nexin-15,24381,0.0719697538813367,0.00356308394283181,0.0649861093533864,0.0789533984092871,5.48387497880635e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GASK1A,Golgi-associated kinase 1A,24111,0.0573717033518818,0.00284033385736707,0.0518046489914423,0.0629387577123212,5.56530863494067e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.0848100971662542,0.0042048919084493,0.0765685090256935,0.0930516853068148,7.60758536744121e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4D,Semaphorin-4D,29694,0.0396644011459351,0.00196797979381115,0.0358071607500652,0.043521641541805,9.73289803216858e-90
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18R1,Interleukin-18 receptor 1,29786,0.0433970330814903,0.00215441349295632,0.0391743826352959,0.0476196835276847,1.22037090963619e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,24951,0.0963769928698592,0.00478147505832309,0.087005301755546,0.105748683984172,1.2270114379095e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",29395,0.144711406018925,0.00719421699266312,0.130610740713305,0.158812071324545,2.18511889925939e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BACH1,Transcription regulator protein BACH1,29434,0.0972265091570307,0.00483701838742017,0.0877459531176872,0.106707065196374,2.90762285805372e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.109896137010363,0.00546914642149022,0.0991766100242421,0.120615663996484,3.31281787946492e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS1BP3,HCLS1-binding protein 3,24240,0.119223440123692,0.00594075695873774,0.107579556484566,0.130867323762817,7.31228299559015e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.105638828806361,0.00526850023151156,0.0953125683525988,0.115965089260124,9.95795433508384e-89
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP2,Methionine aminopeptidase 2,29674,0.0755769473429414,0.00377337307500601,0.0681811361159296,0.0829727585699532,1.18811800198921e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZI2,5-azacytidine-induced protein 2,24867,0.0729084200194935,0.00363943953352593,0.0657751185337827,0.0800417215052043,1.42580793699239e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AREG,Amphiregulin,29349,-0.0601828996928581,0.00300665760695078,-0.0660759486024817,-0.0542898507832346,1.54361145856425e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR4,Complement factor H-related protein 4,24892,0.096752910145452,0.00483230293185938,0.0872815963990076,0.106224223891896,1.76069211916631e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM13A,Protein FAM13A,24805,0.088987771713287,0.00444973586975627,0.0802662894085647,0.0977092540180093,2.82529162604276e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.100134022600508,0.00501131320534544,0.0903118487180314,0.109956196482986,3.16188111299139e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.0395312915966906,0.00197864112390047,0.0356531549938456,0.0434094281995355,3.27554471926639e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAXX,Protein PAXX,24381,0.0603020288133945,0.00301728756064708,0.0543881451945263,0.0662159124322628,3.74780558792255e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRAP,BRCA1-associated protein,24565,0.14423314924177,0.00721846949712895,0.130084949027398,0.158381349456143,4.0370342518193e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.104174685203084,0.0052148038243747,0.0939536697073094,0.114395700698858,4.31857557561467e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEXIM1,Protein HEXIM1,29434,0.106472205256214,0.00533335570893236,0.0960188280667061,0.116925582445721,4.39250288954923e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRADD,Death domain-containing protein CRADD,29163,0.0994240028004588,0.00498102015661581,0.0896612032934918,0.109186802307426,4.7078458716108e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT2,Omega-amidase NIT2,24813,0.0977416747586292,0.00489951100879163,0.0881386331813976,0.107344716335861,7.4411815229745e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.0364035905917913,0.00182671966855963,0.0328232200414144,0.0399839611421682,8.76441628575811e-88
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTBS,Di-N-acetylchitobiase,24653,0.0357805781875517,0.00179558863002544,0.0322612244727018,0.0392999319024015,1.16650658931378e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD1,COMM domain-containing protein 1,24240,0.0804071021240371,0.00403503833891556,0.0724984269797627,0.0883157772683116,1.19150448743504e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TWF2,Twinfilin-2,24938,0.109941365302174,0.00552021565481291,0.0991217426187406,0.120760987985607,1.41667001881062e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.100335040755911,0.00504400927894874,0.0904487825691713,0.11022129894265,1.80603677774856e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNMBP,Dynamin-binding protein,29218,0.0798892053507221,0.00401779239033971,0.0720143322656562,0.0877640784357879,2.12914427761602e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP43,Centrosomal protein 43,28705,0.0909813079677522,0.00457595296921464,0.0820124401480915,0.0999501757874129,2.23967131954662e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAMBP,STAM-binding protein,29163,0.0835340219430963,0.00420172922630802,0.0752986326595326,0.09176941122666,2.26366255124173e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2AP,CD2-associated protein,29478,0.0828722274007828,0.00417263934265123,0.0746938542891864,0.0910506005123792,3.30698683571735e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.0874997182563787,0.00440533814462847,0.0788652554929069,0.0961341810198505,3.32567442411837e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0493136219499018,0.00248283273127509,0.0444472697966026,0.054179974103201,3.34598606973759e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9,Complement component C9,24951,-0.0695194715478098,0.00350304367035442,-0.0763854371417045,-0.0626535059539152,5.66543609443592e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD5,Programmed cell death protein 5,29694,0.0753370089923156,0.00380098070689468,0.067887086806802,0.0827869311778292,7.24734328234285e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.0914612581482784,0.00461459171024488,0.0824166583961985,0.100505857900358,7.55638925998675e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGLAP,Osteocalcin,24938,0.115704170063553,0.00583655220541928,0.104264527740931,0.127143812386174,8.61792996130624e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.124855771895995,0.00630160893982597,0.112504618373936,0.137206925418054,8.62179315449161e-87
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.158482368418469,0.00800734081830298,-0.174176756422343,-0.142787980414595,1.25780116376901e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYTL4,Synaptotagmin-like protein 4,24922,0.0950324116852205,0.0048009212862336,0.0856226059642027,0.104442217406238,1.53398676532519e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0295832168045449,0.00149925481057716,0.0266446773758137,0.0325217562332762,4.12505691338956e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPART,Spartin,24381,0.100710776318898,0.00510129645098577,0.0907122352749659,0.11070931736283,4.41136713399204e-86
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,29581,0.167566791817886,0.00853298169877149,0.150842147688294,0.184291435947478,2.58686760897412e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGLL,Monoglyceride lipase,29536,0.111703669890047,0.00569692932540226,0.100537688412259,0.122869651367836,4.62707174447793e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAG1,Dystroglycan,29581,0.0610719869081623,0.00311492669911771,0.0549667305778916,0.067177243238433,4.75130768372851e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,28916,0.0975228538700521,0.00497783020727351,0.0877663066637961,0.107279401076308,6.51276949138022e-85
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.0992851207791811,0.00507107063118893,0.0893458223420508,0.109224419216311,1.01865396444069e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LG,CMRF35-like molecule 9,29443,-0.0482547458681032,0.00246712097515009,-0.0530903029793974,-0.043419188756809,1.1906840164498e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNST,Consortin,29478,0.13913292389875,0.00711562698997753,0.125186294998394,0.153079552799106,1.33490175054645e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPC,C-type natriuretic peptide,29434,0.0614738326023862,0.00314415472052739,0.0553112893501525,0.0676363758546199,1.37319346993398e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYN,Tyrosine-protein kinase Lyn,29349,0.108446577944734,0.00554716724968622,0.0975741301353495,0.119319025754119,1.42917217359883e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.110539630698686,0.00565052845772218,0.0994645949215502,0.121614666475821,1.43824042192056e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAX,Protein max,28774,0.135032223591713,0.00691480409911106,0.121479207557456,0.148585239625971,2.23741993853983e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYDGF,Myeloid-derived growth factor,24922,0.128392102799072,0.00657828221666775,0.115498669654403,0.14128553594374,3.31674513686623e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLMH,Bleomycin hydrolase,29820,0.0407350087176548,0.00209114633535033,0.0366363619003682,0.0448336555349415,5.43531822004769e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1R,Complement C1r subcomponent,24966,0.0249394571440369,0.00128006932766897,0.0224305212618058,0.0274483930262681,6.45116135190277e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIFBP,KIF-binding protein,29349,0.105474421164229,0.00541973376758008,0.0948517429797725,0.116097099348686,7.92448525325977e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGFR,Opioid growth factor receptor,29349,0.0418198233865536,0.00214983349128648,0.0376061497436321,0.0460334970294751,9.35091988646728e-84
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM17,Splicing factor 45,24867,0.0980487286772421,0.0050395512034354,0.0881712083185087,0.107926249035975,1.09138008558349e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0787451518637513,0.00404911931939357,0.0708088779977399,0.0866814257297627,1.32962351621792e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNLR1,Interferon lambda receptor 1,29434,0.0473257878232213,0.00243584067575085,0.0425515400987497,0.052100035547693,1.4690304634362e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",28916,0.118693542297499,0.006110440167965,0.106717079568288,0.130670005026711,1.62778430492407e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.0605671022568811,0.00311839914532046,0.054455039932053,0.0666791645817092,1.68553999206145e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP5,Fatty acid-binding protein 5,29624,0.0867636352260194,0.00446838530632775,0.078005600025617,0.0955216704264218,1.82597192525828e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,A1BG,Alpha-1B-glycoprotein,24966,0.0218981221154696,0.0011274019364608,0.0196884143200064,0.0241078299109328,2.01842941941745e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE4,Ribonuclease 4,24194,0.0351188664366951,0.00181340047578606,0.0315646015041544,0.0386731313692358,6.31471043524001e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",28774,0.0671928380773934,0.00347292268571123,0.0603859096133994,0.0739997665413874,7.18578079809007e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0660600653072046,0.00341632537035427,0.0593640675813102,0.072756063033099,8.6075269875542e-83
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF2,TNF receptor-associated factor 2,29434,0.0892224970011341,0.00462472171168398,0.0801580424462335,0.0982869515560347,2.00761517439444e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUOM,Fucose mutarotase,24381,0.0809240116103057,0.0041997747945276,0.0726924530130316,0.0891555702075798,4.02349719355199e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.114591529159587,0.00594923972052039,0.102931019307367,0.126252039011807,4.64703445466966e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMVK,Phosphomevalonate kinase,28757,0.138688330773435,0.00721553875623829,0.124545874811208,0.152830786735662,8.09788135675822e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK13,Kallikrein-13,28845,0.0557285710839693,0.00289961442398681,0.0500453268129551,0.0614118153549834,8.29980641852758e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM5,Tripartite motif-containing protein 5,29434,0.108394228057865,0.0056417838977542,0.0973363316182668,0.119452124497463,9.18323621687766e-82
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAT,Linker for activation of T-cells family member 1,29786,0.0953488193799284,0.0049706483590436,0.0856063485962029,0.105091290163654,1.61452115510386e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EREG,Proepiregulin,29163,0.10116506095492,0.00527667527759163,0.0908227774108402,0.111507344498999,2.00910951740005e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HJV,Hemojuvelin,24867,0.0559519007571115,0.00291693861264255,0.0502347010763321,0.0616691004378909,2.0412963196978e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD22,B-cell receptor CD22,29786,0.052695179376422,0.00275071232730569,0.0473037832149028,0.0580865755379411,2.61758362398679e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD36,Platelet glycoprotein 4,24229,0.057288718753524,0.00298976298203276,0.0514287833087397,0.0631486541983082,3.0940116167505e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7,Interleukin-7,29434,0.0811084218622643,0.00423579720740653,0.0728062593357475,0.0894105843887811,3.12266621475602e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPPB,Natriuretic peptides B,28916,-0.168902079952256,0.00882142061634652,-0.186192064360295,-0.151612095544217,3.27928283205538e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.0851464928627316,0.00445002013852556,0.0764244533912215,0.0938685323342417,5.04178110242016e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.0909436636641771,0.00475387410480035,0.0816260704187684,0.100261256909586,5.4106607108459e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDF15,Growth/differentiation factor 15,29820,-0.055867784492895,0.00292325217602226,-0.0615973587578987,-0.0501382102278914,6.18133276565573e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA2,Integrin alpha-2,24381,0.0432805729653869,0.00226379210883649,0.0388435404320674,0.0477176054987065,6.9179583375564e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0417650144237999,0.00218509115168697,0.0374822357664934,0.0460477930811063,7.83368282373802e-81
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.184253461556671,0.00966883056452495,0.165302553650202,0.20320436946314,2.18425476294754e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,28797,0.114803340750144,0.00602762956482205,0.102989186803093,0.126617494697195,2.20905540617692e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FIS1,Mitochondrial fission 1 protein,29453,0.0964789388600444,0.00506640488665832,0.0865487852821941,0.106409092437895,2.29264111110467e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS1,Galectin-1,29478,0.0428799716299023,0.00225315751810408,0.0384637828944183,0.0472961603653863,2.86248624064529e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPI,Mannose-6-phosphate isomerase,29349,0.106933741934039,0.00562805416891044,0.0959027557629747,0.117964728105104,5.15078194157617e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST13,Hsc70-interacting protein,24381,0.0699374918128505,0.00368248425839414,0.062719822666398,0.077155160959303,7.51278260075511e-80
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2,Complement C2,29545,0.0291355587875537,0.00153633236971587,0.0261243473429106,0.0321467702321968,1.00188685298492e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH2,Neutral ceramidase,29218,0.066019875279971,0.00348255869696116,0.0591940602339271,0.0728456903260148,1.15810803137569e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.130579947610715,0.00689243939938575,0.117070766387919,0.144089128833511,1.44323121821275e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0701849309575909,0.00371279025970167,0.0629078620485757,0.0774619998666062,3.15712469222167e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,29566,0.0302360510782189,0.00159956340400352,0.027100906806372,0.0333711953500658,3.18335657742667e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.13912248584582,0.00735959826122842,0.124697673253812,0.153547298437828,3.22645109300027e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL24,C-C motif chemokine 24,29536,0.10289864347941,0.0054451595853235,0.0922261306921758,0.113571156266644,3.52733197948721e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.0785629275909422,0.00416059383084827,0.0704081636824795,0.0867176914994048,5.67243140010915e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDC,Nuclear migration protein nudC,29786,0.078505249370494,0.0041634051894763,0.0703449751991204,0.0866655235418675,7.56211567217824e-79
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MME,Neprilysin,29349,0.0994641636448519,0.00528008533686231,0.0891151963846018,0.109813130905102,1.08336624433443e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,29594,0.0568535119766203,0.00302303314691387,0.0509283670086691,0.0627786569445715,1.9083978114801e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASC3,Protein CASC3,24195,0.0520694816585371,0.00276753896417007,0.0466451052887637,0.0574938580283104,2.09281410797741e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR5,Complement factor H-related protein 5,24623,0.0518478628179361,0.00275706367114091,0.0464440180224999,0.0572517076133723,2.41511820111041e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GLB2,Endophilin-B2,24845,0.0824245001056128,0.00438354990940568,0.0738327422831777,0.0910162579280479,2.49369829546302e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.104422303231842,0.00556081536390339,0.093523105118591,0.115321501345092,3.27554322789546e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.133695765713286,0.00713198308990043,0.119717078857081,0.14767445256949,7.68294668111455e-78
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EHD3,EH domain-containing protein 3,24240,0.14498746998905,0.00774120198785673,0.129814714092851,0.160160225885249,1.01152605697729e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICA1,Islet cell autoantigen 1,28931,0.0979316865247281,0.00523323761665822,0.0876745407960779,0.108188832253378,1.10871802613061e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FETUB,Fetuin-B,29545,0.0406314955081487,0.00217139552887006,0.0363755602715634,0.044887430744734,1.11014074344323e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.122864247371073,0.00657278467046836,0.109981589416955,0.135746905325191,1.59322373656906e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0582166013559278,0.00311584611665776,0.0521095429672786,0.064323659744577,2.27169381959792e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0400504211439757,0.00214489311580575,0.0358464306369964,0.044254411650955,2.33224185377662e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.067561329476679,0.00361820544351904,0.0604696468073817,0.0746530121459763,2.38526066919649e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,29218,0.0974365428191165,0.00521969506138653,0.0872059404987989,0.107667145139434,2.58729619499455e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F12,Coagulation factor XII,24966,0.0512030758646611,0.00274285332497089,0.0458270833477182,0.0565790683816041,3.04181103277069e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.0852724325491537,0.00457141038730089,0.076312468190044,0.0942323969082635,4.11244790307106e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC1,Stanniocalcin-1,29694,0.0532166658437578,0.00285678040569699,0.0476173762485917,0.0588159554389239,5.22328588223384e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.119910380825223,0.00643706940788542,0.107293724785768,0.132527036864678,6.36445994538041e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.0901783096905954,0.00484077983871256,0.0806903812067188,0.099666238174472,6.46408016408385e-77
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0453218047811139,0.0024361571804464,0.0405469367074389,0.0500966728547888,1.01824484002747e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAT2,Signal transducer and activator of transcription 2,24229,0.0951666340107463,0.00511891258051567,0.0851335653529356,0.105199702668557,1.2942134707661e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QDPR,Dihydropteridine reductase,29345,0.0526585207137525,0.00283429890678115,0.0471032948564615,0.0582137465710436,1.30880542617623e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RWDD1,RWD domain-containing protein 1,29694,0.0774024012485365,0.00417208471910778,0.0692251151990852,0.0855796872979877,2.10949404966784e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.0762566855477404,0.00411087031799339,0.0681993797244733,0.0843139913710074,2.77272885587537e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASHC3,WASH complex subunit 3,24845,0.0921487459387756,0.00497077028259583,0.0824060361848878,0.101891455692663,3.32693542598002e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0836118660193148,0.00451577063538588,0.0747609555739585,0.0924627764646711,5.2162012833508e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGA,Protein O-GlcNAcase,24805,0.0862263550118668,0.00466205446603122,0.0770887282584456,0.095363981765288,7.2958316153206e-76
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FST,Follistatin,29536,0.0613489064600741,0.0033229708221387,0.0548358836486822,0.067861929271466,1.11356181240646e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0644899014638064,0.00349470491380192,0.0576402798327546,0.0713395230948581,1.56485475941451e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPP,Lipoma-preferred partner,24111,0.0810931730702087,0.00439547711162308,0.0724780379314275,0.0897083082089899,1.75216167812891e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRAP2,GRB2-related adapter protein 2,29478,0.154971499286326,0.00840741038202388,0.138492974937559,0.171450023635093,1.90807508464497e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.126483765910615,0.00686267421539047,0.113032924448449,0.13993460737278,1.98360517516018e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0612993458222626,0.00332894168768716,0.0547746201143958,0.0678240715301294,3.19889192700548e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS8,Galectin-8,29694,0.073367858848084,0.00398655417671911,0.0655542126617145,0.0811815050344535,3.21176578943545e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,29478,0.0966482134532247,0.00525149650041473,0.0863552803124119,0.106941146594038,3.22795082413159e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAD,Chondroadherin,24381,0.0629951960532925,0.00342200439556143,0.0562880674379921,0.0697023246685929,3.6097622401852e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAM1,Vascular cell adhesion protein 1,29545,-0.0330876660891371,0.00179907350872616,-0.0366138501662403,-0.0295614820120338,4.04101391614047e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAV,Integrin alpha-V,29725,0.020093349784021,0.00109293836297863,0.0179511905925829,0.0222355089754592,4.54776886159117e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN3,Centrin-3,24805,0.0940976296726783,0.00511613515026272,0.0840700047781634,0.104125254567193,4.78133759077116e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB27B,Ras-related protein Rab-27B,24922,0.0995400605821231,0.00541365042816682,0.0889293057429161,0.11015081542133,5.2527308257881e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.120409389619951,0.00654882395009731,0.10757369467776,0.133245084562142,5.50452329948038e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC27,Cell division cycle protein 27 homolog,28797,0.0733868911343363,0.00399883224103549,0.0655491799419067,0.0812246023267658,8.49440369001412e-75
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP1,Syntaxin-binding protein 1,24867,0.0938315665267197,0.00511544153334411,0.0838053011213653,0.103857831932074,1.17266352775204e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEP,Leptin,29478,0.0808000293379388,0.00441803864205768,0.0721406735995057,0.0894593850763718,2.6283940343875e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.104175161915398,0.00569619998416991,0.0930106099464249,0.115339713884371,3.14652912074591e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.0570053533652541,0.00311731208926214,0.0508954216703003,0.0631152850602078,3.31718616027413e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.0596598989318506,0.003264792661238,0.0532609053158241,0.0660588925478771,4.17967306596897e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,24229,0.0596794781648607,0.00326957254175535,0.0532711159830202,0.0660878403467011,6.13980898651278e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0568553781968136,0.00311876334879878,0.050742602033168,0.0629681543604592,9.01550216918932e-74
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF19,Fibroblast growth factor 19,29581,0.0920279336943602,0.00506720039674978,0.0820962209167307,0.10195964647199,2.60989935387687e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLG4,Disks large homolog 4,24845,0.0849794906291793,0.00468053333914995,0.0758056452844454,0.0941533359739132,3.43084893536121e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.105442652255191,0.00581335717661714,0.094048472189021,0.11683683232136,4.01303382651782e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.117053647622226,0.0064600570695957,0.104391935765818,0.129715359478633,5.68496669052981e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.101917948281623,0.00562495731541957,0.0908930319434004,0.112942864619845,6.66725616938155e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.0591213589688722,0.00326402993138103,0.0527238603033654,0.065518857634379,7.56974520921897e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF21,Fibroblast growth factor 21,29674,0.14103784741727,0.0077923417363634,0.125764857613998,0.156310837220542,7.93009179391915e-73
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNAP25,Synaptosomal-associated protein 25,24101,0.056540151079124,0.00312487785674711,0.0504153904798996,0.0626649116783483,1.08601328926293e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAX1BP1,Tax1-binding protein 1,24845,0.0753170722721104,0.00416442964982148,0.0671547901584603,0.0834793543857606,1.2072307777166e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,29820,0.0796174495374104,0.00440667849154363,0.0709803596939849,0.0882545393808359,1.40426543554737e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED8,Protein TMED8,24805,0.12262792466723,0.00678572264321483,0.109327908286529,0.135927941047931,1.56331155644742e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.112754110185642,0.00624391492373459,0.100516036935122,0.124992183436162,1.67398999486778e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NIT1,Deaminated glutathione amidase,24240,0.0563691755680916,0.00312049063574692,0.0502530139220276,0.0624853372141555,1.82467089155198e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0726428672592534,0.00402558430288038,0.0647527220256078,0.0805330124928989,2.10431054902536e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGRN,Agrin,29581,0.0408408633681099,0.00226359224499685,0.036404222567916,0.0452775041683037,2.21138453309007e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0555678189691997,0.00307935717169049,0.0495322789126863,0.061603359025713,2.49286289803517e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C3,Complement C3,23779,0.055430661647777,0.0030720216336668,0.0494094992457901,0.0614518240497639,2.68741477491788e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,24793,0.0655772674837344,0.00363522053295666,0.0584522352391394,0.0727022997283295,2.77342588084989e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMN,Protein amnionless,28931,0.0562672616752214,0.003122709340346,0.0501467513681432,0.0623877719822995,3.45104694292142e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS4,Galectin-4,29454,-0.0645930958072247,0.00358904055746455,-0.0716276152998552,-0.0575585763145941,4.97912240153688e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.111513131722169,0.00619935846741791,0.0993623891260296,0.123663874318308,5.91434658722573e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUGT1,Protein SGT1 homolog,28797,0.0954012728202517,0.00530448659981831,0.0850044790846078,0.105798066555896,6.32761659052054e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0307633654448556,0.00170999780631921,0.02741176974447,0.0341149611452413,6.61297490552347e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.0873033558914914,0.00485458633486507,0.0777883666751558,0.0968183451078269,7.60537107265993e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP2B,DNA topoisomerase 2-beta,24229,0.0944668290495903,0.00525686180241729,0.0841633799168525,0.104770278182328,9.76075398799867e-72
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEXN,Nexilin,24951,0.0816203871522625,0.00454485527347845,0.0727124708162448,0.0905283034882803,1.15803463985915e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0683339245714168,0.00381181817567841,0.0608627609470871,0.0758050881957465,1.78285603080403e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NSFL1C,NSFL1 cofactor p47,29694,0.0766016024019123,0.00427400114935879,0.0682245601491691,0.0849786446546555,1.8691003220089e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.120883559640864,0.00674298867196486,0.107667301843813,0.134099817437915,2.09070138726887e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1B,Meprin A subunit beta,29478,0.137766503911285,0.00769258657083271,0.122689034232452,0.152843973590117,2.39945000728465e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.0891337436712766,0.00497859103208241,0.0793757052483951,0.0988917820941581,2.66383973626014e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRY2,Protein sprouty homolog 2,28931,0.108672101556501,0.00608013563700535,0.0967550357079709,0.120589167405032,4.59601648994673e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.0853054839210796,0.00477194496218244,0.0759524717952021,0.0946584960469572,5.15730904635046e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0604462060120079,0.0033840372922287,0.0538134929192397,0.0670789191047762,6.47748338657321e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANG,Angiogenin,29435,0.0396127731799839,0.00221886849313056,0.035263790933448,0.0439617554265198,6.52450647264801e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBXN1,UBX domain-containing protein 1,24381,0.0812905941212892,0.00455315659856168,0.0723664071881083,0.09021478105447,7.65554014273648e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.103067858370311,0.00577746578260483,0.0917440254364057,0.114391691304217,8.23717292309228e-71
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0329027301014425,0.0018474598648987,0.0292817087662411,0.036523751436644,1.39412044911041e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSB,Arylsulfatase B,29349,0.0646351960643008,0.00363086487437214,0.0575187009105314,0.0717516912180702,1.61508705957646e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YJU2,Splicing factor YJU2,24793,0.0381348460080548,0.00214134023361433,0.0339378191501707,0.0423318728659389,1.66041528055316e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.084731596326951,0.00476045278136914,0.0754011088754674,0.0940620837784345,1.6849312269198e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKA,Diacylglycerol kinase alpha,24229,0.0643810591892472,0.00361573303809702,0.057294222434577,0.0714678959439173,1.79383297349112e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFB2,BPI fold-containing family B member 2,24852,0.0762143408414034,0.00428069381644386,0.0678241809611734,0.0846045007216333,1.79852565397444e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0680118501442045,0.00382022800304943,0.0605242032582276,0.0754994970301814,1.88209216649915e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLGA3,Golgin subfamily A member 3,24867,0.0914211616034213,0.00514341792889927,0.0813400624627788,0.101502260744064,3.03901321183584e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.0907001984592245,0.00511904581125526,0.0806668686691642,0.100733528249285,7.13945724280577e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH9,Protocadherin-9,24805,0.0395944029639073,0.00223489553558838,0.0352140077141541,0.0439747982136605,8.43799403144556e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOLM2,Protein GOLM2,29694,0.0263204069249163,0.00148657622087417,0.0234067175320029,0.0292340963178296,8.71443670391283e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.099748347116535,0.00563233141265539,0.0887089775477305,0.11078771668534,9.61827222954649e-70
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0357589282005653,0.00202099669375992,-0.0397200817203348,-0.0317977746807959,1.27882354293209e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53,Cellular tumor antigen p53,28797,0.0507623380238098,0.00287300660753782,0.0451312450730357,0.0563934309745839,1.7017389863898e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0517375234817363,0.00293078589948088,0.0459931831187537,0.0574818638447188,2.23660077183505e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH2,Cadherin-2,29478,0.0411167651939773,0.00232940760737731,0.0365511262835178,0.0456824041044368,2.27019545388199e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP7,Caspase-7,24845,0.0979075738125915,0.0055443542188652,0.0870406395436157,0.108774508081567,2.30652933458286e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPT,Dermatopontin,29820,0.0305739781474624,0.00173495053868211,0.0271734750916454,0.0339744812032793,3.72240389955374e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB9,Serpin B9,29218,0.0385106458755574,0.00218622382803634,0.0342256471726062,0.0427956445785087,4.2960281878373e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.0894056500908309,0.00507566649665681,0.0794573437573836,0.0993539564242783,4.31274200225575e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,29218,0.0344953458839526,0.00196002973438013,0.0306536876045675,0.0383370041633376,5.65684559907512e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,24381,0.138148181464759,0.0078509441373957,0.122760330955464,0.153536031974055,7.00833268407226e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.040374649969385,0.00229700653446756,-0.0448767827769415,-0.0358725171618286,8.27417967848232e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.102635495289782,0.00583854487839873,0.0911919473281209,0.114079043251444,9.29674437392558e-69
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP5,Platelet glycoprotein V,24381,0.0419112994947852,0.00238918471749091,0.037228497448503,0.0465941015410674,1.80285290896276e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BIN2,Bridging integrator 2,29443,0.103741197969828,0.00592260075506067,0.092132900489909,0.115349495449747,2.39918446240035e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MESD,LRP chaperone MESD,29443,0.13975913112319,0.00798409815005219,0.124110298749088,0.155407963497293,2.9286576409552e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2L,Ataxin-2-like protein,24867,0.0556253886276184,0.00317640729776973,0.0493996303239898,0.0618511469312471,2.98158377516437e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,29169,0.0461821411534498,0.0026409606842434,0.0410058582123327,0.0513584240945668,4.02055333924748e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTF1,Cardiotrophin-1,28916,0.0971538497140709,0.00556315592239217,0.0862500641061823,0.10805763532196,6.04139443197112e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0585081201341918,0.00335308933509855,0.0519360650373986,0.0650801752309849,7.83615057828748e-68
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO2,Roundabout homolog 2,29694,0.0265370637170415,0.00152461710334752,0.0235488141944803,0.0295253132396026,1.61719960016931e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0845647520954085,0.0048645189209402,0.0750302950103657,0.0940992091804513,2.41229825624105e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESM1,Endothelial cell-specific molecule 1,29454,-0.0391780934485809,0.00225426842324012,-0.0435964595581316,-0.0347597273390303,2.55901454184963e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATOX1,Copper transport protein ATOX1,29566,0.0816601197811838,0.00469916576643118,0.0724497548789787,0.0908704846833889,2.63833835904357e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA1,Ephrin type-A receptor 1,29536,0.0380405968833424,0.00218923093838104,0.0337497042441155,0.0423314895225692,2.70218544835633e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,24805,0.066963736259276,0.00385572333663985,0.0594065185194619,0.0745209539990901,3.64383872579972e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTX3,Pentraxin-related protein PTX3,29434,-0.05651020706811,0.00325558858367302,-0.0628911606921091,-0.0501292534441109,3.71677913314204e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.098431503291588,0.00567127053347591,0.0873158130459752,0.109547193537201,3.82006904660905e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD69,Early activation antigen CD69,29344,0.100189128082907,0.00577250702602279,0.0888750143119021,0.111503241853911,3.8329275900371e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGF,Pro-epidermal growth factor,29379,0.117851905467881,0.00679176039578375,0.104540055092144,0.131163755843617,4.10774165565535e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0452489264186463,0.00260792206985934,0.040137399161722,0.0503604536755706,4.21589259770372e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0510613654327414,0.00294652418859438,0.0452861780230964,0.0568365528423863,6.09136244538175e-67
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,24867,0.0691595465729644,0.00400445285411666,0.0613108189788957,0.077008274167033,1.91254523112403e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.0964090349942974,0.00558529753268831,0.0854618518302283,0.107356218158366,1.99200959645702e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCB,Tubulin-folding cofactor B,29218,0.114161761902687,0.00662034982940222,0.101185876237059,0.127137647568316,2.64315175343033e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMPR2,GMP reductase 2,24381,0.0765431861534967,0.00443726692438143,0.0678461429817091,0.0852402293252843,2.76853370714724e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB6,Serpin B6,29623,0.067148413814856,0.00389505641552114,0.0595141032404346,0.0747827243892774,2.8341217587636e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACYBP,Calcyclin-binding protein,24329,0.117206882752772,0.00679769169834891,0.103883407024008,0.130530358481536,3.17578496945457e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,29443,0.0579527731962663,0.00336786240275758,0.0513517628868614,0.0645537835056711,4.90624259836621e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0380206692247353,0.00221122310048489,0.033686671947785,0.0423546665016857,6.12628381234456e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0569159091306844,0.00330845376504178,0.0504313397512025,0.0634004785101663,6.22242388626665e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0659302577850073,0.00383549454969512,0.0584126884676048,0.0734478271024097,7.78505637670999e-66
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2,Microtubule-associated protein 2,24845,0.052396011917592,0.00305197829065556,0.0464141344679071,0.0583778893672769,1.10664897117744e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0650985179079326,0.00379349626654551,0.0576632652255034,0.0725337705903618,1.11694940825872e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0640686404914455,0.00373427053297053,0.0567494702468233,0.0713878107360678,1.16461532003285e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.108405427600518,0.0063202590281453,0.0960177199053528,0.120793135295682,1.26595726901889e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.126001579633366,0.00735436368708709,0.111587026806676,0.140416132460057,1.74824193055177e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD2,Polycystin-2,24111,0.0668386039441713,0.00390392436630117,0.059186912186221,0.0744902957021216,2.52604307131026e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.134387422858729,0.00785829163086263,0.118985171262239,0.14978967445522,2.98894163883377e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.0881898715376532,0.00516169767373735,0.078072944097128,0.0983067989781784,3.95152621896691e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0762979246977619,0.00446790455664573,0.0675408317667363,0.0850550176287875,4.50567994623775e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD226,CD226 antigen,24229,0.0475705055390991,0.00278535093208612,0.0421112177122103,0.0530297933659879,5.131203502598e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.110492698976631,0.00648235393275108,0.0977872852684385,0.123198112684823,7.7579256241988e-65
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CERT,Ceramide transfer protein,28774,0.0688645034110571,0.00404434564864494,0.060937585939713,0.0767914208824012,1.06914833829585e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POMC,Pro-opiomelanocortin,24240,0.0794690319900888,0.00466612543516529,0.0703234261371648,0.0886146378430128,1.15037456442718e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0746859435094992,0.0043912874810223,0.0660790200466955,0.0832928669723029,1.69229247696471e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRAS,Ras-related protein R-Ras,24195,0.146793042467507,0.00863564336168371,0.129867181478607,0.163718903456407,1.99529033655963e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB1,Heat shock protein beta-1,29039,0.0769139734042291,0.0045283498531637,0.0680384076920282,0.0857895391164299,2.17283207802711e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0633955413014654,0.00373472543767883,0.0560754794436148,0.0707156031593159,2.54797578519906e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.141802539134199,0.00834987746839522,0.125436779296144,0.158168298972254,2.54954552478688e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.0753278034594786,0.00444212114589118,0.0666212460135319,0.0840343609054253,3.94591634152187e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D5,TBC1 domain family member 5,29434,0.0870727784081808,0.00514160309144066,0.0769952363489571,0.0971503204674045,5.00209276423434e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PENK,Proenkephalin-A,24381,0.0345886077092128,0.00204164102852666,0.0305869912933005,0.0385902241251251,5.1678587524217e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL18,C-C motif chemokine 18,29166,0.0783330553718197,0.00462812325063724,0.0692619338005708,0.0874041769430687,5.90660974615111e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL8,C-C motif chemokine 8,29683,0.0673657019014083,0.0039812534803305,0.0595624450799606,0.0751689587228561,6.3172043221712e-64
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0260156295197016,0.00154047135566726,0.0229963056625937,0.0290349533768094,1.0961185165132e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.0973136519880806,0.00576564791783054,0.0860129820691328,0.108614321907028,1.49636529315449e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,29386,0.0715795293490933,0.00426349390572618,0.0632230812938699,0.0799359774043166,5.78543625880895e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.115514734709777,0.00687967885171097,0.102030564160423,0.12899890525913,6.44717301023497e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXJ3,Forkhead box protein J3,24229,0.0492259600961645,0.00293213726247685,0.0434789710617098,0.0549729491306191,6.73227571318082e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.103424275364138,0.00616766279664832,0.0913356562827068,0.115512894445568,9.14137775333593e-63
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.039587123285117,0.00236259806186652,0.0349564310838587,0.0442178154863754,1.00183426258375e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0532353705622539,0.00318070415169853,0.0470011904249248,0.059469550699583,1.5550933518796e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK24,Serine/threonine-protein kinase 24,28774,0.0681676113656143,0.004076384064544,0.060177898599108,0.0761573241321205,1.77226867163228e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0673963666145333,0.00403066950645907,0.0594962543818736,0.0752964788471931,1.79541713789357e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP2,Caspase-2,29434,0.0747100998178399,0.00446860437061693,0.0659516352514307,0.083468564384249,1.85569299630791e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.0745410239192686,0.00446198634893522,0.0657955306753556,0.0832865171631817,2.29344000574973e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTD,Deoxycytidylate deaminase,24381,0.10470957876392,0.00627382086667506,0.0924128898652369,0.117006267662603,3.43876941591692e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.0695190300582759,0.0041699888845729,0.061345851844513,0.0776922082720388,4.1494382992614e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.086192635285789,0.00517352556605991,0.0760525251763116,0.0963327453952664,4.97553905338896e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L1,Bcl-2-like protein 1,24845,0.109655148353963,0.00658027096106929,0.0967578172702667,0.122552479437658,5.18403502319965e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFB,Complement factor B,24538,0.0361450969511137,0.00217008288608316,0.0318917344943907,0.0403984594078367,5.98822125503228e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.0297227355392741,0.00178717951145401,0.0262198636968242,0.0332256073817239,7.94768379662154e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COCH,Cochlin,24922,0.0507699240077413,0.00305339158860316,0.0447852764940791,0.0567545715214035,9.50583844260161e-62
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA4,Protein disulfide-isomerase A4,24938,0.0666316101687886,0.00401074931836162,0.0587705415047998,0.0744926788327773,1.19953752137187e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUB1,NEDD8 ultimate buster 1,29434,0.0914723302311563,0.00551162571859947,0.0806695438227014,0.102275116639611,1.41433112790783e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.103441094079965,0.00623084194056747,0.091228643876453,0.115653544283477,1.46342654124248e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN4,Cerebellin-4,29725,0.0347171874722951,0.00209218065927977,0.0306165133801067,0.0388178615644834,1.46397483189017e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP3R1,Calcineurin subunit B type 1,29218,0.0447547574531667,0.00269798139257218,0.0394667139237253,0.0500428009826082,1.62191271906329e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.131380773266364,0.00792150535744859,0.115854622765764,0.146906923766963,1.69358365476569e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0359409661689273,0.00216745403014538,0.0316927562698423,0.0401891760680122,1.77469568300612e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.132423672988524,0.00798922810872436,0.116764785895424,0.148082560081624,1.99882301598428e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSTN,Growth/differentiation factor 8,28916,0.0574599285401153,0.00346794080308822,0.0506627645660624,0.0642570925141682,2.24619289112978e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARA5,Scavenger receptor class A member 5,29694,0.0328281984512031,0.00198144930813768,0.0289445578072533,0.036711839095153,2.24940793209752e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0341599719019874,0.00206184110316804,-0.0382011804641967,-0.030118763339778,2.25832476299341e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.117844969775848,0.00711606012902553,0.103897491922958,0.131792447628738,2.87548725532858e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASPN,Asporin,24922,0.0300634613438073,0.00181867757107839,0.0264988533044936,0.0336280693831209,4.6903737292216e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTDH,Protein LYRIC,24229,0.101735545994371,0.00615400374302512,0.0896736986580417,0.1137973933307,4.69739890179266e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QA,Complement C1q subcomponent subunit A,29646,-0.0247045578079531,0.00149562511826257,-0.0276359830397477,-0.0217731325761584,5.11626782173808e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACTB2,Endoribonuclease LACTB2,29478,0.0717126746954903,0.00434304629315121,0.0632003039609139,0.0802250454300666,5.64889910046601e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GMFG,Glia maturation factor gamma,24922,0.0781537022234715,0.00473690796441902,0.0688693626132102,0.0874380418337328,7.86279345930229e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0410707610626742,0.00249038369006142,0.0361896090301538,0.0459519130951946,7.89300123941455e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL16,C-X-C motif chemokine 16,29786,0.0255815174000786,0.00155180544977643,0.0225399787185168,0.0286230560816404,8.75010319225819e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YWHAQ,14-3-3 protein theta,24381,0.0805211957887681,0.00488341178624419,0.0709497086877294,0.0900926828898067,9.4404357092901e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAG6,Large proline-rich protein BAG6,28916,0.0395410883784435,0.0023991800474209,0.0348386954854985,0.0442434812713884,9.50545004600076e-61
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD207,C-type lectin domain family 4 member K,28835,0.0419547957110787,0.00254747112068119,0.0369617523145436,0.0469478391076138,1.15701329658544e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.06649964628197,0.0040390539218199,0.058583100595203,0.074416191968737,1.41867994195812e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THTPA,Thiamine-triphosphatase,24755,0.095772360197863,0.00581855272885764,0.084367996849302,0.107176723546424,1.49716042625055e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0731029334036854,0.00444391373586947,0.0643928624813812,0.0818130043259895,1.58212780586536e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0796526549775693,0.00485690983686523,0.0701331116973134,0.0891721982578251,3.96230250685366e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.076416741248326,0.00466596488324987,0.0672714500771562,0.0855620324194957,5.098194534654e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.0822396413810724,0.00502404644201235,0.0723925103547282,0.0920867724074166,5.83369513083793e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RP2,Protein XRP2,29349,0.0451615550231423,0.00276048396744942,0.0397510064469415,0.0505721035993432,6.80120486799414e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM106A,Transmembrane protein 106A,24793,0.0764068942003929,0.00466910739737994,0.0672554437015282,0.0855583446992576,7.08723609363919e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0495966648980967,0.00303282383756874,0.043652330176462,0.0555409996197314,7.57197957113253e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN9,Septin-9,29349,0.0306159297583949,0.0018730595220288,0.0269447330952185,0.0342871264215714,8.62438855467336e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,24240,0.061004384976937,0.00373042803630032,0.0536927460257884,0.0683160239280856,8.63605559188975e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIAPIN1,Anamorsin,29566,0.0674355681154843,0.00412656739034154,0.0593474960304149,0.0755236402005537,9.10438304051483e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TALDO1,Transaldolase,24888,0.048028310379875,0.00293804069056309,0.0422697506263713,0.0537868701333786,9.35974359083802e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,29581,0.0941367996396734,0.00576182417388317,0.0828436242588624,0.105429975020484,9.67942730023984e-60
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.0886957211668785,0.00543375777156856,0.0780455559346042,0.0993458863991529,1.25384906661231e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.07433368846072,0.00455848667909632,0.0653990545696912,0.0832683223517487,1.83862950964228e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0352512538636096,0.00216201693214737,0.0310137006766007,0.0394888070506184,1.85509356312432e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0575070598264705,0.00352984892257047,0.0505885559382324,0.0644255637147086,2.06409322810149e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,24805,0.105657123877184,0.00648837830149539,0.0929399024062528,0.118374345348115,2.6036686610278e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.106836847830583,0.006565458941935,0.0939685483043899,0.119705147356775,3.12984148937272e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0299488758575363,0.00184166143181944,0.0263392194511702,0.0335585322639024,3.34246544090201e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.0875389762334923,0.00538380099646017,0.0769867262804304,0.0980912261865542,3.45660085943629e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0549561294187663,0.00338029789183326,-0.0615815132867595,-0.0483307455507732,3.55796316056199e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMT,Catechol O-methyltransferase,28591,0.0901955750506823,0.00555128557051571,0.0793150553324715,0.101076094768893,4.27084002757774e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA13,Carbonic anhydrase 13,29114,0.111645024895875,0.00687249509877264,0.0981749345022811,0.12511511528947,4.39841419699648e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0409510295802592,0.00252256701903163,0.0360067982229572,0.0458952609375612,5.21356698859859e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRG1,Scrapie-responsive protein 1,24922,0.0294813180422944,0.00181624452062798,0.0259214787818636,0.0330411573027253,6.01279964269536e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO9B,Unconventional myosin-IXb,28931,0.0705654199640565,0.00435346795262646,0.0620326227769087,0.0790982171512044,7.91719474940296e-59
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0665070972728767,0.00412616508687568,0.0584198137026003,0.074594380843153,3.34774068045194e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARC,SPARC,29566,0.0744920984682728,0.00463233552604328,0.0654127208372279,0.0835714760993176,6.12193813508438e-58
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,29354,0.0942850267315921,0.00587519565145034,0.0827696432547494,0.105800410208435,1.04030075498525e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0640752290209647,0.00399105474151496,0.0562527617275954,0.071897696314334,1.04807798316713e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0374428793291318,0.00233364148564399,0.0328689420172695,0.042016816640994,1.09286086343821e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0256469254321331,0.00159972056198754,0.0225114731306375,0.0287823777336287,1.33377528062094e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PF4,Platelet factor 4,24822,0.103055188298642,0.00642949179562915,0.0904533843792087,0.115656992218075,1.5721883281658e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,24769,0.092584118687197,0.0057820606322913,0.0812512798479061,0.103916957526488,2.03777780734124e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.0946800063405232,0.00591611339251941,0.0830844240911852,0.106275588589861,2.32534400964651e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AP2B1,AP-2 complex subunit beta,24195,0.0515557677316884,0.00322294119397755,0.0452388029914924,0.0578727324718844,2.66138350804262e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP3,Caspase-3,29820,0.0926237802379953,0.00579443541038735,0.0812666868336362,0.103980873642355,2.81634569824457e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0502079457044615,0.00314055921171043,0.0440524496495091,0.056363441759414,3.03737911433159e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0629982855612772,0.00394308548884441,0.0552698380031421,0.0707267331194122,3.25525608768912e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBR,Delta(14)-sterol reductase LBR,29694,0.0701585580991284,0.0043919798275031,0.0615502776372223,0.0787668385610344,3.34707303214855e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,24805,0.0925161412816689,0.00579225539259071,0.0811633207121912,0.103868961851147,3.83905866201697e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP170,Centrosomal protein of 170 kDa,24240,0.0813933983206663,0.00509628674050839,0.0714046763092698,0.0913821203320627,3.97714353549834e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDRKH,Tudor and KH domain-containing protein,28774,0.089320053913876,0.00559758560127227,0.0783487861353824,0.10029132169237,4.48742824032954e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICALL2,MICAL-like protein 2,24195,0.0720028122218852,0.00451921242349997,0.0631451558718253,0.0808604685719451,7.33154980730453e-57
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRGN,Neurogranin,24951,0.095975508452729,0.00603194978307578,0.0841528868779004,0.107798130027558,1.00833995599152e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0214326013338084,0.00134919079058474,-0.0240770152833545,-0.0187881873842623,1.36938225547705e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0707061675363009,0.00445155516217937,0.0619811194184293,0.0794312156541725,1.41709503080226e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD244,Natural killer cell receptor 2B4,29786,0.0282885496407275,0.00178247959250799,0.0247948896394118,0.0317822096420431,1.7345060329964e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CETN2,Centrin-2,28774,0.0705709090283357,0.00444969540350885,0.0618495060374584,0.0792923120192131,2.08979881192343e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,28797,0.054903961976992,0.00346354890481352,0.0481154061235576,0.0616925178304265,2.36171125018587e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0571346435354665,0.0036050056450395,0.0500688324711891,0.0642004545997439,2.47929761676725e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0268860570988164,0.00169694374428746,0.023560047360013,0.0302120668376199,2.65104393170641e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDHB,Succinate dehydrogenase,24805,0.0719890958189612,0.00454654305209512,0.0630778714368548,0.0809003202010677,3.43064864433888e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.038430312508586,0.00242730528285761,0.0336727941541851,0.0431878308629869,3.49847889222953e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.0962575451101448,0.00608047486809896,0.0843398143686709,0.108175275851619,3.66193385697378e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.045931989567208,0.00290444017961008,0.0402392868151722,0.0516246923192437,4.22358219713468e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBN1,Drebrin,24229,0.0537116835104635,0.00339611870578928,0.0470552908471165,0.0603680761738104,4.63644541390003e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0501130321200781,0.00317183024175171,0.0438962448462448,0.0563298193939115,5.97853546800136e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIA,Melanoma-derived growth regulatory protein,29566,0.0384156358496353,0.00243441257196731,0.0336441872085794,0.0431870844906913,7.19904896322383e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7,Complement component C7,24374,-0.0339274137307868,0.00214997009415845,-0.0381413551153373,-0.0297134723462362,8.02617213845466e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.0642617001259365,0.0040732730408603,0.0562780849658503,0.0722453152860227,8.42550009605551e-56
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP1,Secreted frizzled-related protein 1,29120,0.0450268822341195,0.00285726455378723,0.0394266437086966,0.0506271207595425,1.01721032864972e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,29434,0.0661063392258488,0.00420146880442501,0.0578714603691758,0.0743412180825218,1.48831632399078e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSNL1,Visinin-like protein 1,24845,0.0395587827973603,0.00252371331398529,0.0346123047019491,0.0445052608927714,4.13236198875874e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB1,Beta-crystallin B1,24922,0.0676030939003195,0.00431413791000594,0.0591473835967078,0.0760588042039311,4.43833425725319e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0314707848434643,0.00200899796182106,0.027533148838295,0.0354084208486335,4.83968588094885e-55
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB2B,Ras-related protein Rab-2B,24793,0.0637006145124425,0.00408096999811856,0.0557019133161301,0.0716993157087548,1.14851993395657e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL1,Growth-regulated alpha protein,29420,0.0978617554471857,0.00627471515358028,0.0855633137461684,0.110160197148203,1.27920652874582e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP6,Platelet glycoprotein VI,29400,0.0902381008103047,0.00579632684443729,0.0788773001952076,0.101598901425402,1.9776643616873e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.0825102692603128,0.0052980105430198,0.072126168595994,0.0928943699246316,2.01470061756378e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,24904,0.049254939290355,0.00316660182639714,0.0430483997106166,0.0554614788700934,2.67237601635914e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0511514748683871,0.00329102021894428,0.0447010752392563,0.0576018744975179,2.91131856688395e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0420455033807803,0.00270510741007621,-0.0473475139045296,-0.0367434928570309,2.91985521872028e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0613710280839389,0.00394876266912794,0.0536314532524481,0.0691106029154297,3.003979259157e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.093273560673165,0.0060006222504494,0.0815123410622841,0.105034780284046,3.19642808256339e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPACT,Protein IMPACT,24845,0.0572088105501366,0.00368138504280348,0.0499932958662418,0.0644243252340314,3.34786725180487e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FADD,FAS-associated death domain protein,29478,0.0779190719039676,0.00502776371985525,0.0680646550130513,0.0877734887948839,5.8684497337387e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0392897691835976,0.0025352145804719,0.0343207486058727,0.0442587897613225,6.43897087388355e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.0469662355950955,0.0030348360922116,0.0410179568543608,0.0529145143358303,9.15766467658918e-54
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0394094285773131,0.00254918986677829,0.0344130164384276,0.0444058407161985,1.05527475995496e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT2,Angiopoietin-2,29725,-0.038865499896501,0.00251431016343445,-0.0437935478168325,-0.0339374519761695,1.08357768211303e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD4B,FERM domain-containing protein 4B,24111,0.0718907439647163,0.00465260360945411,0.0627716408901863,0.0810098470392464,1.32832872145701e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROD,Uroporphyrinogen decarboxylase,24381,0.0706747320877739,0.00457528022447421,0.0617071828478044,0.0796422813277433,1.41721590527611e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,24922,0.0280946494497973,0.00181954365610346,0.0245283438838345,0.0316609550157601,1.54852288782008e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0521584109934498,0.0033784735693274,0.0455366027975681,0.0587802191893315,1.60202636850842e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0506943786095354,0.00328766729498708,0.0442505507113607,0.0571382065077101,1.95724878575063e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC22D1,TSC22 domain family protein 1,24867,0.0678768811529796,0.00440452391889489,0.0592440142719456,0.0765097480340136,2.44822826217652e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMTN,Smoothelin,24776,0.0962841926342251,0.00624800649454786,0.0840380999049113,0.108530285363539,2.46587147630175e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSR,"Glutathione reductase, mitochondrial",24867,0.0230804224848222,0.00149819112578767,0.0201439678782784,0.0260168770913661,2.65104509241643e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,29566,0.0847906102219274,0.00551003587335808,0.0739909399101456,0.0955902805337092,3.15161156845199e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINE2,Glia-derived nexin,24922,0.0654073592623863,0.00425398755829826,0.0570695436481217,0.0737451748766509,4.19026673012804e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,29820,0.0725655850668123,0.00473013840413211,0.0632945137947134,0.0818366563389113,6.47331826353818e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C8B,Complement component C8 beta chain,24966,0.0308620347078948,0.00201217558401355,0.0269181705632282,0.0348058988525613,7.46858671852278e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0567531150434705,0.00370237518742199,-0.0640097704108176,-0.0494964596761234,7.85595182711933e-53
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0649440897595245,0.00424495539082892,0.0566239771934998,0.0732642023255492,1.34818029446875e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNCG,Gamma-synuclein,29218,0.0673437336806004,0.00440577136120484,0.0587084218126389,0.0759790455485619,1.53024036332039e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM1,Dynamin-1,24805,0.115412393703998,0.00755973316936513,0.100595316692042,0.130229470715954,2.20622390154684e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.0772269652383217,0.0050604617383489,0.0673084602311578,0.0871454702454855,2.44294635190816e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPBP,Platelet basic protein,24816,0.0853286555538266,0.00559467276932232,0.0743630969259548,0.0962942141816983,2.76807989820996e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0354923713789406,0.00232737468254499,0.0309307170011524,0.0400540257567288,2.84652844181264e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0409075240847542,0.00268234909712729,0.0356501198543847,0.0461649283151237,2.86126133280596e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCS,Copper chaperone for superoxide dismutase,29218,0.0476397925170571,0.00312895307996418,0.0415070444803273,0.0537725405537869,3.80159824447694e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TADA3,Transcriptional adapter 3,24793,0.0398094832745456,0.00261477546328524,0.0346845233665066,0.0449344431825847,4.16722742247664e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG2,Bone marrow proteoglycan,24938,-0.0521425266314819,0.00342551869640827,-0.0588565432764421,-0.0454285099865217,4.34919241339727e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL4,C-C motif chemokine 4,29498,0.0653970065327119,0.00429876343458571,0.0569714302009239,0.0738225828644999,4.57457650501833e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,29786,0.0674396139681321,0.00443704952486939,0.0587429968993881,0.0761362310368761,5.6120924675872e-52
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPI,Glucose-6-phosphate isomerase,24951,0.0473745036202889,0.00312386424104457,0.0412517297078415,0.0534972775327363,1.02060157886739e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOE,Apolipoprotein E,24966,0.0729258104873392,0.00480956825955228,0.0634990566986168,0.0823525642760617,1.06271803031252e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL11,Eotaxin,29786,0.0375349655486003,0.00248120404985492,0.0326718056108847,0.042398125486316,1.65294349247242e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0379301867494839,0.00250756016345142,0.0330153688291192,0.0428450046698487,1.84389463962686e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIAE,Sialate O-acetylesterase,29495,0.0464232627400701,0.0030712132436322,0.040403684782551,0.0524428406975892,1.99256134123454e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0278461951729962,0.00184282276456551,0.0242342625544478,0.0314581277915446,2.17199310807609e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.0665548402100944,0.00441081128556352,0.0579096500903899,0.0752000303297989,3.27898118425414e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTC,Probetacellulin,28797,0.0739320792224027,0.00490246715632487,0.064323243596006,0.0835409148487995,3.41118904203849e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRZB,Secreted frizzled-related protein 3,29123,0.0256307924568851,0.0016998174577937,0.0222991502396095,0.0289624346741608,3.49926294013857e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MIF,Macrophage migration inhibitory factor,29386,0.0675855531582016,0.00448251829034713,0.0587998173091212,0.076371289007282,3.53659280043708e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F2R,Proteinase-activated receptor 1,29536,0.0569230830272067,0.00377685331020609,0.0495204505392027,0.0643257155152106,3.86289873537935e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSO,Cathepsin O,29786,0.0301060445807315,0.00199880082931779,0.0261883949552686,0.0340236942061944,4.43964095055068e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX6,Peroxiredoxin-6,29725,-0.0593785436387695,0.00394424093409151,-0.0671092558695889,-0.0516478314079501,4.97761476386899e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS10,Regulator of G-protein signaling 10,24867,0.0593584748180222,0.0039449152558881,0.0516264409164815,0.0670905087195629,6.07384653833572e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RFC4,Replication factor C subunit 4,24793,0.021143389832656,0.00140520402865425,0.0183891899364937,0.0238975897288183,6.11426308497911e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.071991649201503,0.00479016844498138,0.0626029190493395,0.0813803793536665,7.91776056664566e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.0972733805545881,0.00647749715340889,0.0845774861339067,0.10996927497527,9.46252467995171e-51
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0335084092977139,0.00223587860501154,0.0291260872318913,0.0378907313635365,1.38110517949685e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.069563503901075,0.00464460347520499,0.0604600810896732,0.0786669267124768,1.72091895291287e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN3,Ataxin-3,24845,0.0611478919454498,0.0040828658620268,0.0531454748558773,0.0691503090350223,1.73265028438046e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESYT2,Extended synaptotagmin-2,24845,0.0814697852392471,0.00543990686221621,0.0708075677893033,0.0921320026891909,1.74271839907295e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLU,Clusterin,24966,0.0314681395277257,0.00210130714149684,0.0273495775303919,0.0355867015250595,1.7596553959447e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.109645733288037,0.00732472151090902,0.0952892791266554,0.124002187449419,1.80304189717688e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0238704871678971,0.00159583121217617,0.0207426579920318,0.0269983163437624,2.11861998224106e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0310355530056994,0.00207762673979909,0.0269634045956932,0.0351077014157056,3.08408101313059e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAN,Neurocan core protein,29694,0.0367673931058911,0.00246470476971401,0.0319365717572517,0.0415982144545306,3.85121959896941e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0573114389768848,0.00384408329529189,0.0497770357181127,0.0648458422356569,4.43516480449259e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0252204466540993,0.00169541238330255,0.0218974383828263,0.0285434549253723,7.77842481459277e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0682180385341966,0.00458588781319903,0.0592296984203265,0.0772063786480667,7.89598770326249e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.0802218488274065,0.00539883614056257,-0.0908035676629091,-0.0696401299919038,9.19290373242079e-50
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADD1,Alpha-adducin,24381,0.0687619274444846,0.00463035312786076,0.0596864353138775,0.0778374195750917,1.14316990758284e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABHD14B,Protein ABHD14B,29121,0.0561015318040995,0.00378167784124714,0.0486894432352552,0.0635136203729439,1.3193268987815e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK7,Kallikrein-7,23801,0.0384402971457575,0.00259062852904965,0.0333626652288202,0.0435179290626948,1.38244929249492e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0694703223437965,0.00468333187285103,0.0602909918730085,0.0786496528145845,1.44807701828936e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TST,Thiosulfate sulfurtransferase,28706,0.073984386920992,0.00499037186704993,0.0642032580615741,0.0837655157804098,1.53113753503052e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX8,Syntaxin-8,29434,0.0472319849601076,0.00318606463824891,0.0409872982691398,0.0534766716510755,1.53495317010421e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB33A,Ras-related protein Rab-33A,24111,0.065178848733059,0.00440303909371199,0.0565488921093835,0.0738088053567345,2.30390084698562e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA3,Annexin A3,29640,0.067932075000651,0.00459127362135818,0.058933178702789,0.0769309712985131,2.33645523682248e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0335058391718193,0.00226504856030296,-0.0379453343500131,-0.0290663439936255,2.65625683435381e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0520554473251728,0.00352190820993404,0.0451525072337021,0.0589583874166436,3.17092070545043e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL7,C-C motif chemokine 7,29434,0.0571039700066086,0.00386786954410986,0.0495229457001532,0.0646849943130639,3.76795680931336e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNM3,Dynamin-3,24867,0.0535860901273922,0.00362858956187879,0.0464740545861098,0.0606981256686746,3.82187434916869e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD276,CD276 antigen,29454,-0.0349836160484591,0.00237069908351598,-0.0396301862521504,-0.0303370458447678,4.17625547528254e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0453634684357193,0.00308222121620636,0.0393223148519549,0.0514046220194838,7.37137825429614e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR2,Folate receptor beta,29694,-0.0284017607596052,0.00193142888655751,-0.032187361377258,-0.0246161601419525,8.88556490596933e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0631985439340907,0.00429710692730651,0.05477621435657,0.0716208735116115,9.37420798871023e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB4,Ephrin type-B receptor 4,29820,-0.0241990115566042,0.00164604879857889,-0.0274252672018189,-0.0209727559113896,9.37624629576491e-49
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0490659667606559,0.00333962698183733,0.0425202978762548,0.0556116356450571,1.08834114806903e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.0912485881140014,0.00621148132033368,0.0790740847261474,0.103423091501855,1.10994689181475e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARFIP1,Arfaptin-1,24867,0.0668642260297905,0.00455262894540959,0.0579410732967877,0.0757873787627933,1.25005858197059e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSC2,Desmocollin-2,29135,-0.0332686501313346,0.00226717479553759,-0.0377123127305883,-0.028824987532081,1.40977553478475e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLB1,Beta-galactosidase,29218,0.0404367296569003,0.00276035882600038,0.0350264263579396,0.0458470329558611,2.02875622131892e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.115323240700577,0.00787666942783011,0.0998849686220302,0.130761512779124,2.26981371427752e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP10,Caspase-10,28774,0.0688687784952593,0.0047142818756882,0.0596287860189104,0.0781087709716082,3.68753598354672e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1,Allograft inflammatory factor 1,28797,0.0504737336904818,0.00345881711263846,0.0436944521497104,0.0572530152312532,4.63773961522584e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0499606461958947,0.00342783762539071,0.0432420844501289,0.0566792079416605,5.95572120415461e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL26,C-C motif chemokine 26,29434,0.0856638458229794,0.0058776153485878,0.0741437197397473,0.0971839719062115,5.99049423277809e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGA,Glycoprotein hormones alpha chain,29443,0.0770891393362877,0.00529155266524108,0.0667176961124152,0.0874605825601603,6.55956775943225e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0374218225089764,0.00257165288589054,0.0323813828526309,0.0424622621653219,9.04482890782572e-48
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0517898858884469,0.0035688888584581,0.0447948637258691,0.0587849080510248,1.49799961902374e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,24195,0.07692613782917,0.00530488279357053,0.0665285675537718,0.0873237081045682,1.88897848964153e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REEP4,Receptor expression-enhancing protein 4,24867,0.059595675605805,0.00411018331119234,0.0515397163158681,0.067651634895742,1.9063710984603e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPA1,Inositol monophosphatase 1,29218,0.0583115346265651,0.00402396697166513,0.0504245593621014,0.0661985098910287,2.01649597668479e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPT1,Angiopoietin-1,29322,0.0803546047126553,0.00554702697669389,0.0694824318383353,0.0912267775869754,2.16440016878135e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDS,Iduronate 2-sulfatase,29786,0.0084888642252908,0.00058643225636375,0.00733945700281785,0.00963827144776375,2.50888833186407e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0466114270359968,0.00322303394769274,0.0402942804985191,0.0529285735734746,3.2768662162725e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARK7,Parkinson disease protein 7,29443,0.0497381709469043,0.00344143419290107,0.0429929599288182,0.0564833819649904,3.49595960957493e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.0511612475283481,0.00354481793298862,0.0442134043796904,0.0581090906770058,5.03864854585008e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA1,GDNF family receptor alpha-1,29674,0.0268732860428293,0.00186528624099884,0.0232173250104716,0.030529247075187,6.72953786982226e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0623734592802666,0.00433047827588658,0.0538857218595289,0.0708611967010043,7.16280815950951e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID1,Nidogen-1,29518,0.0359881168179859,0.00250205863516595,0.0310840818930607,0.0408921517429112,9.47052780434609e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C19orf12,Protein C19orf12,28774,0.0611475475684146,0.00425121722159517,0.0528151618140881,0.0694799333227412,9.54116537444393e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRG,Histidine-rich glycoprotein,24833,0.0298948821533667,0.00207788725324607,0.0258222231370044,0.033967541169729,9.61036816231289e-47
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DXO,Decapping and exoribonuclease protein,24845,0.0433431060372418,0.00301392643277439,0.037435810229004,0.0492504018454796,1.05027678610656e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRN1,Secernin-1,29434,0.0529255205268589,0.00368204236957547,0.045708717482491,0.0601423235712269,1.08561060416144e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,29434,0.0540628918554514,0.00376504947373402,0.0466833948869327,0.0614423888239701,1.3424236231505e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAP3,Cytosol aminopeptidase,28931,0.0459489727926444,0.00320762861485077,0.0396620207075369,0.0522359248777519,2.20499481868409e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX4,Syntaxin-4,29349,0.056057379189907,0.00391489309291368,0.0483841887277962,0.0637305696520178,2.38648991210787e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSP1,Lymphocyte-specific protein 1,29434,0.0378616615147831,0.00264788097309814,0.0326718148075108,0.0430515082220555,3.17894636917353e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD27,CD27 antigen,29566,-0.0391742396469102,0.00274582225502267,-0.0445560512667547,-0.0337924280270658,5.00832918166927e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0441658990524189,0.00309571479668877,0.0380982980509089,0.0502335000539289,5.06025463835691e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGH,Gamma-glutamyl hydrolase,28984,0.0320744804465768,0.00224930610709747,0.0276658404766658,0.0364831204164879,5.58241901867432e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0377655399458208,0.00264817274008207,0.03257512137526,0.0429559585163817,5.81190737478671e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0629882621786547,0.00441708101687678,0.0543307833855762,0.0716457409717332,5.96308192673045e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6AP2,Renin receptor,28797,0.0381324457162486,0.00267502573927764,0.0328893952672644,0.0433754961652327,5.98566854768157e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTF2,Transcription termination factor 2,24195,0.0463156423089265,0.00324877221083996,0.0399480487756801,0.0526832358421728,6.28478219248643e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0268124335148292,0.00188368169648017,0.023120417389728,0.0305044496399303,8.51859464508512e-46
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,28797,0.0424370215140165,0.00298612481666884,0.0365842168733456,0.0482898261546874,1.11153870077048e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAO1,Hydroxyacid oxidase 1,29725,0.119698251553983,0.0084367101842477,0.103162299592858,0.136234203515109,1.53628891690934e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MARCO,Macrophage receptor MARCO,29478,0.024609748503223,0.0017362589356687,0.0212066809893124,0.0280128160171337,1.87247988540067e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",29349,0.0758514796596171,0.00536029230067392,0.0653453067502962,0.086357652568938,2.60993260193467e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO2,Gamma-enolase,29694,0.0609185227537073,0.00431797270350869,0.0524552962548303,0.0693817492525843,4.73365402565559e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.063594937878681,0.00450624239802393,0.0547627027785541,0.0724271729788079,4.79362455029463e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,24938,0.0246914527316356,0.0017508418233557,0.0212598027578584,0.0281231027054128,5.45165609841249e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C5,Complement C5,24966,0.014116017068779,0.00100372979422216,0.0121487066721036,0.0160833274654544,9.42977778219877e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0392159804804785,0.00278900519623275,0.0337495302958623,0.0446824306650947,9.87808749915554e-45
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOXO3,Forkhead box protein O3,28797,0.0893364387399192,0.00635630849985026,0.0768780740802127,0.101794803399626,1.01261382240391e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA6,Integrin alpha-6,29434,0.0482555697731385,0.00343646097056551,0.0415201062708301,0.0549910332754469,1.19847512363944e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,24229,0.080343354430157,0.00572178043118241,0.0691286647850395,0.0915580440752745,1.2967976143546e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLUL1,Clusterin-like protein 1,29435,-0.0416801476004713,0.00297228725181025,-0.0475058306140194,-0.0358544645869232,1.57071510069293e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0445425434602299,0.0031787911043207,0.0383121128957613,0.0507729740246985,1.93242742204173e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0496011440923106,0.00354651581621542,0.0426499730925284,0.0565523150920928,2.65552796502691e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0526921708092453,0.00377236559398002,0.0452983342450444,0.0600860073734461,3.41090984668825e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF7,SLAM family member 7,29434,-0.0540078127320776,0.00386673907814018,-0.0615866213252324,-0.0464290041389229,3.41797500945131e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0527835347374144,0.00377909462774948,0.0453765092670254,0.0601905602078034,3.41919755236784e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0549277949673606,0.00394132236410951,0.0472028031337059,0.0626527868010152,5.58029920626614e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0599869389579774,0.00431199564587348,0.0515354274920654,0.0684384504238894,7.39353144349509e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.0734383067810711,0.00527734880943461,0.0630947031145793,0.0837819104475629,7.50126258266815e-44
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGFAC,Hepatocyte growth factor activator,24720,0.0258110212110959,0.00185873851193852,0.0221678937276964,0.0294541486944954,1.11931244759853e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBI,Acyl-CoA-binding protein,29329,0.0716870907380258,0.00516929575672408,0.0615552710548466,0.081818910421205,1.36225447427885e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS9,Galectin-9,29453,0.0291218385497249,0.00210217188491561,0.0250015816552903,0.0332420954441595,1.66625782180502e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAN,Brevican core protein,29218,0.0310136628031796,0.00224615026110267,0.0266112082914184,0.0354161173149408,3.14193237713322e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1,Integrin beta-1,29474,0.0197788121721372,0.00143413633312706,0.0169679049592081,0.0225897193850662,3.90810846635769e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0511764984665485,0.00371594340870356,0.0438932493854895,0.0584597475476074,5.09967767376736e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.0511090619988731,0.00371053745877113,0.0438364085796817,0.0583817154180645,5.30676708335554e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0592156004803883,0.00430830764243033,0.0507713175012248,0.0676598834595517,7.50474895830453e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO1A,Coronin-1A,28847,0.0810303012506097,0.00589685036997888,0.0694724745254511,0.0925881279757683,7.84075090375273e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.0444870252418708,0.00323827992315403,0.0381399965924889,0.0508340538912527,8.71751678811371e-43
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFA,Vascular endothelial growth factor A,29683,0.0521558125150673,0.00380455224738909,0.0446988901101847,0.0596127349199499,1.21350559327806e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0682732569778798,0.00498122737115164,0.0585100513304226,0.0780364626253371,1.27046277850863e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPY,Pancreatic prohormone,29400,0.0919681483292446,0.00671183673114605,0.0788129483361984,0.105123348322291,1.32861196861877e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLNK,B-cell linker protein,24229,0.0362061779443378,0.00264272944829391,0.0310264282256817,0.0413859276629938,1.45753783370805e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0395167686345801,0.00288497690685757,0.0338622138971393,0.0451713233720209,1.50328406117619e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXN,Paxillin,28774,0.0464320602194173,0.00339572821083484,0.039776432926181,0.0530876875126536,1.98025735410039e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD40LG,CD40 ligand,29786,0.0700386073549917,0.00512457234941743,0.0599944455501336,0.0800827691598499,2.14056729308354e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0504712848495963,0.0036925268312578,0.043233932260331,0.0577086374388616,2.24017532764316e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.0253557184915064,0.00185698492001281,0.0217160280482813,0.0289954089347315,2.55844654853211e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0361784909238876,0.00264979966468148,0.0309848835811119,0.0413720982666633,2.74300792502174e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGA,Fibrinogen alpha chain,24407,0.0279106363317478,0.00204738749032256,0.0238977568507156,0.03192351581278,3.67276754359266e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPSE,Heparanase,24688,0.0845622596425103,0.00620910007810744,0.0723924234894197,0.0967320957956008,4.37902360402228e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0575703409256769,0.0042287340070695,0.0492820222718207,0.0658586595795331,4.46043264572941e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN2,Matrilin-2,29497,0.0266497659619435,0.00196185951293903,0.022804521316583,0.030495010607304,6.66968505341298e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",24845,0.0953605933560691,0.00702050529107563,0.0816004029855608,0.109120783726577,7.1158129396868e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BDNF,Brain-derived neurotrophic factor,24938,0.0746279291805679,0.00549710981541159,0.0638535939423612,0.0854022644187746,7.84616459896448e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEPD,Xaa-Pro dipeptidase,24951,0.0235274864550594,0.00173332356400702,0.0201301722696057,0.0269248006405132,8.0845035816073e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB10,Ras-related protein Rab-10,24922,0.0480341261554172,0.00353937876092018,0.0410969437840136,0.0549713085268207,8.34166748721638e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VGF,Neurosecretory protein VGF,24867,0.0272627334223643,0.00200888738102724,0.0233253141555509,0.0312001526891777,8.37998842932646e-42
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0561597135053381,0.0041505993431963,0.0480245387926733,0.0642948882180028,1.37283910313123e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0408820083080352,0.00302247824049894,-0.0468060656594131,-0.0349579509566572,1.45913911962897e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.0809717886521421,0.00599572103350086,0.0692201754264804,0.0927234018778037,2.06601545105252e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUS,RNA-binding protein FUS,28765,0.0351903116479918,0.00260657917943832,0.0300814164562927,0.0402992068396909,2.07533540499701e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME1,Proteasome activator complex subunit 1,29192,0.0330274457635866,0.00244733451480171,0.0282306701145752,0.0378242214125979,2.21969633741759e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164,Sialomucin core protein 24,29443,0.0238333815281893,0.00176682017515433,0.0203704139848868,0.0272963490714918,2.39606210295381e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBCA,Tubulin-specific chaperone A,24381,0.076469387641519,0.00567231338763735,0.0653516534017498,0.0875871218812882,2.83911884201129e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0257132949504389,0.00190763739155621,0.0219743256629887,0.0294522642378891,2.91783223245457e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPCAM,Epithelial cell adhesion molecule,29457,-0.0861464380516961,0.00639419814829371,-0.0986790664223518,-0.0736138096810405,3.00527931825437e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.031965360263248,0.00237710775221162,0.0273062290689132,0.0366244914575828,4.49522136266322e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STXBP3,Syntaxin-binding protein 3,28797,0.0388317055158919,0.00288954838504753,0.0331681906811988,0.0444952203505851,4.77224106008375e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0259070258571356,0.00192923675202556,-0.0296883298911057,-0.0221257218231655,5.42908270715124e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0781374330625842,0.00582567852270267,0.0667191031580869,0.0895557629670814,6.76404893890503e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0776995476461576,0.00580250440351127,0.0663266390152755,0.0890724562770397,9.49814470185752e-41
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PARD3,Partitioning defective 3 homolog,24445,0.0655656337029127,0.00490410541118524,0.0559535870969897,0.0751776803088358,1.26592225815941e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0383036995908308,0.00286712472375519,0.0326841351322706,0.0439232640493909,1.44991735369642e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1F,Protein phosphatase 1F,24922,0.0465089042722049,0.003487170033578,0.039674051006392,0.0533437575380178,1.93745415737702e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD84,SLAM family member 5,29434,0.0274639087484083,0.00206199811590015,0.023422392441244,0.0315054250555726,2.34741725423639e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.0672155311829488,0.0050500582273239,0.057317417057394,0.0771136453085037,2.78981839368594e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,23906,0.0470483705434769,0.00353503632503273,0.0401196993464127,0.053977041740541,2.84932361852356e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC4,Apical endosomal glycoprotein,24793,0.0487871344642423,0.00367269697335643,0.0415886483964637,0.0559856205320209,3.9466851519658e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKN3,Serine/threonine-protein kinase N3,24445,0.0662484683980898,0.00499393123483431,0.0564603631778146,0.0760365736183651,5.02855333112895e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0285459307656229,0.00215259516357088,0.0243268442450239,0.0327650172862218,5.05256855896284e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0247363483697993,0.00186573745967002,0.021079502948846,0.0283931937907525,5.573210837485e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA4,Annexin A4,29341,0.0629564102009218,0.00475145165179388,0.0536435649634058,0.0722692554384378,5.88454562060223e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS2,Thrombospondin-2,29443,-0.0326886705135648,0.00247030992711462,-0.0375304779707095,-0.0278468630564202,7.3933739238413e-40
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0504715563795584,0.00382085381200952,0.0429826829080197,0.0579604298510971,1.00220499770207e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.0799694547231968,0.00605856749098808,0.0680946624408601,0.0918442470055334,1.15214431820104e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0462297914879683,0.00350329369799637,0.0393633358398954,0.0530962471360411,1.26618137182907e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH7,Protocadherin-7,24805,0.0304100893484337,0.00230535228075593,0.0258915988781521,0.0349285798187153,1.34299442409447e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM,Paralemmin-1,24657,0.0261065453319317,0.00197919185152824,0.0222273293029364,0.0299857613609271,1.35566929410784e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0797862508425859,0.00605713631841566,0.0679142636584912,0.0916582380266806,1.71900922867788e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM3,Junctional adhesion molecule C,24381,0.0441816728547034,0.00335476867949093,0.0376063262429011,0.0507570194665056,1.78633083460243e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA12,Carbonic anhydrase 12,29349,-0.0283528398369394,0.00215446995454149,-0.0325756009478407,-0.0241300787260381,1.92861560942513e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GET3,ATPase GET3,24922,0.0479866402614639,0.00364627327643107,0.040839944639659,0.0551333358832688,2.00649433086826e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA2,Apolipoprotein A-II,24951,-0.0420823201843686,0.00320060559381308,-0.0483555071482422,-0.035809133220495,2.35526917657222e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LARP1,La-related protein 1,24793,0.054580853047917,0.00415564871425957,0.0464357815679683,0.0627259245278658,2.83956018565289e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS1,Nephrin,24229,0.0296621121741639,0.00225947479437962,0.0252335415771798,0.0340906827711479,3.10400960369979e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGLN1,Egl nine homolog 1,29434,0.0470050237840451,0.00358245807368156,0.0399834059596292,0.0540266416084609,3.22217637883654e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APP,Amyloid-beta precursor protein,29395,0.0575117901009081,0.00438868879910503,0.0489099600546622,0.066113620147154,3.99316630269481e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEMIP2,Cell surface hyaluronidase,24229,0.0287299482401497,0.00219528154485436,0.0244271964122352,0.0330327000680642,5.29109347820525e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RILP,Rab-interacting lysosomal protein,29632,0.0511773057398013,0.00392051066523982,0.0434931048359312,0.0588615066436713,7.74608597308502e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0136555475009337,0.00104652377215377,0.0116043609075123,0.0157067340943551,8.28281371866523e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP5,Microfibrillar-associated protein 5,29820,0.0351281390884362,0.00269408710182541,0.0298477283688584,0.040408549808014,9.37634808740259e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRBP,Acrosin-binding protein,24793,0.0334535524410798,0.00256496788627007,0.0284262153839904,0.0384808894981691,9.41073873394826e-39
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL5,Fc receptor-like protein 5,29443,-0.0493463435280483,0.00379792708855685,-0.0567902806216198,-0.0419024064344769,1.71193467713441e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0555296712560037,0.00427835053579216,0.047144104205851,0.0639152383061563,2.14122407028687e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0221404299220915,0.00170924050291393,0.0187903185363802,0.0254905413078028,2.85504897860125e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRK5,G protein-coupled receptor kinase 5,28916,0.0444550383914916,0.00343587936872351,0.0377207148287935,0.0511893619541897,3.48559852799877e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0761843243410237,0.00589173072109182,0.0646365321276838,0.0877321165543637,4.03138689156885e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,28797,0.0393601386818907,0.00304607653897519,0.0333898286654994,0.0453304486982821,4.3407438694147e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0624276625036719,0.00483298760620689,0.0529550067955064,0.0719003182118374,4.59215356599879e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0700807890123144,0.00544174310670231,0.0594149725231779,0.0807466055014509,7.54132972848794e-38
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.020715107701987,0.00161221035025158,0.0175551754154939,0.0238750399884801,1.10242652860943e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZD2,PDZ domain-containing protein 2,24111,0.0513004039971403,0.00399200341448122,0.0434760773047571,0.0591247306895235,1.13215533416146e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,29443,0.0450792452956258,0.00351024848891555,0.0381991582573513,0.0519593323339002,1.20120989362485e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1RL,Complement C1r subcomponent-like protein,24925,0.0165941127246905,0.00129239400798413,0.0140610204690416,0.0191272049803394,1.2912769738289e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0318271751886238,0.00248372382033784,0.0269590765007616,0.0366952738764859,1.80208174071039e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRD2,Protein ZNRD2,24805,0.0582498841560254,0.00454960531699467,0.0493326577347158,0.0671671105773349,2.06512693270731e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0429662226259511,0.00336220729667431,0.0363762963244695,0.0495561489274327,2.70739965027381e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTNB,Dystrobrevin beta,24752,0.0367458353666159,0.00287577711084206,0.0311093122293655,0.0423823585038663,2.86545004086848e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.0728370235099967,0.00570363969521545,0.0616578897073744,0.084016157312619,3.03852487273008e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,28931,0.0564206811226263,0.00442149398471159,0.0477545529125916,0.065086809332661,3.43095884694851e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,29349,0.0499306667169247,0.00392855488342349,0.0422306991454146,0.0576306342884347,6.53873599439561e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOF,Apolipoprotein F,24951,0.0210461543181841,0.00165573422536273,0.0178009152364732,0.0242913933998951,6.68214507864668e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP7,Matrilysin,28870,0.0418874319765783,0.00329934179444276,0.0354207220594705,0.0483541418936861,7.83958471299149e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0408883794205116,0.00322317666974595,0.0345709531478095,0.0472058056932137,9.23180871584165e-37
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECE1,Endothelin-converting enzyme 1,28774,0.0294926173413999,0.0023307315353192,0.0249243835321743,0.0340608511506256,1.33456559966793e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FXN,"Frataxin, mitochondrial",29725,0.0612195436293798,0.00483834380161284,0.0517363897782187,0.070702697480541,1.33864262831642e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0181720818772678,0.00143777027374377,0.01535405214073,0.0209901116138056,1.60102404744711e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3,Galectin-3,29544,0.0247801749242198,0.00196735874500082,0.0209241517840182,0.0286361980644214,2.76608052636899e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,24805,0.069362215889124,0.00550888985461943,0.0585647917740699,0.0801596400041781,3.05714426710203e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF1,Scavenger receptor class F member 1,29820,0.0351586734157345,0.00279630298208521,0.0296779195708475,0.0406394272606216,3.65985479248526e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.039204067928993,0.00312090448465034,0.0330870951390783,0.0453210407189076,4.4132494540955e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0569483565122123,0.00454067692136749,0.0480486297463321,0.0658480832780926,5.69324773949382e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MVK,Mevalonate kinase,28931,0.065781449746275,0.00525335773010584,0.0554848685952675,0.0760780308972824,7.03127805376923e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST3,Cystatin-C,29530,0.0234192530826683,0.00187064923069439,0.0197527805905073,0.0270857255748293,7.22124149966418e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0504603039789374,0.00403264707912554,0.0425563157038513,0.0583642922540234,7.82650458367117e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1R1,Interleukin-1 receptor type 1,29390,-0.018993440289333,0.00152023044423422,-0.021973091960032,-0.0160137886186339,9.95033060728832e-36
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0317438871975094,0.0025422617613405,0.026761054145282,0.0367267202497368,1.13262943581015e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB6,Integrin beta-6,28931,0.0250426068199165,0.00200860996873085,0.0211057312812041,0.028979482358629,1.38421427551235e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML1,Trem-like transcript 1 protein,24951,0.0435463898471811,0.00349461888433922,0.0366969368338763,0.050395842860486,1.55503112247586e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EBI3_IL27,Interleukin-27,29674,-0.0254084606070645,0.00204261495142454,-0.0294119859118566,-0.0214049353022724,1.96313399913553e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF3,Trefoil factor 3,29426,-0.0379829779943131,0.00306106619468734,-0.0439826677359003,-0.0319832882527259,2.88334065173038e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0348263318500309,0.0028069151653865,0.0293247781258734,0.0403278855741884,2.93248187504452e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX9,Sorting nexin-9,29478,0.0557968122450621,0.00450736426741004,0.0469623782809385,0.0646312462091858,4.15027206582201e-35
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL3,C-C motif chemokine 3,29434,0.0490734519115344,0.00399184805704147,0.0412494297197331,0.0568974741033356,1.19536758373442e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC79,Protein unc-79 homolog,24016,0.045789073580185,0.00372386953920136,0.0384902892833503,0.0530878578770197,1.20865203217655e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNMT,Histamine N-methyltransferase,29082,0.0382160362777151,0.0031105232643923,0.0321194106795062,0.044312661875924,1.31194026594238e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACYP1,Acylphosphatase-1,24297,0.0534250823908754,0.00434883572162407,0.0449013643764922,0.0619488004052586,1.38297796203153e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL,Podocalyxin,29349,0.0122792648975922,0.00100197927221855,0.0103153855240438,0.0142431442711405,1.91766908092836e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL2,C-C motif chemokine 2,29169,0.042457324781943,0.00346591500643842,0.0356641313693237,0.0492505181945623,2.04262929817659e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0505863400920713,0.0041316920192838,0.0424882237342751,0.0586844564498676,2.28524627754839e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF2,Fibroblast growth factor 2,29434,0.0544642422291656,0.00445288486283773,0.0457365878980036,0.0631918965603275,2.56550880752466e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL3,Insulin-like 3,24845,0.0611270700149178,0.0050017317734672,0.0513236757389221,0.0709304642909135,3.00535799131355e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMSB10,Thymosin beta-10,29443,0.061168370631916,0.00500682768408802,0.0513549883711035,0.0709817528927285,3.05375322858869e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0299681838522744,0.00245534076224116,0.0251557159582817,0.034780651746267,3.66447661409258e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NHLRC3,NHL repeat-containing protein 3,23825,0.0258917337712487,0.0021246598338466,0.0217274004969094,0.0300560670455881,4.64574980884477e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSNAX,Translin-associated protein X,24111,0.031816795254518,0.00261179692641477,0.0266976732787451,0.036935917230291,4.88464137781743e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0354554731758345,0.00291447714981125,0.0297430979622045,0.0411678483894646,5.74512873332347e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0544303549364357,0.00447759043750273,0.0456542776789303,0.063206432193941,6.68614332449851e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0185612635375067,0.00152890569087687,0.0155646083833881,0.0215579186916254,7.77096900021573e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,24951,0.0209416126449476,0.0017271828663515,0.0175563342268986,0.0243268910629965,9.72269765651869e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LBP,Lipopolysaccharide-binding protein,29594,-0.0467262403357778,0.0038548669258946,-0.0542817795105312,-0.0391707011610244,9.78685427083244e-34
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDUA,Alpha-L-iduronidase,29725,0.0368202673180554,0.00304122004577409,0.0308594760283382,0.0427810586077726,1.16309491215507e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0352687463479246,0.00291639946895301,0.0295526033887767,0.0409848893070725,1.43034348248747e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAL,Integrin alpha-L,24229,0.0349418876530451,0.00289178008084337,0.0292739986945921,0.0406097766114981,1.61864734248028e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.0429666750309712,0.00355931326165874,0.0359904210381201,0.0499429290238223,1.79064137374342e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0463167384357746,0.00384830482726402,0.0387740609743372,0.0538594158972121,2.76840802676881e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0347587330570335,0.00289198105201127,0.0290904501950914,0.0404270159189756,3.39101080727417e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATG4A,Cysteine protease ATG4A,28797,0.0466839945138307,0.00388472257661396,0.0390699382636674,0.0542980507639941,3.46005210276157e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOA,Elongin-A,29349,0.0414035203311009,0.00345159920555545,0.0346383858882122,0.0481686547739895,4.48589653663175e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN6,Dynactin subunit 6,28774,0.056505077758199,0.00471114851301002,0.0472712266726994,0.0657389288436986,4.5866620642263e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",24240,0.0691379206172232,0.00576400761042169,0.0578404657007967,0.0804353755336497,4.69609659654908e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0454094584892084,0.0038012828308948,0.0379589441406546,0.0528599728377622,8.14228642212071e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC1,MANSC domain-containing protein 1,29566,-0.0217572917865774,0.00182147920146271,-0.0253273910214443,-0.0181871925517105,8.22104454417007e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA9,Carbonic anhydrase 9,29725,-0.0360748196019499,0.00302078385661756,-0.0419955559609203,-0.0301540832429794,8.47737665462805e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT2A1,Bile salt sulfotransferase,29434,0.0441136119121644,0.00369534911156925,0.0368707276534887,0.0513564961708402,8.9724735343399e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0206058109933306,0.00172614469214893,-0.0239890545899425,-0.0172225673967187,9.27012807521871e-33
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLB,Beta-klotho,28774,-0.0583283641357389,0.0048941395179229,-0.0679208775908678,-0.04873585068061,1.13863475458088e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,29349,0.028220971478349,0.0023707106992111,0.0235743785078953,0.0328675644488028,1.3408947467422e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO2,Amphoterin-induced protein 2,29349,0.018046475491519,0.00151724799751176,0.015072669416396,0.021020281566642,1.50706304971127e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0600832551170045,0.00505788425059229,0.0501698019858436,0.0699967082481653,1.86119748206753e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOTL2,Angiomotin-like protein 2,24711,0.037931221527747,0.00320321307675654,0.0316529238973042,0.0442095191581898,2.90801417271931e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELE,E-selectin,29820,0.0393326133685203,0.00332248706338471,0.0328205387242863,0.0458446880127544,2.92242535769521e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0427579705216207,0.00361589383706979,0.0356708186009639,0.0498451224422775,3.55430024696585e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0681537000858573,0.00576461140387798,0.0568550617342565,0.0794523384374581,3.64329684517491e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WDR46,WD repeat-containing protein 46,24793,0.0281332510372879,0.00238491433026824,0.0234588189499621,0.0328076831246136,4.96659510107182e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANPEP,Aminopeptidase N,29531,0.0218469899365242,0.0018544072245801,0.0182123517763472,0.0254816280967012,5.76020954055454e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNAS,Neuroendocrine secretory protein 55,24867,0.0689625576619524,0.00585793965990177,0.0574809959285449,0.0804441193953599,6.5767483805581e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0284066944054943,0.0024140903695698,-0.0331383115298511,-0.0236750772811375,6.80482671795637e-32
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAC1,Cartilage acidic protein 1,29820,0.0233165394954609,0.00198706803368845,0.0194218861494315,0.0272111928414902,1.0004831207664e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.0445688076954337,0.00380165497449324,0.0371175639454269,0.0520200514454404,1.13367438999226e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0525375360050317,0.00448071904789846,0.0437553266711507,0.0613197453389127,1.15054845792066e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.0753663148740019,0.00643580043704065,0.0627521460174022,0.0879804837306016,1.37050024208175e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0217660041967909,0.00185882523512441,0.0181227067359471,0.0254093016576348,1.38701097987856e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL1,Follistatin-related protein 1,24240,-0.0177105388075423,0.00151350372294209,-0.0206770061045088,-0.0147440715105758,1.51942454807868e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0439515221519641,0.00375727315088788,0.0365872667762238,0.0513157775277043,1.53858983249513e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPLAH,5-oxoprolinase,24240,0.0531269390430869,0.00454360084739118,0.0442214813822002,0.0620323967039736,1.6881160477335e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP6,Bone morphogenetic protein 6,28884,0.0318608547743885,0.00272648103167081,0.0265169519523138,0.0372047575964633,1.77579847244033e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRL,Prolactin,29694,-0.0583359812047505,0.00500519191245979,-0.0681461573531717,-0.0485258050563293,2.5294476574185e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STK4,Serine/threonine-protein kinase 4,29478,0.0665830529935856,0.00571325693176274,0.0553850694073306,0.0777810365798406,2.5609640733525e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0283257642780558,0.00243080674429774,-0.0330901454968794,-0.0235613830592322,2.60101721071518e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK4,Kallikrein-4,29725,-0.0484118607781207,0.00415662784133388,-0.0565588513471351,-0.0402648702091063,2.78283264344369e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.0459181429284738,0.00394435811563755,0.0381872010218242,0.0536490848351234,2.98003294532425e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBKS,Ribokinase,28795,0.0381329169784693,0.00328700063118463,0.0316903957413474,0.0445754382155912,4.76848748870332e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR3,Toll-like receptor 3,29786,0.0467655950984045,0.00403413915648878,0.0388586823516865,0.0546725078451225,5.24649772898465e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SWAP70,Switch-associated protein 70,24805,0.0274546814676648,0.00237355836292652,0.0228025070763289,0.0321068558590008,7.27884311044787e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP8,Caspase-8,29632,0.0469414280943393,0.00406361095616635,0.0389767506202532,0.0549061055684254,8.43081808187122e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASS1,Argininosuccinate synthase,24111,0.0607447885933119,0.00526347646332873,0.0504283747251876,0.0710612024614363,9.89507773128393e-31
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0242299979982817,0.0021019775038125,-0.0283498739057542,-0.0201101220908092,1.11729022383927e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRB1,Chymotrypsinogen B,29443,0.0423266560511175,0.00367454798380265,0.0351245420028643,0.0495287700993707,1.23305230308498e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0320295492850611,0.00278106998387029,0.0265786521166754,0.0374804464534469,1.25873609565035e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREML2,Trem-like transcript 2 protein,29443,0.0257906202575077,0.00224028825620649,0.0213996552753429,0.0301815852396724,1.33203619923131e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0334214021014847,0.00291101935565027,0.0277158041644102,0.0391270000385592,1.91079130492564e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18,Interleukin-18,29335,0.034829362034949,0.0030340176871657,0.0288826873681042,0.0407760367017938,1.9402078462201e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0743562157474228,0.00648094023420371,0.0616535728883836,0.0870588586064621,2.0938287537546e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SF3B4,Splicing factor 3B subunit 4,29349,0.0552493745237456,0.00481658394591954,0.0458088699897433,0.0646898790577479,2.15086484796608e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFAP,Glial fibrillary acidic protein,28753,0.0350124296403749,0.0030537781513251,0.0290270244637777,0.0409978348169721,2.29504071923176e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17D,Interleukin-17D,28931,0.0258346730065911,0.00225743171326654,0.0214101068485887,0.0302592391645936,2.91872794544233e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP6,Gastrotropin,28872,0.0425049729431898,0.003719576031947,0.0352146039205737,0.049795341965806,3.54439883631064e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MILR1,Allergin-1,28931,-0.0380425025057896,0.00333562383920389,-0.0445803252306292,-0.0315046797809499,4.58234189739503e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRDT,Bromodomain testis-specific protein,24111,0.027894325404093,0.00244649810969177,0.0230991891090971,0.0326894616990889,4.89414314237411e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0276056190572319,0.00242612995778897,0.0228504043399655,0.0323608337744983,6.17377811938267e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPMT,Thiopurine S-methyltransferase,28797,0.0546191049914132,0.00480601241825631,0.0451993206516308,0.0640388893311956,7.25451653172708e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0327456622058846,0.00288582426443872,0.0270894466475847,0.0384018777641844,9.11797683329146e-30
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0361123251489976,0.00318645767546195,0.0298668681050922,0.0423577821929031,1.04037925748374e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0304599026528515,0.00268741676226901,0.0251925657988043,0.0357272395068988,1.05475468764272e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0499443488900832,0.00441273362644444,0.0412953909822521,0.0585933067979143,1.22625923460601e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0230342494383419,0.0020381110902217,-0.0270289471751764,-0.0190395517015074,1.4836608528205e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0402073961432756,0.00356574750815182,0.0332185310272981,0.0471962612592532,2.04169543957056e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0262149105283454,0.00232608805327601,0.0216557779439244,0.0307740431127664,2.1212065548768e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK6,Kallikrein-6,29519,0.0227742794313082,0.00202349180779998,0.0188082354880203,0.0267403233745962,2.51303897018868e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX16,Syntaxin-16,28797,0.0430430583614025,0.00383464683104677,0.0355271505725509,0.0505589661502542,3.54347910702329e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0240263475369845,0.00214041362329017,0.0198311368353358,0.0282215582386333,3.60811574135694e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,24445,0.0259977740545618,0.00231699064356547,0.0214564723931735,0.0305390757159501,3.81191383719217e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,29694,0.0339891587094941,0.00303160594668522,0.028047211053991,0.0399311063649971,4.09283387278232e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,24867,0.0265081100348976,0.0023677672741016,0.0218672861776585,0.0311489338921367,5.03955319956503e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHI3L1,Chitinase-3-like protein 1,28935,-0.0581937984652992,0.00520189419438359,-0.068389511086291,-0.0479980858443073,5.41299947342201e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM1,Probable carboxypeptidase X1,29566,0.0507040316118484,0.00453392600575607,0.0418175366405665,0.0595905265831303,5.6317454893376e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDT,D-dopachrome decarboxylase,24938,0.0302073177985241,0.00270321146440117,0.0249090233282978,0.0355056122687504,6.36086789393639e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0236399432954629,0.0021161049381976,0.0194923776165956,0.0277875089743302,6.43202651600621e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRH,Corticoliberin,28751,0.0638655293611348,0.00573676010951675,0.0526214795464819,0.0751095791757876,9.95880573609265e-29
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0292286733087179,0.0026252066333098,0.0240832683074307,0.0343740783100052,1.0086336036991e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA4,Laminin subunit alpha-4,29581,0.024565807555129,0.00220694564828172,0.0202401940844968,0.0288914210257612,1.00943025031955e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMM2,Phosphomannomutase 2,24111,0.0444041014188947,0.0039914024051367,0.0365809527048268,0.0522272501329626,1.11437092355453e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOB,Apolipoprotein B-100,24951,0.0165915455021702,0.00149188251240576,0.0136674557778549,0.0195156352264855,1.15536777426988e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR1,Complement receptor type 1,24903,0.0264679293476835,0.0023817526559793,0.0217996941419641,0.0311361645534029,1.26946453104037e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY75,Lymphocyte antigen 75,29434,0.0284857559970776,0.00256680790107183,0.0234548125109768,0.0335166994831784,1.46614395771717e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLTA,Clathrin light chain A,28916,0.0345095663350154,0.00311093376740636,0.0284121361508989,0.0406069965191319,1.54927942493204e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0276193531740293,0.00249026368718475,0.0227384363471472,0.0325002700009114,1.585182440973e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS27,Serine protease 27,29395,0.0294764745532687,0.00266006114456481,0.0242627547099217,0.0346901943966157,1.76419569404315e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMA,Granzyme A,29786,0.0253335703503699,0.00228808424297408,0.0208489252341407,0.0298182154665991,1.95024528344533e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF22,Kinesin-like protein KIF22,24111,0.090253172790909,0.00815916059459667,0.0742612180254995,0.106245127556318,2.25510857942582e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBD,Thrombomodulin,29478,0.0209280700700021,0.00189313299870184,0.0172175293925465,0.0246386107474577,2.36466962074898e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAP18,Chromatin complexes subunit BAP18,24845,0.0484669122737606,0.00439440856880112,0.0398538714789104,0.0570799530686108,3.21244540658693e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB2,Calretinin,28774,0.0222019586427812,0.00201824645834445,0.0182461955844261,0.0261577217011364,4.31791711138555e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HPCAL1,Hippocalcin-like protein 1,29786,0.053151504599736,0.00484442286563698,0.0436564357830875,0.0626465734163845,5.91510059311283e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0481994228451467,0.00439664220845773,0.0395820041165695,0.0568168415737238,6.71596087271488e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HGF,Hepatocyte growth factor,29786,0.024876568746068,0.00226983762377826,0.0204276870034626,0.0293254504886734,6.75548165087998e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL1,Fc receptor-like protein 1,29478,0.0328706318525581,0.00300090814952892,0.0269888518794814,0.0387524118256347,7.2307387150603e-28
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH3,Neurexophilin-3,24229,0.021936243956195,0.0020086416859647,0.0179993062517042,0.0258731816606858,1.06239851479467e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF6,SLAM family member 6,28797,0.0275505458010873,0.00252603117345716,0.0225995247011113,0.0325015669010634,1.21346112563231e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI1,Neuroserpin,24329,0.0221203750690978,0.0020295545890808,0.0181424480744994,0.0260983020636961,1.34800482900731e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.0308247649820227,0.00283902946845016,0.0252602672238604,0.036389262740185,2.11750406657687e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENAH,Protein enabled homolog,28931,0.0341958593198298,0.00315062324451568,0.0280206377605791,0.0403710808790805,2.16337090896959e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSL,Cathepsin L1,29478,0.0174401296414488,0.00160789621293941,0.0142886530640876,0.0205916062188101,2.33287531583085e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSHB,Thyrotropin subunit beta,29478,0.0550848864003996,0.00508283178027003,0.0451225361110703,0.0650472366897288,2.57620861286417e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,28797,0.0283393208618487,0.00261556152965063,0.0232128202637335,0.0334658214599639,2.6561485620704e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSN,Gelsolin,24845,0.0136905342386146,0.00126382054936678,0.0112134459618557,0.0161676225153734,2.77435623587477e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BP1,SH3 domain-binding protein 1,24805,0.0343607565712578,0.0031754478897295,0.028136878707388,0.0405846344351276,3.15796332273474e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM2,Paralemmin-2,24845,0.0271159836960634,0.00250968608473208,0.0221969989699886,0.0320349684221383,3.7652200248168e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA14,Carbonic anhydrase 14,29725,0.0253476557665253,0.00235066682574506,0.020740348788065,0.0299549627449856,4.63928720234791e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0337589007335448,0.00313085601174012,0.0276224229505341,0.0398953785165554,4.68356146624296e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSD,Cathepsin D,27442,0.0288508978713535,0.00268765225343922,0.0235830994546127,0.0341186962880944,7.91605049636417e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.0476650117964454,0.00444161235017076,0.0389594515901107,0.0563705720027801,8.14264223089547e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0272137790598606,0.00253698251087012,-0.0321862647811661,-0.0222412933385552,8.5280094498433e-27
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0443595834764982,0.00414272772652742,0.0362398371325045,0.052479329820492,1.06964704451231e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA6,Corticosteroid-binding globulin,24966,0.0119675700357898,0.00111770201577892,0.00977687408486312,0.0141582659867165,1.07508228677605e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMD,Dystrophin,24240,0.0366542165211561,0.00342399716952432,0.0299431820688885,0.0433652509734238,1.10525151558376e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIPF,Gastric triacylglycerol lipase,24240,0.043276968079469,0.00404679279181691,0.0353452542075078,0.0512086819514301,1.24326903913759e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP3,Stromelysin-1,29443,-0.034572622094485,0.00324105806387984,-0.0409250958996895,-0.0282201482892805,1.62254623600019e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMNL1,Formin-like protein 1,28774,0.0431132328275701,0.00405550588741979,0.0351644412882273,0.0510620243669129,2.39849145221446e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVALB,Parvalbumin alpha,29599,0.0788239374154692,0.00741595991913161,0.0642886559739713,0.0933592188569672,2.43820510872187e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS2,Trypsin-2,29594,0.0375077695793834,0.00353447017943395,0.0305802080276929,0.044435331131074,2.92227420654061e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0504070640621364,0.00476021027282874,0.0410770519273921,0.0597370761968807,3.73251118901876e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGA,Chromogranin-A,24938,-0.0615339606162319,0.00581848235392475,-0.0729381860299244,-0.0501297352025394,4.39187528165648e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCT,Secretin,24195,0.0328511894877297,0.00311147982820411,0.0267526890244497,0.0389496899510098,5.31115289725e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP1,Guanylate-binding protein 1,24816,0.0451140319396342,0.00428145090627151,0.036722388163342,0.0535056757159264,6.6107306876577e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIT,Vitrin,24922,0.0262792089732553,0.00249432373616497,0.021390334450372,0.0311680834961387,6.71183804555585e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGED1,Melanoma-associated antigen D1,28797,0.0335893214135459,0.00319430385622902,0.027328485855337,0.0398501569717548,8.17393449788526e-26
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTN4R,Reticulon-4 receptor,29725,0.0234069152667165,0.00223206495124802,0.0190320679622704,0.0277817625711626,1.1030981366459e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAA10,N-alpha-acetyltransferase 10,24111,0.0354124374513385,0.0033818808951479,0.0287839508968486,0.0420409240058283,1.32924918387188e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMP,Cartilage oligomeric matrix protein,29214,0.0232763565253329,0.00222544196035324,0.0189144902830406,0.0276382227676253,1.47547543947858e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.033066868352317,0.00316501716232826,0.0268634347141536,0.0392703019904804,1.69723518696175e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.0302524923449964,0.00289878603450406,0.0245708717173684,0.0359341129726243,1.87940122402038e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GC,Vitamin D-binding protein,24966,0.0179103516386329,0.00171686146064623,0.0145453031757662,0.0212754001014995,1.99734590313438e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE2,Angiotensin-converting enzyme 2,28916,0.0354813556375793,0.00341494840007099,0.0287880567734401,0.0421746545017184,3.05007230181993e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.0788529920550159,0.00758952134646305,-0.0937284538940835,-0.0639775302159483,3.05620739496451e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN3,Calsyntenin-3,24845,0.0210193323821184,0.00202373411553074,0.0170528135156782,0.0249858512485587,3.22039529078401e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.0360904603051788,0.00347789743815271,0.0292737813263995,0.0429071392839581,3.55983072648262e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TREH,Trehalase,24938,0.0514367509050059,0.00496255421800136,0.0417101446377232,0.0611633571722885,4.02501151128474e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C7orf50,Uncharacterized protein C7orf50,24845,0.015295245394316,0.00147891848236677,0.0123965651688771,0.0181939256197548,5.10431535551751e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ING1,Inhibitor of growth protein 1,28719,0.0314114794232518,0.00303951525864553,0.0254540295163066,0.0373689293301971,5.44955006430526e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MET,Hepatocyte growth factor receptor,29507,0.0135078492458682,0.00130723177685366,0.010945674963235,0.0160700235285013,5.50313290753718e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPAG1,Sperm-associated antigen 1,24867,0.0396339016636663,0.00383669192610312,0.0321139854885041,0.0471538178388284,5.77856265332351e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERI1,3'-5' exoribonuclease 1,24445,0.0231997362669534,0.00224824384913853,0.0187931783226419,0.027606294211265,6.50221913290476e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0205062961217371,0.00198767166210748,0.0166104596640065,0.0244021325794678,6.52799569271507e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASSF2,Ras association domain-containing protein 2,28797,0.0380466690858524,0.00368965916744563,0.030814937117659,0.0452784010540458,6.89332016097005e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.02396784874197,0.00232522346952933,-0.0285252867422475,-0.0194104107416925,7.16516311226051e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0226559991369787,0.0021994398284474,0.0183450970732218,0.0269669012007356,7.70317761556589e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0304682357267694,0.00295865759254132,-0.0362672046081504,-0.0246692668453884,7.91944792640511e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XG,Glycoprotein Xg,29693,0.0219136386612821,0.00212824234775212,0.0177422836596879,0.0260849936628762,8.03778457194257e-25
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0774243420016893,0.00753846069694961,0.0626489590356681,0.0921997249677105,1.07178973422057e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA1,Carboxypeptidase A1,29820,0.0411107820730099,0.00401526795070099,0.033240856889636,0.0489807072563839,1.46206553861367e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.0458773200187849,0.00448107629181083,-0.0546602295507341,-0.0370944104868357,1.47321736086819e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PER3,Period circadian protein homolog 3,24229,0.0815444400296654,0.00796593061093582,0.0659312160322312,0.0971576640270997,1.52446667082572e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.02318749825381,0.00226871691698926,-0.027634183411109,-0.0187408130965111,1.76613876866636e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG4,Desmoglein-4,29242,0.0333990840193869,0.00328110791446153,0.0269681125070423,0.0398300555317315,2.69581953031465e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRD1,Natural killer cells antigen CD94,29786,0.0311416049435267,0.00306373532611323,0.0251366837043447,0.0371465261827086,3.12559476746787e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,24229,0.0218507276953097,0.00215154976672061,0.0176336901525373,0.0260677652380821,3.49083987855923e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD86,T-lymphocyte activation antigen CD86,24805,0.0201363752804343,0.00198572841840452,0.0162443475803614,0.0240284029805071,4.06839103632064e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD72,B-cell differentiation antigen CD72,24381,0.0286175504616363,0.002840306482411,0.0230505497561107,0.0341845511671619,7.89343405154262e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A13,Protein S100-A13,24229,0.0235070819882538,0.00233471659960904,0.0189310374530201,0.0280831265234875,8.48073538532698e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NID2,Nidogen-2,29443,0.048751628786643,0.0048431950979741,0.0392589663946138,0.0582442911786723,8.53301266395193e-24
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0460764825648115,0.00458562112195628,0.0370886651657772,0.0550642999638458,1.02377327662785e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0239456076919505,0.00238391821533855,0.0192731279898869,0.028618087394014,1.05908048468081e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0498290958525456,0.004971210130537,0.0400855239966931,0.0595726677083981,1.33435495720243e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,-0.0217471702346557,0.00217111613698511,-0.0260025578631465,-0.0174917826061649,1.40689610580473e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,29434,0.0309824345268501,0.00309518286623717,0.0249158761090253,0.037048992944675,1.50415345224467e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0218675035334852,0.00218840361782064,0.0175782324425567,0.0261567746244136,1.82618146835361e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEP1A,Meprin A subunit alpha,24805,0.0476278513078242,0.00477350861098921,0.0382717744302854,0.0569839281853631,2.11612411028884e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP9,Caspase-9,24229,0.0417136047852236,0.00418083874412768,0.0335191608467334,0.0499080487237139,2.12562668349472e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGKZ,Diacylglycerol kinase zeta,28931,0.023333740952937,0.0023474857865016,0.0187326688113939,0.0279348130944802,3.04185261772843e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0314800378456541,0.00317020493718775,0.0252664361687662,0.0376936395225421,3.36106595438935e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.0180150771801936,0.00181714824425405,-0.0215766877389315,-0.0144534666214557,3.93858477995091e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0182317961076475,0.00184158770015178,0.01462228421535,0.021841307999945,4.60381032074229e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0539646563511872,0.00545226208321838,0.0432782226680791,0.0646510900342952,4.70215431362969e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPPK1,Epiplakin,24240,0.0482447213563251,0.00488652339825412,0.038667135495747,0.0578223072169032,6.0220201856213e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM1,Intercellular adhesion molecule 1,29391,0.0187371511884885,0.00190552670139371,0.0150023188537568,0.0224719835232201,8.79646890788437e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCA,Calcitonin,29163,0.0403896010334135,0.00410770790185191,0.0323384935457837,0.0484407085210432,8.83863180754748e-23
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAM,Signal transducing adapter molecule 1,24793,0.0239798770493771,0.00244289001582504,0.01919181261836,0.0287679414803942,1.05493568535511e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS53,Serine protease 53,24845,0.024321599747023,0.00247785648058726,0.019465001045072,0.0291781984489741,1.06111381746305e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0388268088017619,0.00395753692362275,0.0310700364314613,0.0465835811720625,1.11451803540723e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH17,Cadherin-17,29478,-0.0440426728111449,0.00449215159636452,-0.0528472899400193,-0.0352380556822704,1.16791466093445e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PQBP1,Polyglutamine-binding protein 1,28797,0.0360765520774481,0.00368080046228716,0.0288621831713652,0.0432909209835309,1.20625138441265e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0147875660605248,0.00151052477500754,0.01182693750151,0.0177481946195396,1.36941708525623e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN5,Contactin-5,29511,0.0239664075684772,0.00245021038241563,0.0191639952189425,0.0287688199180118,1.46501092967101e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.043461572022073,0.00444613407258321,0.0347471492398099,0.0521759948043361,1.58074464835003e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VASN,Vasorin,29065,0.0177697642857566,0.00181887590507953,0.0142047675118008,0.0213347610597125,1.64625153282153e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTN2,Dynactin subunit 2,29349,0.0608549992605836,0.00623623787432222,0.0486319730269121,0.0730780254942551,1.83926131498998e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENR,Density-regulated protein,24229,0.0371435763683363,0.00381347102372126,0.0296691731618427,0.04461797957483,2.23543351376804e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0328138552829758,0.00337121778298641,0.0262062684283224,0.0394214421376291,2.34394817120035e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLF4,Krueppel-like factor 4,24101,0.0256141219532224,0.00263669311274596,0.0204462034522403,0.0307820404542045,2.87381507821726e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMB1,Laminin subunit beta-1,24240,0.0195359885413552,0.00201646250952278,0.0155837220226906,0.0234882550600199,3.7110528107259e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0315265181951978,0.00325602994149259,-0.0379083368805232,-0.0251446995098723,3.86051884811388e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPL,Periplakin,24229,0.0209807147268042,0.00217164776104157,0.0167242851151627,0.0252371443384457,4.82976156378851e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0227112462938157,0.00235233841457422,0.0181006630012502,0.0273218295863811,5.0624833753027e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AFAP1,Actin filament-associated protein 1,24381,0.0538733273171434,0.00558091471766456,0.0429347344705208,0.0648119201637659,5.22045314136949e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,28719,0.0422766300005262,0.0043832679121059,0.0336854248927986,0.0508678351082537,5.57306526324346e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICOSLG,ICOS ligand,29349,0.0121895026639262,0.0012640775449481,0.00971191067582794,0.0146670946520245,5.67307097760975e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XRCC4,DNA repair protein XRCC4,28774,0.023603051229194,0.00244881062814476,0.0188033823980303,0.0284027200603578,5.93102699265386e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0583661638992709,0.00606595749987225,0.0464768871995213,0.0702554405990205,7.0706698712949e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECM1,Extracellular matrix protein 1,24349,0.0234795518185022,0.00244145740475609,0.0186942953051802,0.0282648083318241,7.41116686077636e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0377634753754901,0.00392961763061378,0.030061424819487,0.0454655259314931,7.93854706406679e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMB,RGM domain family member B,29694,0.0170990401556865,0.00177972565715852,0.0136107778676558,0.0205873024437172,7.98323178307962e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBN,Nibrin,28931,0.0332871249894995,0.00346870523699725,0.0264884627249849,0.0400857872540141,8.92000417513166e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCRIB,Protein scribble homolog,24240,0.0575083525169281,0.00599605866868472,0.0457560775263061,0.0692606275075502,9.5330243119005e-22
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM1,Neural cell adhesion molecule 1,29594,0.0191445811577959,0.00199764993261849,0.0152291872898637,0.0230599750257282,1.0083333023027e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5,T-cell surface glycoprotein CD5,29683,0.0217057097420484,0.00227083909308242,0.0172548651196069,0.02615655436449,1.28417434084137e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGMN,Legumain,29581,0.0226092299527411,0.00236739223311177,0.017969141175842,0.0272493187296402,1.38980919311686e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0474459767505245,0.00497207845848627,0.0377007029718915,0.0571912505291576,1.51799006485593e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOLA1,BolA-like protein 1,24101,0.034579544557184,0.00362363835884683,0.0274772133738442,0.0416818757405238,1.51820146425116e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.020392570482704,0.00213730472135426,-0.0245816877365584,-0.0162034532288497,1.53889606065083e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0298944796470551,0.00313518253720199,0.0237495218741392,0.036039437419971,1.610167449398e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0308806544884749,0.00323892178403763,0.0245323677917612,0.0372289411851887,1.62179928563222e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.019011702518351,0.00199550874928447,0.0151005053697535,0.0229228996669486,1.75717337391365e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0358966799465748,0.00377589898949207,0.0284959179271703,0.0432974419659793,2.13872064505528e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17C,Interleukin-17C,28931,-0.0442326254759054,0.00465952068440098,-0.0533652860173313,-0.0350999649344795,2.41245315476404e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.0349593949459601,0.00368504548136021,0.0277367058024941,0.0421820840894261,2.58856220549837e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAP,Prosaposin,24761,0.017866103871395,0.00188515277634814,0.0141712044297526,0.0215610033130374,2.83638535866054e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ASAH1,Acid ceramidase,24732,0.0292239160511087,0.00308783195407733,0.0231717654211171,0.0352760666811002,3.21280123709426e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0163483936768666,0.00172763752015833,0.0129622241373563,0.019734563216377,3.2538533673722e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMOT,Angiomotin,24381,0.0251710798421963,0.00267295106835521,0.0199320957482201,0.0304100639361725,5.04154015979581e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.052390846173392,0.00556974634678892,0.0414741433336857,0.0633075490130983,5.5073023439798e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.0643977342624267,0.00685294234766582,0.0509659672610017,0.0778295012638517,6.07764776927378e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,24883,0.00924019604118846,0.000983633427335493,0.0073122745236109,0.011168117558766,6.260027626014e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,24888,0.0304574548820498,0.00324654396752689,0.0240942287056971,0.0368206810584025,7.04169697456577e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAPK2,Death-associated protein kinase 2,24229,0.0334228605703821,0.00356274247364045,0.0264398853220468,0.0404058358187174,7.07584738026442e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.0176541453225754,0.00188346120854281,-0.0213457292913193,-0.0139625613538315,7.51977707830142e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP2,Retinol-binding protein 2,29349,-0.0476085087877771,0.00508421457429911,-0.0575735693534034,-0.0376434482221508,8.20955607248474e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY96,Lymphocyte antigen 96,29218,-0.0220177303985268,0.00235402227285781,-0.0266316140533281,-0.0174038467437255,9.08836378069606e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0307119103001436,0.00328452431403731,0.0242742426446304,0.0371495779556567,9.47216382429284e-21
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.027686558747773,0.00296324241686865,0.0218786036107105,0.0334945138848356,1.01152047129515e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSS,Cathepsin S,23389,0.0151570901461254,0.00162225617211312,0.0119774680487837,0.0183367122434671,1.01554540113762e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL11,C-X-C motif chemokine 11,29694,0.0485216690410313,0.00520248777184983,0.0383247930082056,0.058718545073857,1.16640124482411e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0408515384252082,0.00439066788230545,0.0322458293758895,0.0494572474745269,1.45837300189324e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1A,Protein phosphatase 1A,28797,0.0191255455384486,0.00205824253879958,0.0150913901624015,0.0231597009144958,1.61502601517866e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0155534649217182,0.00167632154066641,0.012267874702012,0.0188390551414243,1.85735783429812e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1A,Lithostathine-1-alpha,29353,-0.0301167569924539,0.00325492549921314,-0.0364964109709117,-0.0237371030139961,2.33370271631867e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA2,Adenosine deaminase 2,29328,-0.0261239440034827,0.0028307961341139,-0.0316723044263459,-0.0205755835806194,2.92403223453581e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTL1,Cytokine-like protein 1,24938,0.0147693992478075,0.00160085258555119,0.0116317281801271,0.0179070703154878,3.0268326357335e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0186538963338883,0.00202243900751089,0.0146899158791669,0.0226178767886096,3.06155928047461e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.0206298072497231,0.00223659811198419,0.0162460749502341,0.0250135395492121,3.08996681109002e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0425599049204223,0.00462183161003204,0.0335011149647595,0.0516186948760851,3.52339544283509e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,24240,0.0242604035235608,0.00263444445827516,0.0190968923853415,0.0294239146617801,3.55337452538091e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0350165816537073,0.00380642231384447,0.0275559939185721,0.0424771693888424,3.83675282784277e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AK1,Adenylate kinase isoenzyme 1,29478,0.0382121743085039,0.00415547172023088,0.0300674497368514,0.0463568988801565,3.96646155585205e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXN,Thioredoxin,24647,0.0266809918082703,0.00290468835184624,0.0209878026386516,0.0323741809778889,4.41019121910515e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFHR2,Complement factor H-related protein 2,24789,0.034778694630572,0.00378655463971276,0.027357047536735,0.042200341724409,4.43724125957359e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD46,Membrane cofactor protein,29331,0.0173899398583815,0.00189408334970063,0.0136775364929683,0.0211023432237947,4.53578775031929e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0213967389805441,0.00233283759323326,-0.0259691006632812,-0.0168243772978069,5.00374019620543e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX6,Syntaxin-6,28797,0.040715801754151,0.00444538010181139,0.0320028567546006,0.0494287467537013,5.56904532678396e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA3,Protein disulfide-isomerase A3,24381,0.0152355043964926,0.00166394451921968,0.011974173138822,0.0184968356541631,5.78351500324184e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0356718203746997,0.00389752017538648,0.0280326808309422,0.0433109599184572,5.98231476837778e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0210979275297838,0.00231071962311333,-0.0256269379910859,-0.0165689170684816,7.24537724285867e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0247703841123887,0.00271957095183626,0.0194400250467897,0.0301007431779878,8.99292594970707e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0480715747007177,0.00528217664611286,0.0377185084743365,0.0584246409270989,9.63019817136687e-20
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDGF,Hepatoma-derived growth factor,29688,0.0561600185570565,0.00617921940208723,0.0440487485289656,0.0682712885851475,1.06462803383052e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0439828815721493,0.00484502815252518,0.0344866263931999,0.0534791367510986,1.17530217248498e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.0181845100317715,0.00200310726211583,-0.0221106002655185,-0.0142584197980245,1.18441228820532e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDM1,Nuclear protein MDM1,24195,0.018825738126274,0.00207816279860708,0.0147525390410041,0.0228989372115439,1.41571706741848e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0233922911849453,0.00258672764640655,0.0183223049979885,0.0284622773719021,1.61164819707714e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIT2,Slit homolog 2 protein,28774,0.0311254976916194,0.00344198002897307,0.0243792168348321,0.0378717785484066,1.61904290429628e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDCP1,CUB domain-containing protein 1,29218,0.0311259712829497,0.00344242494041031,0.0243788183997455,0.0378731241661539,1.6328754593026e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRK1,Protein BRICK1,28774,0.0267336662428046,0.00296025131942804,0.0209315736567256,0.0325357588288836,1.80672452916578e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMS,Spermine synthase,24101,0.0383138537704234,0.00424516110873665,0.0299933379972996,0.0466343695435472,1.92271793543105e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,24445,0.042237489728371,0.00468153203851461,0.0330616869328824,0.0514132925238596,1.97666879538106e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0189251428466342,0.00209950328321542,-0.0230401692817364,-0.014810116411532,2.10201319516293e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,29378,0.0242199114567308,0.00269174980182774,0.0189440818451484,0.0294957410683132,2.4374082869117e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2orf69,UPF0565 protein C2orf69,24195,0.0355884246017102,0.00395475136267402,0.0278371119308691,0.0433397372725513,2.44345999211475e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSR,Insulin receptor,24229,0.0101482093776643,0.00112776197636554,0.00793779590398789,0.0123586228513408,2.45132719377614e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL2A1,Collagen alpha-1(II) chain,24240,0.0481197286078964,0.00535297135868804,0.0376279047448678,0.0586115524709249,2.66436183829491e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0318807684600035,0.0035592498914616,0.0249046386727388,0.0388568982472682,3.52129683502614e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0323871994899043,0.00361536953290287,0.0253010752054146,0.0394733237743939,3.53275577100844e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSNK1D,Casein kinase I isoform delta,24229,0.037991330716065,0.00424277408217797,0.0296754935149962,0.0463071679171338,3.6570620820945e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS3BP,Galectin-3-binding protein,24966,0.0180358362324384,0.0020146386343401,0.0140871445091318,0.0219845279557449,3.71522745682745e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QL2,Complement C1q-like protein 2,24229,0.0255413672293142,0.00285337969795018,0.0199487430213318,0.0311339914372965,3.76065529433617e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELENOP,Selenoprotein P,24966,0.0134362707948676,0.00150234723016579,0.0104916702237426,0.0163808713659926,4.02511683154959e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEK,Angiopoietin-1 receptor,29566,0.0128915525698734,0.00144463338013662,0.0100600711448056,0.0157230339949412,4.76177605735621e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMPER,BMP-binding endothelial regulator protein,24381,0.013509278404258,0.00151546696796335,0.0105389631470498,0.0164795936614661,5.24691391666355e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.032062112762817,0.00359731744581081,0.0250113705690278,0.0391128549566062,5.31157197790684e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.0284514780379954,0.00319435788741907,-0.0347124194973367,-0.022190536578654,5.54857531687976e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD274,Programmed cell death 1 ligand 1,29218,0.0201491486972204,0.00226516561048842,0.0157094241006631,0.0245888732937778,6.15900161856209e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0565008438710774,0.00635452009687505,0.0440459844812024,0.0689557032609525,6.37225115441316e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,24240,0.0308864054511377,0.00347478087550813,0.0240758349351417,0.0376969759671336,6.60190007854413e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPH1,Neurexophilin-1,28774,0.0224587495479828,0.0025277127659772,0.0175044325266674,0.0274130665692981,6.75591898014073e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLRX,Glutaredoxin-1,29291,0.032891691701787,0.00370770272850455,0.0256245943539181,0.0401587890496559,7.64013659287126e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0363473309222153,0.00411013607489122,0.0282914642154285,0.044403197629002,9.91082506376929e-19
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC13,Mucin-13,28774,0.0300455925332812,0.00340148085608675,0.0233786900553511,0.0367124950112112,1.07489117443022e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0290041062017149,0.00328644707802268,0.0225626699287904,0.0354455424746393,1.1631818650214e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APRT,Adenine phosphoribosyltransferase,29192,0.0278095190277568,0.00315927113898486,0.0216173475953464,0.0340016904601671,1.41023717337709e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD101,Immunoglobulin superfamily member 2,24805,0.0249795443196986,0.00284162823783501,0.019409952973542,0.0305491356658552,1.58257500688778e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD14,Monocyte differentiation antigen CD14,28954,0.0240375634246127,0.00273925694291129,0.0186686198165066,0.0294065070327188,1.79766984246579e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL19,C-C motif chemokine 19,29694,0.071127404157633,0.00812228471369663,0.0552077261187876,0.0870470821964784,2.1082250428153e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0145867269300164,0.00166570168688024,0.0113219516237312,0.0178515022363017,2.10838964048837e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0240084280457825,0.00274313641134425,0.0186318806795478,0.0293849754120173,2.22725864754087e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGF,Placenta growth factor,29786,0.0150638213803481,0.00173292890621425,0.0116672807241682,0.0184603620365281,3.71764993411344e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0294898459629729,0.00339262498146304,0.0228403009993053,0.0361393909266404,3.73571576439041e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTN,Pleiotrophin,28916,0.0287638615852382,0.00331021410884251,0.0222758419319069,0.0352518812385695,3.83152385568549e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGRN,Neugrin,24845,0.0127744838252931,0.00147033312450645,0.00989263090126047,0.0156563367493258,3.90662614982808e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.020638878231577,0.00237798355955829,0.0159780304548427,0.0252997260083112,4.18922744588225e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0401673323318543,0.00462978295746428,0.0310929577352243,0.0492417069284843,4.35781424123088e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,29566,0.0242549767986397,0.00279719982496879,0.0187724651417008,0.0297374884555785,4.49211414982441e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX1,Peroxiredoxin-1,28669,-0.0517055130629072,0.00596853096902782,-0.0634038337622017,-0.0400071923636127,4.83146251060971e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGES2,Prostaglandin E synthase 2,24037,0.0316310614624549,0.00365842559306418,0.0244605473000491,0.0388015756248607,5.65678988993127e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0174257617400368,0.00201731993115291,0.0134718146749771,0.0213797088050966,6.00020602287197e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELOB,Elongin-B,24111,0.0227387688331984,0.00263443954256959,0.017575267329762,0.0279022703366348,6.43170551386828e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0210976624964644,0.00244779103690125,0.016299992064138,0.0258953329287909,7.15613746950257e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCP1,Plastin-2,24938,0.0271060246172861,0.00314533472988242,0.0209411685467166,0.0332708806878557,7.22021699562592e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0218152752676115,0.00253268672019627,0.0168512092960268,0.0267793412391962,7.44310676549166e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0352351975525606,0.00409549808369415,-0.0432623737966011,-0.02720802130852,8.11235342601129e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0222039234980309,0.0025821597247383,0.0171428904375438,0.027264956558518,8.43505234903981e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.0313643628654584,0.00364761772862789,0.0242150321173477,0.038513693613569,8.47088906803342e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAYN,Layilin,29163,-0.0198918817096587,0.00231431384245534,-0.0244279368408712,-0.0153558265784463,8.72415777183606e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX7,Syntaxin-7,24229,0.0283526112173446,0.00329896193437963,0.0218866458259605,0.0348185766087286,8.86719421706692e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LACRT,Extracellular glycoprotein lacritin,24732,0.0283436986645925,0.00330207357594188,0.0218716344557464,0.0348157628734386,9.72669539629334e-18
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTRK3,NT-3 growth factor receptor,29694,0.0122763455768821,0.00143190693344536,0.00946980798732924,0.015082883166435,1.05251122502919e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPB1,Carboxypeptidase B,29820,0.0333842438033286,0.00390049020205534,0.0257392830073001,0.0410292045993571,1.19242744153783e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0253439509897617,0.00296303897501431,0.0195363945987336,0.0311515073807898,1.2651986657879e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0239452972672647,0.00279990129159206,0.0184574907357443,0.0294331037987851,1.2780285382209e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0362012592143026,0.00424428265112795,0.0278824652180918,0.0445200532105134,1.55557953300534e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH1,Protocadherin-1,29713,0.0119692624117582,0.00140352678676596,0.00921834990969689,0.0147201749138194,1.558702670609e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYGD,Gamma-crystallin D,24845,0.0546057061207357,0.00642062118386337,0.0420212886003635,0.0671901236411079,1.92106514170765e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDF1,Endothelial differentiation-related factor 1,24867,0.0383745600860828,0.00451310105579117,0.0295288820167321,0.0472202381554335,1.95114852355836e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0195670115917429,0.00230605010254124,0.0150471533907621,0.0240868697927237,2.25574503371673e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0578213355794321,0.0068143560988467,0.0444651976256925,0.0711774735331716,2.27162932139291e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0225971865647779,0.00267646397709634,-0.0278430559598867,-0.017351317169669,3.23617578410371e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX1,Neuronal pentraxin-1,29443,0.0227081620394728,0.00268968084063788,0.0174363875918225,0.027979936487123,3.24140417434625e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGXT,Serine--pyruvate aminotransferase,29478,0.0429642958749393,0.00509501539331353,0.0329780657040448,0.0529505260458338,3.53246416029767e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL1,Chordin-like protein 1,29536,0.0175503563131875,0.00208264384233749,0.013468374382206,0.021632338244169,3.70656177827015e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0658735078746591,0.00781870097471651,0.0505488539642147,0.0811981617851034,3.79661369272564e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0406439693652931,0.00483919483152425,0.0311591474955055,0.0501287912350806,4.70597424655609e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALCAM,CD166 antigen,29820,0.0108121884699912,0.00129399201783109,0.0082759641150423,0.0133484128249402,6.78439858226201e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKD1,Polycystin-1,24922,0.0146675766638828,0.00176201907587007,0.0112140192751775,0.0181211340525881,8.91312971768111e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENSA,Alpha-endosulfine,24793,0.0291281619404525,0.00350230343322243,0.0222636472113365,0.0359926766695685,9.49154849969455e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL3A1,Collagen alpha-1(III) chain,24938,-0.0128541498225828,0.00154573231220098,-0.0158837851544967,-0.00982451449066883,9.56589919132895e-17
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0211064078197617,0.00256325112747799,0.0160824356099048,0.0261303800296185,1.89741539852718e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0337898003470391,0.00410482790131023,0.0257443376604711,0.0418352630336072,1.93798345641915e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,29545,0.0159993861323323,0.00194486026555872,0.0121874600118372,0.0198113122528274,2.00605713986702e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYM,Ketimine reductase mu-crystallin,24101,0.0416659649170872,0.00506478552168225,0.03173898529459,0.0515929445395844,2.02242880381605e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADA,Adenosine deaminase,29786,0.0189175471194805,0.00230028745822075,0.0144089837013679,0.0234261105375932,2.04764927816065e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHCY,Adenosylhomocysteinase,29478,0.0366642114380022,0.00446529546779771,0.0279122323211187,0.0454161905548857,2.28364906454365e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0172990259811606,0.00210982408864978,0.013163770767407,0.0214342811949142,2.53421278158992e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPB2,Coatomer subunit beta',24111,0.0234342863772808,0.0028604180460091,0.0178278670071029,0.0290407057474586,2.68201614982647e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,24915,-0.0135173582792367,0.00165093099094626,-0.0167531830214914,-0.010281533536982,2.78861473862026e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST5,Cystatin-D,28890,0.0301066286913688,0.00367762072863379,0.0228984920632466,0.0373147653194911,2.80036351174116e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.0230422571514625,0.00281604401066724,0.0175228108905547,0.0285617034123703,2.89082253755478e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0342576765109633,0.00418912015204497,0.0260470010129551,0.0424683520089714,3.00640280655749e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX5,Sorting nexin-5,24240,0.0161744604054662,0.00198001261443725,0.0122936356811692,0.0200552851297632,3.26354877137642e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,29581,0.0220082398216486,0.0026957333097384,0.0167246025345613,0.0272918771087358,3.3659013741273e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CABP2,Calcium-binding protein 2,24195,0.0353233691763156,0.00433550937256304,0.0268257708060921,0.0438209675465392,3.89482848859418e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.020426301062939,0.00251121599228116,-0.0253482844078101,-0.015504317718068,4.344899926733e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.019998283225813,0.00245980749951061,0.0151770605267722,0.0248195059248538,4.49122045221587e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTB,Lymphotoxin-beta,24793,0.0188108551643747,0.00231648737074152,0.0142705399177214,0.0233511704110281,4.86002802054007e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TF,Serotransferrin,24966,0.0116266980322367,0.00143463457335609,0.00881481426845881,0.0144385817960147,5.54648489687043e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPM3,Tropomyosin alpha-3 chain,24111,-0.0237600641332416,0.00293554722879397,-0.0295137367016777,-0.0180063915648054,6.04852892707092e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0476197131989788,0.00588886465726201,0.0360775384707452,0.0591618879272123,6.37869088137406e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,L1CAM,Neural cell adhesion molecule L1,29566,0.0154831986541677,0.0019156282467983,0.0117285672904431,0.0192378300178924,6.5816141195858e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCN1,Ficolin-1,24919,0.0299739625779011,0.00371622558774604,0.0226901604259189,0.0372577647298834,7.60701845593343e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.0204798995029039,0.00254221575957651,-0.0254626423916738,-0.0154971566141339,8.19287908251358e-16
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0410399546890791,0.00512242600190322,0.0309999997253488,0.0510799096528095,1.18078744498053e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME3,Nucleoside diphosphate kinase 3,29497,0.0126522128800071,0.00158026964080034,0.00955488438403842,0.0157495413759758,1.22465370395263e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM3,Myomesin-3,24381,-0.0496231514433669,0.00620050130949791,-0.0617761340099828,-0.037470168876751,1.26709869399176e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0296373255092402,0.00370384949224137,0.0223777805044471,0.0368968705140333,1.28138608078001e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNF,Tumor necrosis factor,28868,0.0202353341250863,0.00253053061028153,0.0152754941289345,0.0251951741212381,1.32783729824159e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.019243489887058,0.00241065343083978,0.014518609162612,0.023968370611504,1.48452962280415e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPQ,Carboxypeptidase Q,24920,0.0195100932837336,0.0024457585276959,0.0147164065694496,0.0243037799980176,1.56196121156113e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSZ,Cathepsin Z,29487,0.0166513215079549,0.00208811984674663,0.0125586066083316,0.0207440364075783,1.58739481352303e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.0152011000352745,0.00190954941053485,0.0114583831906262,0.0189438168799228,1.77294675855329e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN1,Prorelaxin H1,24867,-0.0363776467012378,0.00457200503403967,-0.0453387765679555,-0.02741651683452,1.84315782686322e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTXR,Neuronal pentraxin receptor,29478,0.0179097166582744,0.00225225778140777,0.0134952914067152,0.0223241419098337,1.90211953044519e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0219999832451985,0.00276705567255035,0.0165765541269998,0.0274234123633972,1.93330809198817e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BPIFA2,BPI fold-containing family A member 2,23405,-0.0584922411103054,0.00735919048564839,-0.0729162544621763,-0.0440682277584346,1.97753662345372e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDA,Cytidine deaminase,24890,0.0245603432916643,0.00309690939961238,0.018490400868424,0.0306302857149045,2.27207491287981e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL3,Myosin light chain 3,24240,-0.038453396294135,0.00485176600152503,-0.0479628576571241,-0.028943934931146,2.36676789321031e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTPN,Myotrophin,28916,0.0171811030534901,0.00217067902169038,0.0129265721709769,0.0214356339360032,2.55884633349696e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDHB15,Protocadherin beta-15,24793,-0.0210076601430796,0.00265585801218831,-0.0262131418469687,-0.0158021784391905,2.68218992711455e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPC1,Glypican-1,29725,0.0153701927236374,0.00194794254862116,0.0115522253283399,0.0191881601189348,3.11327445551117e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLC,Galectin-10,29426,-0.0345995631052955,0.00438674084232375,-0.0431975751562501,-0.026001551054341,3.1942842684734e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIFR,Leukemia inhibitory factor receptor,29434,-0.0126700198230255,0.00160776254130334,-0.01582123440398,-0.00951880524207091,3.37195409463259e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0235037300729054,0.00298591029086074,-0.0293561142429925,-0.0176513459028184,3.62221179179353e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0402267565409989,0.00511184532967718,0.0302075396948317,0.0502459733871662,3.71435806910174e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0346448988622923,0.0044164127252436,-0.0433010678037698,-0.0259887299208149,4.49094776855248e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLPS,Colipase,29400,0.0367529417486869,0.00469150126193638,0.0275575992752916,0.0459482842220822,4.88691900637152e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0132830815964945,0.00169559798554105,-0.016606453648155,-0.00995970954483407,4.92327184947668e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,29349,0.0187751466652977,0.00239843248423029,0.0140742189962063,0.023476074334389,5.11950506297949e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO1,Roundabout homolog 1,29497,0.0124528548567688,0.00159266889501836,0.00933122382253285,0.0155744858910048,5.50744446491819e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,28722,0.0277142331449827,0.00355035906340152,0.0207555293807157,0.0346729369092497,6.10151564816707e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0307290884671865,0.00394433730672458,0.0229981873460063,0.0384599895883666,6.92368312265073e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0182591399387414,0.00235218279199107,-0.0228694182110439,-0.0136488616664389,8.63677221587342e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0174161861393143,0.00224508946064333,0.0130158107964533,0.0218165614821752,8.94102151510479e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR15L,Protein GPR15L,24805,0.0314856348908216,0.0040584224280557,0.0235311269318324,0.0394401428498108,8.95233288052839e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG1B,Lithostathine-1-beta,29820,-0.028893489510178,0.00372829783071626,-0.0362009532583819,-0.0215860257619741,9.49701322734483e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD83,CD83 antigen,29434,0.0174141134626818,0.00224826923775697,0.0130075057566781,0.0218207211686854,9.82090098649942e-15
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,29443,-0.0218217661388863,0.00282974605876515,-0.027368068414066,-0.0162754638637066,1.28199376214592e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00895907736031958,0.00116591981572388,0.00667387452150076,0.0112442801991384,1.5881871754228e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0299157569651413,0.0038977469913131,0.0222761728621676,0.0375553410681149,1.70459050590982e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCA2A,Guanylin,29333,-0.0173818255457407,0.00226573463540126,-0.0218226654311272,-0.0129409856603542,1.75113529385368e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCOF1,Treacle protein,24922,0.0159151474094204,0.00207494160754299,0.0118482618586361,0.0199820329602046,1.78044103026682e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM2,Myomesin-2,24111,-0.0260003360942332,0.00339387603469506,-0.0326523331222355,-0.0193483390662309,1.91488067944723e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0160928088669723,0.00210558129451074,0.0119658695297312,0.0202197482042133,2.18703806906833e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0282612435289171,0.00371795520215781,0.0209740513326878,0.0355484357251464,3.03674732910232e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA4,Carbonic anhydrase 4,29820,-0.0119484620316885,0.00157273034503292,-0.015031013507953,-0.00886591055542397,3.11293223930388e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD1,Bromodomain-containing protein 1,24445,-0.0154770843793358,0.0020374600769541,-0.0194705061301659,-0.0114836626285058,3.15719373067266e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX2,Sorting nexin-2,24793,0.040974495285021,0.00539474921304361,0.0304007868274555,0.0515482037425865,3.18026552611398e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL25,C-C motif chemokine 25,29786,0.0246597398636547,0.00324955627022204,0.0182906095740195,0.0310288701532899,3.32695190797486e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0320553951985567,0.00422470414464669,0.0237749750750492,0.0403358153220642,3.35712683580749e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRN,Progranulin,29313,0.0123694649050311,0.0016316311305821,0.00917146788909024,0.0155674619209721,3.52917970844064e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL32,Interleukin-32,29434,-0.0218033130326166,0.00287962087847944,-0.0274473699544363,-0.0161592561107969,3.79473562983285e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMMT,MICOS complex subunit MIC60,24793,0.0223340330615927,0.00294996260832582,0.016552106349274,0.0281159597739113,3.8339809785523e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,29725,0.0184307732312734,0.00244097865177126,0.0136464550738018,0.0232150913887451,4.45790818823513e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LGALS7_LGALS7B,Galectin-7,29320,0.02092464385228,0.0027773946859793,0.0154809502677606,0.0263683374367994,5.06616966789312e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0182462939235797,0.0024255865775765,0.0134921442315298,0.0230004436156297,5.5647413400813e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERMAP,Erythroid membrane-associated protein,24229,0.0223161868675708,0.00296779124495787,0.0164993160274534,0.0281330577076882,5.69117015794165e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0282153598412544,0.00376186403223982,0.0208421063380643,0.0355886133444444,6.54741329916671e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG3,Proteasome assembly chaperone 3,29434,0.0249595542810996,0.00333064490264682,0.0184314902719118,0.0314876182902873,6.87298802072853e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,24381,0.0140155007665823,0.00187151529884237,0.0103473307808513,0.0176836707523133,7.18357044964675e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEPR,Leptin receptor,29478,-0.0153605735504009,0.00205388807165259,-0.01938619417084,-0.0113349529299618,7.71045508833725e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST2,Bone marrow stromal antigen 2,29694,0.0259365207789222,0.00347016639456028,0.0191349946455841,0.0327380469122604,7.98499861224644e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYT1,Synaptotagmin-1,24845,0.0196083581119339,0.0026240689536843,0.0144651829627127,0.0247515332611551,8.12806200618875e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,29434,-0.0323647761998281,0.00433480713374774,-0.0408609981819737,-0.0238685542176825,8.47938298867959e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSDE1,Cold shock domain-containing protein E1,24111,0.0587535011557283,0.00787085141819733,0.0433266323760615,0.074180369935395,8.63209984942931e-14
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0201689555838433,0.00270978991504855,0.0148577673503482,0.0254801438173385,1.0163019052683e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0138799666604285,0.00186618062421153,0.0102222526369739,0.0175376806838831,1.05908675777626e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0140692010816581,0.00189211781018498,-0.0177777519896207,-0.0103606501736955,1.06878503206988e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAM,Basal cell adhesion molecule,29443,-0.0118229819858307,0.0015927580108762,-0.014944787687148,-0.00870117628451331,1.17627363621463e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0150709121820799,0.00203516877472304,-0.019059842980537,-0.0110819813836227,1.35225921283196e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.02512530045983,0.0033952008143319,0.0184707068637395,0.0317798940559205,1.39531589754379e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.0122416644273295,0.00165526370089747,-0.0154859812810885,-0.00899734757357042,1.45342960409407e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA2,Annexin A2,23907,0.0347927931103443,0.00470976753971052,0.0255616487325117,0.044023937488177,1.5466999187863e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0221447953386217,0.00301096559034551,-0.0280462878956989,-0.0162433027815445,1.96279622976944e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0231299683696461,0.00315131729037589,0.0169533864805094,0.0293065502587829,2.20514395146364e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.0318767614229837,0.00435010664184059,0.0233505524049762,0.0404029704409913,2.39971600717074e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGN,Secretagogin,28931,-0.0213625157768762,0.00292006296706772,-0.0270858391923289,-0.0156391923614235,2.62554391368776e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0383685848225934,0.00524598562808846,0.02808645299154,0.0486507166536468,2.66276744370325e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,24240,0.0116476021506464,0.001593830422285,0.00852369452296778,0.014771509778325,2.79684498068492e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFIC,Nuclear factor 1 C-type,24867,0.0215370719047243,0.00295442412030036,0.0157464006289356,0.027327743180513,3.19756763725665e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0291828348031879,0.00400588123872048,0.0213313075752957,0.03703436203108,3.29776926663054e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0173735088407844,0.0023851151982867,0.0126986830521425,0.0220483346294264,3.33628035190991e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0257375228103925,0.00353983347199639,0.0187994492052796,0.0326755964155054,3.67824660583699e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POF1B,Protein POF1B,24229,-0.022164838969727,0.00305140052576101,-0.0281455840002185,-0.0161840939392354,3.87669657149684e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DSG3,Desmoglein-3,29589,0.0164012869177124,0.00226290640565279,0.0119659903626329,0.0208365834727918,4.33688294020511e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD93,Complement component C1q receptor,28353,-0.0150802249823113,0.00208306756863288,-0.0191630374168317,-0.0109974125477909,4.62029847291421e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRC,Chymotrypsin-C,29456,0.0305620948532406,0.00422353035710978,0.0222839753533054,0.0388402143531758,4.72880424352266e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0241146389920491,0.00334476781078928,0.0175588940829021,0.030670383901196,5.74733789212971e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0181943423476785,0.00252748164212691,0.0132404783291097,0.0231482063662472,6.25896590041925e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL3,Fc receptor-like protein 3,28931,0.025768996057597,0.00358376268015862,0.0187448212044861,0.0327931709107079,6.61271821435984e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0373152632580579,0.00519001034959965,-0.0474876835432732,-0.0271428429728426,6.64183766181138e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHPS,Deoxyhypusine synthase,24793,0.0194254502886689,0.00270287298531384,0.0141278192374538,0.024723081339884,6.81231842217159e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,24229,-0.058723196546862,0.00817626218159987,-0.0747486704227977,-0.0426977226709262,7.06030862030711e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0162708656132383,0.00227473954856482,0.0118123760980513,0.0207293551284254,8.6986792222122e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OCLN,Occludin,24867,0.0208216951558875,0.00291318191265359,0.0151118586070865,0.0265315317046886,9.08741938336797e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0200389057636966,0.00280542471381477,0.0145402733246197,0.0255375382027736,9.35482652381723e-13
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0408893608958777,0.00573326146374059,0.0296521684269461,0.0521265533648093,1.01664377931414e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARF2,Scavenger receptor class F member 2,29694,-0.0137505351523688,0.00192922701002495,-0.0175318200920177,-0.00996925021271992,1.0455236448716e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA12,Serpin A12,28628,0.0527140844563659,0.0074022473878509,0.0382056795761781,0.0672224893365537,1.09387171676524e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF1,Trefoil factor 1,29319,-0.0371260005637035,0.00522386815032757,-0.0473647821383455,-0.0268872189890614,1.21307385158329e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLO1,Lactoylglutathione lyase,28916,0.0271930186299755,0.00383256922184513,0.0196811829551591,0.034704854304792,1.32094719915352e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPO,Erythropoietin,29434,-0.0356170252449957,0.0050200521584288,-0.0454563274755162,-0.0257777230144753,1.32322414297343e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN2,Contactin-2,29725,0.0209425653533365,0.00295264544701866,0.0151553802771799,0.0267297504294931,1.34349858898831e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MST1,Hepatocyte growth factor-like protein,24615,0.0301937407744457,0.00426078161415688,0.0218426088106982,0.0385448727381932,1.41323476185261e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,24951,0.0124377991386724,0.00175527186681604,0.00899746627971293,0.0158781319976318,1.4174720069689e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.021151716335547,0.0029854140576724,0.0153003047825091,0.0270031278885849,1.42849323025263e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP9,Fatty acid-binding protein 9,29434,0.0262255061227328,0.00370524781459403,0.0189632204061285,0.0334877918393371,1.49593963405969e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0270453900441379,0.00382125750387489,0.0195557253365431,0.0345350547517327,1.50013192678803e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNLY,Granulysin,29443,0.0244280668008535,0.00345274970112077,0.0176606773866568,0.0311954562150502,1.52832579712717e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHB,Lutropin subunit beta,28797,0.0406819774229832,0.00575180043340598,0.0294084485735075,0.0519555062724589,1.5517942424984e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.019082555228933,0.00270178843378678,0.0137870498987109,0.0243780605591551,1.66723256284518e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LUZP2,Leucine zipper protein 2,24793,0.0209578896114763,0.00297131274518859,0.0151341166309067,0.026781662592046,1.79171032584588e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.0338628051747472,0.00480302035363464,0.0244488852816233,0.0432767250678711,1.83262755524823e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN2,Alpha-actinin-2,24111,-0.0277500641216477,0.00394158200566799,-0.0354755648527569,-0.0200245633905384,1.96920540336902e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,24845,0.111638318720171,0.0158949302316124,0.0804842554662106,0.142792381974131,2.21928287498138e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,28733,0.0133178100178225,0.00189706809476543,0.00959955655208226,0.0170360634835628,2.26461200624748e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0276042279501881,0.0039407083697133,-0.0353280163548261,-0.01988043954555,2.52585659940668e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTG,Protogenin,29725,0.0115442144072109,0.00164876225122742,0.00831264039480519,0.0147757884196167,2.58161597782345e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWF,von Willebrand factor,29820,-0.0335972648498954,0.0047993618359171,-0.0430040140482929,-0.0241905156514979,2.60705121664515e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RETN,Resistin,29362,-0.0195220107405395,0.0027924260099025,-0.0249951657199484,-0.0140488557611306,2.7865376282828e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L,Seizure 6-like protein,29566,0.0127094007622171,0.00181966274886756,0.00914286177443673,0.0162759397499976,2.91956372972414e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.00968528331830708,0.00138872343123359,0.00696338539308924,0.0124071812435249,3.14054433871694e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL8,Interleukin-8,29218,0.0310387809135395,0.00448429390937067,0.022249564851173,0.039827996975906,4.55582806263516e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEO1,Neogenin,24867,0.0100712539888315,0.00145580158725145,0.0072178828778187,0.0129246250998444,4.69131604824092e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA9,Serpin A9,29227,0.0331044033144929,0.00478912806611113,0.0237177123049151,0.0424910943240707,4.86282400858698e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN4B,Sodium channel subunit beta-4,24240,0.0195182232571811,0.00283326758872846,0.0139650187832733,0.0250714277310889,5.75835858140114e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0158324868645309,0.0023003622030975,0.0113237769464598,0.020341196782602,5.99298681296435e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSH,Pro-cathepsin H,28852,0.0333970904444282,0.00485316319602613,0.023884890580217,0.0429092903086394,6.04318607823096e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF16,Fibroblast growth factor 16,24229,0.0218960623605212,0.00318386355296564,0.0156556897967085,0.0281364349243338,6.25255711058395e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL4,Myosin light chain 4,24240,-0.0236717268011546,0.00345491391103405,-0.0304433580667814,-0.0169000955355279,7.47720140045634e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0265987624259251,0.00388744844329655,0.0189793634770639,0.0342181613747863,7.98399739581947e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2,Brorin,29114,0.0180596631411661,0.00264047362632959,0.0128843348335601,0.0232349914487721,8.10102716718116e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR3,Small proline-rich protein 3,24845,0.0308213005780416,0.00450972662491593,0.0219822363932064,0.0396603647628769,8.42506813196431e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SELL,L-selectin,24966,0.0105314052595467,0.00154157725186899,0.00750991384588352,0.01355289667321,8.59157487182603e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.012815557418653,0.00187650212478248,0.00913761325407928,0.0164935015832266,8.68694149745366e-12
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK4,Dickkopf-related protein 4,29169,0.0206711741370782,0.00303681998245145,0.0147190069714733,0.026623341302683,1.01691141324613e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA7,Carbonic anhydrase 7,24445,-0.0155341868655319,0.0022830251430899,-0.0200089161459881,-0.0110594575850757,1.0395162664307e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARSA,Arylsulfatase A,29443,0.020092719157112,0.00296134866506353,0.0142884757735874,0.0258969625406365,1.18293484899262e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0220790871196473,0.00325452652271764,-0.0284579591041739,-0.0157002151351208,1.19004068478013e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0188857873160977,0.00278467466277983,0.0134278249770492,0.0243437496551461,1.20715340180138e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0158042101557027,0.00233319882676008,0.0112311404552529,0.0203772798561524,1.28406724263351e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300LF,CMRF35-like molecule 1,29725,0.0269931487240168,0.00399066666216488,0.0191714420661736,0.03481485538186,1.36654002153654e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFHD1,EF-hand domain-containing protein D1,24867,0.0158330359117603,0.00234088734992819,0.011244896705901,0.0204211751176195,1.37504567326417e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRELP,Prolargin,29454,0.0103585359407741,0.00153827142453364,0.00734352394868812,0.01337354793286,1.68231862079623e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0242351503198394,0.00360131233150688,0.0171765781500859,0.0312937224895929,1.73991864799791e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP10,Bone morphogenetic protein 10,24381,0.012747883028588,0.00189563993501953,0.0090324287559497,0.0164633373012263,1.79668190120123e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA,Lymphotoxin-alpha,29434,0.017759558763446,0.00265195189495453,0.0125617330493351,0.0229573844775568,2.16883127843335e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0133491125365133,0.00199978095887827,0.00942954185711192,0.0172686832159148,2.51232034653563e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD209,CD209 antigen,29527,0.0171668574989912,0.00257310925670262,0.0121235633558541,0.0222101516421284,2.57430117063981e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.0109660707976687,0.00164812165400085,0.00773575235582705,0.0141963892395104,2.90916115042224e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAS2,Growth arrest-specific protein 2,24445,0.0233248874774888,0.00350766214562325,0.0164498696720673,0.0301999052829104,2.99895439463108e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRSF1,G-rich sequence factor 1,23862,0.0356942711106187,0.00536937212255972,0.0251703017504017,0.0462182404708358,3.04023369337961e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,24111,0.0201511793786531,0.0030404347753852,0.0141919272188981,0.026110431538408,3.48087568772117e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1B,Interleukin-1 beta,28745,0.0246625710661999,0.00372680306326532,0.0173580370621998,0.0319671050701999,3.71441131871362e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00972948462057234,0.00147414828859231,0.00684015397493141,0.0126188152662133,4.17940454580159e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NADK,NAD kinase,29478,0.023567217830616,0.00357501434457779,0.0165601897152435,0.0305742459459885,4.40663949556626e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0291141320395445,0.00442402204992262,0.0204430488216961,0.0377852152573928,4.75386901452593e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0152240170296863,0.00231436883060668,0.0106878541216972,0.0197601799376754,4.8457606044248e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD6,MICOS complex subunit MIC25,24793,0.0126444683227817,0.00192424695907389,0.00887294428299683,0.0164159923625665,5.09273585328828e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINI2,Serpin I2,24805,0.0247445400558889,0.0037688574312162,0.0173575794907051,0.0321315006210727,5.28737279172594e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0172892342539881,0.0026348912280068,-0.0224536210608815,-0.0121248474470948,5.42595136279251e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH5,Cadherin-5,29820,-0.0130947001900918,0.00200939303052198,-0.0170331105299149,-0.00915628985026871,7.2995377815548e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGN,Mimecan,29443,-0.0181546564656302,0.00278686037389272,-0.0236169027984599,-0.0126924101328005,7.41695065801685e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0212831514318015,0.00326871310874285,0.0148764737386655,0.0276898291249374,7.57569010200161e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITM2A,Integral membrane protein 2A,29434,-0.0259518979402081,0.00399455940650188,-0.0337812343769518,-0.0181225615034644,8.33497483799933e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLAU,Urokinase-type plasminogen activator,29443,0.0125032885401694,0.00192515048330239,0.00872999359289667,0.016276583487442,8.4520819802624e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SFRP4,Secreted frizzled-related protein 4,24381,0.0178370421745364,0.0027474831983362,0.0124519751057974,0.0232221092432753,8.62547359037396e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,-0.0167076515148003,0.00257417709271372,-0.0217530386165192,-0.0116622644130814,8.69213016429981e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.0168265250960964,0.00259528500415903,0.0117397664879447,0.0219132837042481,9.10717157890717e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP9,Matrix metalloproteinase-9,29411,-0.0259253621056028,0.00400415510699001,-0.0337735061153032,-0.0180772180959023,9.6552041865931e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0134045067661027,0.00207100239828613,-0.0174636714667435,-0.00934534206546184,9.8131554969957e-11
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPB6,Heat shock protein beta-6,29725,0.0164429900186877,0.00254194852839041,0.0114607709030425,0.0214252091343329,1.00414614749823e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0115512785371689,0.00178951774504166,0.00804382375688728,0.0150587333174506,1.10238403064649e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.0163355336573399,0.0025309244759151,0.0113749216845463,0.0212961456301335,1.10356632234125e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL5A1,Collagen alpha-1(V) chain,24381,-0.0172426235768574,0.00268388496044184,-0.0225030380993234,-0.0119822090543914,1.34745045097648e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,28774,0.0361840440429838,0.00563876144096367,0.025132071618695,0.0472360164672725,1.41129230837576e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.0131272256782355,0.00204591757732121,0.00911722722668596,0.0171372241297851,1.42140881173175e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BGN,Biglycan,28750,-0.0505308203593401,0.00791999643234047,-0.0660540133667274,-0.0350076273519528,1.79598623177528e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP1,"Fatty acid-binding protein, liver",29454,-0.0396453992156106,0.00621442171636927,-0.0518256657796943,-0.0274651326515268,1.80210783175872e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0204985493882964,0.00321441580313148,0.0141982944141587,0.0267988043624341,1.83783502317534e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN4,CCN family member 4,29725,0.0169017551715477,0.00265098308718667,0.0117058283206618,0.0220976820224336,1.84855243070646e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POSTN,Periostin,24938,-0.0160278911295804,0.00251478178809392,-0.0209568634342445,-0.0110989188249163,1.88028234581497e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,-0.0116619936003508,0.00183185897531182,-0.0152524371919619,-0.0080715500087396,1.96613726858205e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12A_IL12B,Interleukin-12,29349,0.0326995052528029,0.0051391085000376,0.0226268525927292,0.0427721579128766,2.00931728876214e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",24101,-0.0306308565032337,0.00483416826805536,-0.0401058263086222,-0.0211558866978452,2.39474468963232e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPR,Nucleoprotein TPR,24111,0.020067635864268,0.00317423134378327,0.0138461424304528,0.0262891292980832,2.62646939737797e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0243022124464357,0.00384446695731933,0.0167670572100899,0.0318373676827816,2.63003820147065e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCOR1,REST corepressor 1,28916,0.0186925046127046,0.00295749014003261,0.0128958239382407,0.0244891852871685,2.64700009252451e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FEN1,Flap endonuclease 1,28797,0.0262597272566542,0.0041633458606081,0.0180995693698624,0.0344198851434461,2.87954170010575e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACE,Angiotensin-converting enzyme,24951,-0.0109630217414224,0.00173918654115914,-0.0143718273620943,-0.00755421612075045,2.95803652255859e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL20,C-C motif chemokine 20,29786,0.0365208509290714,0.00580244605225328,0.0251480566666549,0.0478936451914878,3.13605566805102e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,-0.012398466110648,0.00197539042208636,-0.0162702313379373,-0.00852670088335872,3.51185013988065e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0161896647309685,0.00258425298952734,0.0111245288714949,0.0212548005904421,3.78636315057712e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JCHAIN,Immunoglobulin J chain,28931,-0.0254409745423105,0.0040796376778049,-0.0334370643908081,-0.0174448846938129,4.54853837567311e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.0186390041086042,0.00299551099297,0.012767802562383,0.0245102056548254,4.96449270693767e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0185573805506964,0.00298620311294222,0.0127044224493296,0.0244103386520631,5.23506495765083e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0190756820451579,0.00307661633084055,-0.0251058500536054,-0.0130455140367104,5.71273419099309e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PZP,Pregnancy zone protein,24966,0.0218909449196176,0.00354391035957838,0.0149448806148439,0.0288370092243912,6.63152056629051e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FSTL3,Follistatin-related protein 3,29351,-0.0130245925554278,0.00210970661675236,-0.0171596175242624,-0.00888956758659314,6.76045991075171e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0223618554502909,0.00362559579215412,0.0152556876976688,0.029468023202913,7.01616905662649e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.012170768693253,0.00198206467453889,0.00828592193115682,0.0160556154553493,8.33312969327883e-10
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0119307245311084,0.00195308778916094,0.00810267246435291,0.0157587765978638,1.02023801639194e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WIF1,Wnt inhibitory factor 1,29725,0.0137670829040209,0.00225407019444564,0.00934910532290741,0.0181850604851343,1.0235895492073e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.0170941943325745,0.00280429604555119,-0.0225906145818548,-0.0115977740832942,1.10290737055791e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.040296207383094,0.00661545190159922,0.0273299216559596,0.0532624931102285,1.13746427381574e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB1A1,Uteroglobin,29523,0.0222565397751311,0.00365766529133502,0.0150875158041145,0.0294255637461478,1.17995293368713e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0151173155176442,0.00248523882149173,0.0102462474275204,0.019988383607768,1.19525290178841e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSE,Cathepsin E,24381,0.0210235691318001,0.00346991542963721,0.0142225348897112,0.0278246033738891,1.39140272236647e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN1,Nectin-1,24229,0.0130102989532687,0.00215237499384976,0.00879164396532315,0.0172289539412142,1.51947705341447e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,28797,0.0133334799108885,0.00221410587933013,0.00899383238740146,0.0176731274343756,1.74295573845614e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGR1,Prostaglandin reductase 1,24922,0.0325722967891994,0.00541414738418968,0.0219605679161877,0.0431840256622112,1.8111110052987e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRNN,Cornulin,28580,0.0265430884819735,0.00442744179251941,0.0178653025686355,0.0352208743953116,2.05760490185655e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH17,Protocadherin-17,29478,-0.0142904037950872,0.00238526171093843,-0.0189655167485265,-0.00961529084164789,2.10808432834485e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYZL2,Lysozyme-like protein 2,24016,0.0143616187750685,0.00239776352723954,0.00966200226167897,0.019061235288458,2.13365321406359e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN2,Prefoldin subunit 2,28774,0.0220446551900332,0.00368276517019316,0.0148264354564546,0.0292628749236118,2.17746792731454e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0113559991733051,0.00189815681550359,0.00763561181491806,0.0150763865316921,2.22076050180509e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAA4,Serum amyloid A-4 protein,24966,0.0130094110342537,0.00217522334107385,0.00874597328574895,0.0172728487827584,2.25170271027051e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0171347281324443,0.00286796917866208,0.0115135085422666,0.022755947722622,2.33424080337494e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD1,Leiomodin-1,24867,-0.0140737602100877,0.00235651788856515,-0.0186925352716754,-0.00945498514849997,2.37154062424705e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCND2,G1/S-specific cyclin-D2,24445,0.0145936549386293,0.00244840910811086,0.00979477308673203,0.0193925367905266,2.54971879971224e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL19,Interleukin-19,28654,-0.0277302692494598,0.00465992573855395,-0.0368637236970255,-0.018596814801894,2.69940225171586e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA7,Thyroxine-binding globulin,24966,0.00732091034107911,0.00123041253379288,0.00490930177484507,0.00973251890731316,2.71777636449113e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0221712280157244,0.00372732244640875,0.0148656760207633,0.0294767800106856,2.74629746008744e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL1,Delta-like protein 1,29566,-0.0117554010334323,0.0019791088028229,-0.0156344542869652,-0.00787634777989941,2.88655835116954e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0248168634816526,0.00419171086513076,0.0166011101859963,0.0330326167773089,3.25239884461532e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXTL1,Exostosin-like 1,24111,0.018738230506434,0.00316771160969497,0.0125295157514318,0.0249469452614361,3.35571512748793e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0183421022399659,0.00310889887020064,0.0122486604543726,0.0244355440255592,3.67862176883633e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0159568232314327,0.0027063085430513,-0.0212611879758132,-0.0106524584870521,3.76131348750308e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MDK,Midkine,29455,0.0198260100605342,0.0033632750100344,0.0132339910408667,0.0264180290802016,3.79099181179086e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSV,Cathepsin L2,29618,0.016168839880779,0.00274298094835234,0.0107925972220085,0.0215450825395496,3.79602074285825e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THY1,Thy-1 membrane glycoprotein,29694,-0.0111172464374544,0.00188947076417477,-0.0148206091352369,-0.00741388373967181,4.05278665288157e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSTB,Cystatin-B,29030,0.0165587894862842,0.00281587281934024,0.0110396787603774,0.0220779002121911,4.13461140270449e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,24381,0.0206517697690255,0.00351785107541925,0.0137567816612037,0.0275467578768472,4.39942142909938e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0190376832069771,0.0032538869993656,0.0126600646882205,0.0254153017257337,4.95506995801787e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0167085316781981,0.00285721815503481,0.0111083840943299,0.0223086792620663,5.0337180088239e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA1,Alpha-1-antitrypsin,24548,-0.00316102846856262,0.000540895987101505,-0.00422118460328157,-0.00210087233384367,5.15877399830151e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,24938,0.00835071027668079,0.00143035655698469,0.0055472114249908,0.0111542091283708,5.34211961975152e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,XCL1,Lymphotactin,29725,0.0214158265358637,0.00366858124361655,0.0142254072983753,0.0286062457733521,5.34978246946773e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,-0.0130699534033991,0.00224354859135842,-0.0174673086424616,-0.00867259816433659,5.75085964610571e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0269523170800396,0.00463570463728584,-0.0360382981691198,-0.0178663359909594,6.17154390258009e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL34,Interleukin-34,28722,0.0139038235911499,0.0023930567915046,0.00921343227980087,0.0185942149024989,6.31062448734655e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0263234192810326,0.0045375427458603,0.0174298354991464,0.0352170030629188,6.66228790186929e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL22,Interleukin-22,24793,-0.0260453420045788,0.00449078872441618,-0.0348472879044345,-0.0172433961047231,6.72304820463064e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP8,GTPase IMAP family member 8,24016,0.0196588941021536,0.00339107134344808,0.0130123942689954,0.0263053939353118,6.82546440428931e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.02075327312357,0.00358674053395519,0.0137232616770178,0.0277832845701221,7.27671575800672e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0165717355262362,0.00286569856595863,0.0109549663369573,0.0221885047155151,7.43481566460326e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN4,Nectin-4,29566,-0.0122342354343473,0.00211605634098835,-0.0163817058626845,-0.00808676500601016,7.47281566332546e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.0151107858135737,0.00261467624012474,0.00998602038292921,0.0202355512442182,7.59447941238201e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC2,Mucin-2,24938,0.0350207914774034,0.00607353594844826,0.0231166610184448,0.046924921936362,8.20706204358897e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0149278869329958,0.00259021415921433,0.00985106718093573,0.0200047066850559,8.35431251337129e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.019338132102541,0.00335676647238827,0.01275886981666,0.025917394388422,8.44792795812511e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0113418511922137,0.00197082010032122,0.00747904379558412,0.0152046585888433,8.75649541260906e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0395844759183117,0.0068828126403203,0.0260941631432839,0.0530747886933395,8.96764183266426e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP1,Interstitial collagenase,28424,0.0348140645007256,0.00605464008119636,0.0229469699415807,0.0466811590598705,9.01673523420677e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LXN,Latexin,29117,-0.0256003038244573,0.00445376665712729,-0.0343296864724268,-0.0168709211764879,9.12000571421317e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0270598780408964,0.00470974459722194,0.0178287786303414,0.0362909774514514,9.25549949065637e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF1C,Kinesin-like protein KIF1C,24111,0.0138724546213252,0.0024160984879386,0.00913690158496559,0.0186080076576849,9.48701233431894e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM5,Intercellular adhesion molecule 5,29478,0.0170784618870365,0.00297706065071974,0.0112434230116258,0.0229135007624472,9.7491443441769e-09
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPME1,Protein phosphatase methylesterase 1,29349,0.0225711448204285,0.00395851376713027,0.0148124578368531,0.0303298318040038,1.1959918688347e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAT,Catalase,24587,0.0202071492633255,0.00355311633701267,0.0132430412427806,0.0271712572838703,1.30633371925658e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPG,Macrophage-capping protein,29174,0.0219036238790141,0.0038600774163665,0.0143378721429358,0.0294693756150925,1.40493673184372e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,29542,0.0115870105121469,0.00204636609403042,0.00757613296784729,0.0155978880564465,1.50797778125107e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKK3,Dickkopf-related protein 3,29820,-0.0110073113025328,0.00194796838373649,-0.0148253293346563,-0.00718929327040929,1.61287800504329e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A12,Protein S100-A12,29023,0.0280592958530824,0.00496628277080901,0.0183253816222967,0.037793210083868,1.61988243943376e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0148488858306987,0.00263583170094038,0.00968265569685554,0.0200151159645418,1.78530683007801e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGT,Angiotensinogen,24951,0.00862920156639428,0.00153374256846677,0.00562306613219941,0.0116353370005892,1.86156076354843e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0319915109614148,0.00569480574937164,0.0208296916926464,0.0431533302301832,1.95690195992622e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNPY2,Protein canopy homolog 2,28916,0.0226525944327974,0.00403519502776673,0.0147436121783746,0.0305615766872202,1.99797348922082e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGA11,Integrin alpha-11,29434,0.0127096930880868,0.0022674884619179,0.00826541570272768,0.0171539704734459,2.09893855991056e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.0208357357423799,0.00371952117271811,0.0135454742438524,0.0281259972409074,2.14137418554219e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAP,Cartilage-associated protein,24195,0.0181503288828644,0.00324021188845372,0.0117995135814951,0.0245011441842336,2.14706685489763e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,0.00973036218417242,0.00174062994902054,0.00631872748409217,0.0131419968842527,2.2926883620745e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFF2,Trefoil factor 2,29536,-0.0212936102679683,0.00381502794284499,-0.0287710650359444,-0.0138161554999921,2.40533172845025e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0165631237356444,0.00297559217040852,0.0107309630816437,0.0223952843896451,2.62434900222514e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THBS4,Thrombospondin-4,29518,0.016632281396934,0.00299331902228149,0.0107653761132623,0.0224991866806057,2.7766240992019e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,29288,0.0082707310447682,0.00148959972000568,0.00535111559355708,0.0111903464959793,2.84349876053191e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM2,Intercellular adhesion molecule 2,29820,-0.0116944083590702,0.00210743254576414,-0.0158249761487679,-0.00756384056937244,2.8953988990096e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL2,Fc receptor-like protein 2,29645,0.0180907438658853,0.00326104110140474,0.011699103307132,0.0244823844246386,2.92195503221814e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST1,Cystatin-SN,21656,0.0387415169154676,0.00699786737280707,0.0250256968647658,0.0524573369661695,3.12711687853426e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CILP,Cartilage intermediate layer protein 1,24938,0.0199938694276431,0.00361394204422378,0.0129105430209645,0.0270771958343217,3.19002988687756e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,24738,-0.00994369725604749,0.0018013742350058,-0.0134743907566589,-0.00641300375543612,3.42282218605296e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPO,Lactoperoxidase,28452,-0.0220442869292836,0.00399420842722731,-0.0298729354466491,-0.0142156384119181,3.43783271736651e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KITLG,Kit ligand,29478,-0.0136124713604072,0.00246757046777539,-0.018448909477247,-0.00877603324356748,3.48625862369959e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPL14,60S ribosomal protein L14,24240,0.0147440658397024,0.00267259939196102,0.00950577103145875,0.019982360647946,3.48853724227093e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE3,Eosinophil cationic protein,29343,0.0395841119486991,0.00718704849314592,0.0254974969021331,0.0536707269952652,3.66598652477468e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0140483877109224,0.00255139460095821,0.00904765429304427,0.0190491211288004,3.70380912568034e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN2,Ataxin-2,24101,0.0405514406288893,0.00737036084555649,0.0261055333715986,0.0549973478861801,3.79410615621317e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",24845,0.0218381630740491,0.00398435919565986,0.0140288190505557,0.0296475070975424,4.27106786590972e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0207146413275115,0.00378958557129594,0.0132870536077714,0.0281422290472515,4.63577802647011e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.0144459449030044,0.00265130020040967,-0.0196424932958073,-0.00924939651020139,5.12572542973108e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA2,GDNF family receptor alpha-2,29349,0.00759634408982906,0.00139425688280041,0.00486360059954025,0.0103290875801179,5.12592004040855e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN3,Neuronal-specific septin-3,24867,-0.0272014950258079,0.00503018296165546,-0.0370606536306526,-0.0173423364209632,6.44437922149659e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS1,"Nitric oxide synthase, brain",28774,-0.0193774071936184,0.00358596080229099,-0.0264058903661087,-0.0123489240211281,6.58033537216251e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD302,CD302 antigen,29349,0.0109216048302966,0.00202151412926544,0.00695943713693633,0.0148837725236569,6.61611030663952e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.00940086323757609,0.00174496499047738,-0.0128209946189118,-0.00598073185624042,7.21477713183204e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROBO4,Roundabout homolog 4,24240,-0.00641627088550383,0.00119565002054198,-0.00875974492576611,-0.00407279684524155,8.10855652171696e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRUNE2,Protein prune homolog 2,24445,0.0104108951269791,0.00194147985347201,0.00660559461417397,0.0142161956397842,8.28915368805665e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPA2,Replication protein A 32 kDa subunit,24229,0.0113388647700383,0.00211634159895072,0.00719083523609492,0.0154868943039818,8.50258422285881e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00664860021354885,0.00124137766576684,0.00421549998864583,0.00908170043845186,8.59205692756219e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPP1,Tripeptidyl-peptidase 1,29286,0.0162313338654137,0.00303542332403764,0.0102819041503,0.0221807635805275,8.99420304647565e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0113801787981777,0.00212870671305829,-0.0155524439557719,-0.00720791364058342,9.05768559985975e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17A,Interleukin-17A,28879,-0.0151300093508552,0.00283050388873445,-0.0206777969727748,-0.00958222172893571,9.09311529139387e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0182747787006737,0.00342153822062083,0.0115685637882569,0.0249809936130906,9.32212036978496e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,29581,0.0100783460810909,0.0018902192419515,0.00637351636686591,0.0137831757953158,9.79353392063049e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.0119827646223376,0.00224747306344153,-0.016387811826683,-0.0075777174179922,9.80337176619011e-08
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLL4,Delta-like protein 4,24240,0.0303743941435214,0.00570681297605814,0.0191890407104474,0.0415597475765953,1.03272493607605e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0138758040973858,0.00261649674253017,-0.0190041377127449,-0.00874747048202664,1.14760582435781e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OBP2B,Odorant-binding protein 2b,29137,-0.0219248018150123,0.00414798331066736,-0.0300548491039203,-0.0137947545261043,1.26158078101477e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00932687776818983,0.00176452813157596,-0.0127853529060787,-0.00586840263030095,1.2623543408802e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,28797,-0.0164443488865645,0.00311302597920715,-0.0225458798058106,-0.0103428179673185,1.28405814225851e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL14,C-C motif chemokine 14,29435,0.0137539551591321,0.00262077920759922,0.00861722791223765,0.0188906824060266,1.54790427725426e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB8,Serpin B8,29786,0.0194882635683357,0.0037239894835125,0.0121892441806512,0.0267872829560202,1.67757008149823e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG2,Secretogranin-2,29559,0.0112399020814837,0.00215689508450049,0.00701238771586274,0.0154674164471047,1.88934028141162e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,28916,0.0186340998749576,0.00358240135629215,0.011612593216625,0.0256556065332902,1.98961690911948e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,29030,0.0100412635708907,0.00193066077904236,0.00625716844396765,0.0138253586978137,1.99620898328059e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00670515131166238,0.00129215579832987,-0.00923777667638892,-0.00417252594693584,2.12942947241634e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171B,Protein FAM171B,24793,0.00934188647468963,0.00180258331372993,0.00580882317977898,0.0128749497696003,2.2064819898403e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MELTF,Melanotransferrin,24922,0.0101761190637594,0.00196627047818945,0.00632222892650808,0.0140300092010107,2.29260006527221e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALCB,Calcitonin gene-related peptide 2,24845,0.0137907055232381,0.0026680631207581,0.00856130180655223,0.019020109239924,2.37415707382651e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0140543374800159,0.00272624466414561,0.00871089793829054,0.0193977770217413,2.55035256540811e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0238472115072492,0.00463479683027933,0.0147630097199017,0.0329314132945967,2.68849438040362e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.012831584197088,0.00250425578885263,-0.0177399255432392,-0.0079232428509369,3.01561951555517e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB2,Lysosome membrane protein 2,28762,0.0107736098038675,0.00210534642361445,0.00664713081358321,0.0149000887941519,3.11995377681844e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMOX1,Heme oxygenase 1,29165,-0.0162632960084417,0.00317981448327791,-0.0224957323956664,-0.010030859621217,3.16492190288567e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0123242386939771,0.00241519651082135,0.00759045353276724,0.0170580238551869,3.36809273877274e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0204066216935916,0.00401586258828404,0.0125355310205548,0.0282777123666283,3.77189776671003e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0172618774261806,0.00340094881670153,0.0105960177454456,0.0239277371069156,3.89118502609822e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0225458268144207,0.00444280243583754,0.0138379340401791,0.0312537195886623,3.91031605944945e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0114686486031837,0.00226103937665775,0.00703701142493446,0.0159002857814328,3.95889976984631e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,29725,0.0193121832176116,0.00381186673211894,0.0118409244226585,0.0267834420125647,4.07980599524055e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0137410825220711,0.00271673600793679,-0.0190658850976272,-0.00841627994651494,4.26922511644118e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0185794971221942,0.00367791147789371,0.0113707906255226,0.0257882036188659,4.40700469374134e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0103349775949142,0.00204932859558617,0.00631829354756533,0.0143516616422631,4.6134507022215e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.010171878947283,0.00201789933037472,0.0062167962597485,0.0141269616348174,4.66287723706722e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,29725,0.0195224590890681,0.00388044434270978,0.0119167881773569,0.0271281300007792,4.90806958084303e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0145931540384046,0.00290073299450646,0.00890771736917194,0.0202785907076373,4.91799572623385e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC1,Sialoadhesin,29581,-0.01412800171092,0.00280945930710416,-0.0196345419528441,-0.00862146146899583,4.96633260739703e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRTN3,Myeloblastin,28671,-0.0157515434743483,0.00314428323654967,-0.0219143386179857,-0.00958874833071099,5.48724988118127e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD59,CD59 glycoprotein,28277,0.00761638250706126,0.00152619889012901,0.0046250326824084,0.0106077323317141,6.06038175904654e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.012398430478011,0.00249090271299593,0.00751626116053894,0.017280599795483,6.4857707510417e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.014770334664607,0.00297025850384099,0.00894862799707868,0.0205920413321354,6.64630265571465e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DGCR6,Protein DGCR6,24101,0.0144122407052129,0.00290986933955761,0.00870889679967998,0.0201155846107458,7.3616871188907e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN2,Calsyntenin-2,29786,-0.0129558482061694,0.00261975290907656,-0.0180905639079594,-0.0078211325043793,7.63826911871438e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COLEC12,Collectin-12,29454,0.00860987425518807,0.00174351705370369,0.00519258082992884,0.0120271676804473,7.92692864198069e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLASP1,CLIP-associating protein 1,24016,0.0239904177967906,0.00485894197094445,0.0144668915337395,0.0335139440598417,7.97123234925481e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,29433,0.0243049997565244,0.00492878892134932,0.0146445734706797,0.0339654260423691,8.2157599091111e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.0157187193701424,0.00319375241251159,-0.0219784740986651,-0.00945896464161967,8.63549815430714e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBP1,Z-DNA-binding protein 1,24229,0.0132772201153495,0.00270562498959834,0.00797419513573676,0.0185802450949623,9.29546791121907e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMB,Granzyme B,29434,0.0211672250951857,0.00431601307021297,0.0127078394775683,0.0296266107128031,9.42383394860831e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2,Apoptosis regulator Bcl-2,24805,0.0174828410387007,0.00356518880536764,0.0104950709801801,0.0244706110972212,9.46125357798007e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,29581,-0.00875505734683352,0.00178679401559543,-0.0122571736174006,-0.00525294107626648,9.6407173226275e-07
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.0115702394671379,0.00236807288654152,0.00692881660951651,0.0162116623247592,1.03494274225746e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAX,Apoptosis regulator BAX,28722,0.0292091593362363,0.00597850519949222,0.0174912891452316,0.0409270295272411,1.03618836543678e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUC16,Mucin-16,29349,0.0611247286659678,0.0125209933430035,0.036583581713681,0.0856658756182546,1.05684830635591e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGR,Tyrosine-protein kinase Fgr,28774,0.0183493773963126,0.0037594328720322,0.0109808889671295,0.0257178658254957,1.06173536354023e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOSB,Protein fosB,28774,0.0124946549444347,0.00256615523480851,0.00746499068421007,0.0175243192046594,1.12749123240701e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA2,Carbonic anhydrase 2,29368,0.0219996175017214,0.00454260281716979,0.0130961159800686,0.0309031190233742,1.28573700696501e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.00882927862278436,0.00182686440796425,0.00524862438317442,0.0124099328623943,1.35275246113174e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR158,Probable G-protein coupled receptor 158,24867,0.0115087411844876,0.00238275800551288,0.00683853549368232,0.0161789468752928,1.3733969285732e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSPN,Persephin,29434,0.0300248683403628,0.00621941836403343,0.0178348083468573,0.0422149283338683,1.38880879192175e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0092604671974854,0.00192048355422923,0.0054963194311961,0.0130246149637747,1.42870976621796e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF3,Neurotrophin-3,29434,0.0110781645773152,0.00229754756784855,0.00657497134433202,0.0155813578102983,1.43025635734907e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD3,Bromodomain-containing protein 3,24111,0.0153533076326115,0.003188311419139,0.00910421725109905,0.0216023980141239,1.47723959374456e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.010596130729718,0.00220543371195398,0.00627348065428824,0.0149187808051478,1.55866998053768e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCAM,Cell surface glycoprotein MUC18,29594,-0.0105628710593376,0.00220014513579833,-0.0148751555255023,-0.00625058659317284,1.58655436118065e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP8,Neutrophil collagenase,29640,-0.0229649482950369,0.0047908208306646,-0.0323549571231395,-0.0135749394669343,1.64665261830069e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM3,Intercellular adhesion molecule 3,29820,-0.0082706849530215,0.00172675482150252,-0.0116551244031664,-0.00488624550287655,1.67810014151224e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA2,Ephrin type-A receptor 2,28347,-0.00998698795483216,0.00208568381004591,-0.0140749282225221,-0.00589904768714218,1.69005275691376e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HYAL1,Hyaluronidase-1,29265,-0.00728747827954109,0.0015228017055934,-0.0102721696225042,-0.00430278693657803,1.713320108996e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0139614816327517,0.00292533952275493,0.00822781616815205,0.0196951470973514,1.82921545016095e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA4C,Semaphorin-4C,29349,0.0088962076281916,0.00186506226449874,0.00524068558977406,0.0125517296666091,1.85179298775133e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0121715962175546,0.00255609228392626,0.00716165534105909,0.01718153709405,1.92990124054758e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0131831928985568,0.00277605451776926,0.00774212604372909,0.0186242597533846,2.05667456604749e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0268952317967657,0.00566456782185665,-0.0379977847276047,-0.0157926788659266,2.06460785223144e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3C,Protein FAM3C,29433,0.00941944954812514,0.00198512128020542,0.00552861183892252,0.0133102872573278,2.09459266928511e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0135725358702536,0.00286695131446383,0.00795331129390448,0.0191917604466027,2.21206379358195e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,24445,0.0142948598164757,0.00302330916088401,0.00836917386114304,0.0202205457718084,2.27763850837465e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0086404527315336,0.00183039550773512,0.00505287753637275,0.0122280279266944,2.36327874564257e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A11,Protein S100-A11,29208,0.0142157321669547,0.00301205976216894,0.00831209503310361,0.0201193693008059,2.37397765756976e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00709056374508493,0.00150519654726249,0.00414037851245045,0.0100407489777194,2.4795160767993e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB37,Ras-related protein Rab-37,28931,0.0256294786814637,0.00544659149011902,0.0149541593608304,0.0363047980020969,2.54291263656461e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSM,Oncostatin-M,29293,-0.0221174333118472,0.00470110458353457,-0.0313315982955749,-0.0129032683281194,2.55360650187964e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0124922282605099,0.00265787000047973,0.00728280305956967,0.0177016534614502,2.61441193960901e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CX3CL1,Fractalkine,29218,-0.0104967196320832,0.00223774251628643,-0.0148826949640046,-0.0061107443001618,2.73419300126965e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGBL1,Integrin beta-like protein 1,24938,-0.0115959689281494,0.00247284061764393,-0.0164427365387315,-0.00674920131756726,2.75550651207544e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PVR,Poliovirus receptor,29694,0.0114709357199918,0.00244924471780804,0.00667041607308805,0.0162714553668956,2.83322549408249e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR2,Interferon gamma receptor 2,29218,0.0161381918109754,0.00344905686084867,0.009378040363712,0.0228983432582388,2.89546376263642e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0198992057539016,0.00425859797011106,-0.0282460577753193,-0.011552353732484,2.98835256641224e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSTN1,Calsyntenin-1,28774,0.0159878984215412,0.00342193163994972,0.00928091240723971,0.0226948844358426,2.99360045173878e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,29173,0.00877123303105887,0.00187895722445215,0.00508847687113265,0.0124539891909851,3.0529209384673e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NINJ1,Ninjurin-1,28797,0.0170677350742887,0.00366288222061367,0.0098884859218859,0.0242469842266915,3.18170338788232e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA4,Carboxypeptidase A4,23902,0.0135787876765339,0.00291667787404946,0.00786209904339697,0.0192954763096708,3.24827365004796e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,24845,0.0114574337421895,0.00246472886525646,0.00662656516628682,0.0162883023180922,3.35982425691147e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAL,Galanin peptides,29581,0.0197768430558913,0.00426739819019319,0.0114127426031126,0.0281409435086699,3.59495566553878e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.00864465172333154,0.00187659770398391,-0.01232278322314,-0.00496652022352307,4.11458813386144e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMOD4,Tropomodulin-4,24016,-0.0125669367094055,0.00273003591068919,-0.0179178070943563,-0.00721606632445465,4.18152744112461e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CR2,Complement receptor type 2,29594,0.0141753949660653,0.00308338454905438,0.00813196124991873,0.0202188286822119,4.29669083548645e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BMP4,Bone morphogenetic protein 4,29169,-0.0140772452047836,0.00306377465907696,-0.0200822435365745,-0.0080722468729928,4.35104144776828e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CIT,Citron Rho-interacting kinase,24195,0.0137938734595287,0.00301138963386606,0.00789154977715124,0.0196961971419062,4.66028658119686e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,29434,0.0106922541392276,0.0023345134059098,0.00611660786364444,0.0152679004148109,4.66705834760067e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNC5D,Netrin receptor UNC5D,24229,0.00804792127681179,0.00175732752178922,0.00460355933410493,0.0114922832195187,4.6810266455279e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERC2,ERC protein 2,24195,0.0229079579187876,0.00501134871637225,0.013085714434698,0.0327302014028772,4.8730139581558e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHNAK2,Protein AHNAK2,24240,0.00901646415617657,0.00197566352840473,0.0051441636405033,0.0128887646718498,5.04909235143636e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB1,Lamin-B1,24756,0.0178145080310982,0.00390614535808058,0.0101584631292603,0.0254705529329362,5.12433098142021e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,29349,0.00788313939187582,0.00172923245737518,0.00449384377542047,0.0112724350083312,5.16664945280596e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEG1,Protein LEG1 homolog,23603,-0.0212162822869682,0.00465480493384769,-0.0303396999573096,-0.0120928646166267,5.1919015809324e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1,Programmed cell death protein 1,29661,0.0129025268682401,0.00283942066164637,0.0073372623714132,0.018467791365067,5.53958588670975e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK8,Kallikrein-8,28443,0.010804328977917,0.00238460080298297,0.00613051140407034,0.0154781465517636,5.89786946099884e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNR,Tenascin-R,29218,0.0126524861165422,0.00279599705503892,0.00717233188866588,0.0181326403444184,6.05720335114557e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0167288975935944,0.00370498416287687,0.00946712863435576,0.0239906665528331,6.35401545482481e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0195039627881841,0.00432225461948927,0.0110323437339852,0.0279755818423831,6.4331109715828e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS22,Brain-specific serine protease 4,24229,0.0104771060159949,0.00232695721329594,0.00591626987793489,0.015037942154055,6.74744518984854e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TTN,Titin,24111,-0.020132069826965,0.00447222506047973,-0.0288976309455053,-0.0113665087084248,6.77665957430978e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STC2,Stanniocalcin-2,29396,-0.00770858444550762,0.00171764538410214,-0.0110751693983478,-0.00434199949266742,7.22087141062001e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASET2,Ribonuclease T2,29697,-0.00787822480063414,0.00175713491074485,-0.011322209225694,-0.00443424037557424,7.36816193971812e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.0084424931948009,0.0018843960913873,-0.01213590953392,-0.00474907685568179,7.48508073781471e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMD,Osteomodulin,29581,0.0127752681440502,0.00285390505334732,0.00718161423948948,0.018368922048611,7.61896563634267e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0136305787857783,0.00304522648765695,-0.0195992227015859,-0.00766193486997067,7.63235579032053e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSG,Basigin,29760,0.00607512724523542,0.00135892981865162,0.00341162480067825,0.00873862968979259,7.83165782433346e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.0141037891985897,0.00315999576975696,-0.0202973809073134,-0.0079101974898661,8.10326641855177e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0155893419182386,0.00349662064967186,0.0087359654448818,0.0224427183915955,8.29339916140752e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.020976422683285,0.00470914775619687,0.0117464930811391,0.0302063522854308,8.44355779478153e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGF,Beta-nerve growth factor,29218,0.00358209158334371,0.000806016447231695,0.00200229934676959,0.00516188381991783,8.85472904693537e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.0545170430789769,0.0122715205144543,0.0304648628706465,0.0785692232873072,8.92171947581326e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR4,Proline-rich protein 4,24203,-0.0205793688520914,0.00463407827688947,-0.0296621622747947,-0.011496575429388,8.99899209523468e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JAM2,Junctional adhesion molecule B,29694,0.00784723828252925,0.00176743014162656,0.00438307520494119,0.0113114013601173,9.03190922618855e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,-0.0165795704647506,0.00373918964805392,-0.0239083821749362,-0.00925075875456487,9.290889651637e-06
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSBP1,Heat shock factor-binding protein 1,24240,0.0279617079912906,0.00635292036112228,0.015509984083491,0.0404134318990903,1.0801692789955e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA1,Carbonic anhydrase 1,28867,0.0173691924069604,0.00395424303272562,0.00961887606281818,0.0251195087511026,1.12429860759694e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBS,Cystathionine beta-synthase,24240,0.0149284841398398,0.00340101609444211,0.00826249259473324,0.0215944756849463,1.141345007562e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL4,Early placenta insulin-like peptide,24793,-0.0149384916869937,0.00341506603096299,-0.0216320211076812,-0.00824496226630626,1.22324888493155e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.0135412765604224,0.00309671334290129,0.00747171840833587,0.0196108347125089,1.23167058157134e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI16,Peptidase inhibitor 16,24951,0.00712034277136652,0.00163030484782849,0.00392494526962268,0.0103157402731104,1.26188020805154e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YAP1,Transcriptional coactivator YAP1,24845,0.00784153752028482,0.00179592588643681,0.00432152278286868,0.011361552257701,1.26884127588053e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,27939,-0.0115463552627803,0.00264875395466081,-0.0167379130139155,-0.00635479751164515,1.31025994116856e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EP300,Histone acetyltransferase p300,24229,0.00874137494473706,0.00200955980920628,0.00480263771869276,0.0126801121707814,1.36759027572747e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNXB,Tenascin-X,29443,0.00743193171370613,0.00170935419788913,0.00408159748584344,0.0107822659415688,1.37970698248897e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,-0.0121603826143224,0.00279912489014389,-0.0176466673990044,-0.00667409782964035,1.40154893262775e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRDL2,Chordin-like protein 2,29478,-0.0152875499813638,0.00353461468323018,-0.022215394760495,-0.00835970520223267,1.52965834535756e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH6,Cadherin-6,29478,-0.0109648469670786,0.00253986070721322,-0.0159429739532165,-0.00598671998094071,1.58604137438121e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12B,Interleukin-12 subunit beta,29786,0.0155265175867331,0.00360165536034197,0.00846727308046281,0.0225857620930033,1.63084409364854e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0331675800886361,0.00771846525538052,0.0180393881880903,0.0482957719891819,1.7355199989198e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0108324361562049,0.00252140314051988,-0.0157743863116239,-0.00589048600078594,1.74436500148719e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIP,Gastric inhibitory polypeptide,24240,0.0145505880554573,0.00339533021818856,0.00789574082780769,0.0212054352831069,1.83056229122663e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSC1,Hamartin,24229,0.0213665320599593,0.00499554171385548,0.0115752703008026,0.0311577938191161,1.90051981230911e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0127327304842468,0.00298307727675541,0.00688589902180618,0.0185795619466874,1.97681622095196e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP4,Guanylate-binding protein 4,28774,0.0138183387043711,0.00325255859914602,0.00744332385004487,0.0201933535586973,2.15929480989347e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA5,Protein disulfide-isomerase A5,24016,0.017342434842101,0.00408587162929482,0.00933412644868316,0.0253507432355188,2.19915136688934e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM25,Transmembrane protein 25,24867,-0.0127427454405843,0.0030029603632106,-0.0186285477524771,-0.0068569431286915,2.20961278130644e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NTF4,Neurotrophin-4,28797,0.0110826836200215,0.00261207443158503,0.00596301773411487,0.0162023495059282,2.21372190240874e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0176643688886482,0.00416775484037175,0.00949556940151962,0.0258331683757769,2.26009791266724e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.015843738219902,0.0037436088897754,0.00850626479594227,0.0231812116438618,2.32262508129859e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS5,Transmembrane protease serine 5,29079,0.0106830998824381,0.00252501866802785,0.00573406329310354,0.0156321364717727,2.33471417102964e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,29478,0.00889693816466936,0.00210335288669542,0.00477436650674634,0.0130195098225924,2.34517618583319e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0147034139106193,0.00348116905928458,0.0078803225544215,0.0215265052668171,2.41181495472084e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0054949567009275,0.00130867513572392,-0.00805995996694638,-0.00292995343490862,2.69040823276254e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,0.00738111631235649,0.00175989828790401,0.00393171566806462,0.0108305169566484,2.74811261304041e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN1,Contactin-1,29820,0.0075675828454696,0.00180453520967961,0.00403069383449756,0.0111044718564416,2.75297976143692e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INHBB,Inhibin beta B chain,24381,0.0144446964441217,0.00344731098609275,0.00768796691137995,0.0212014259768635,2.79770707142232e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYY,Peptide YY,24111,0.0268976304192339,0.00645954541166392,0.0142369214123726,0.0395583394260952,3.13789458629487e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP152,Centrosomal protein of 152 kDa,24016,0.0115609613819528,0.00277788558226683,0.00611630564070983,0.0170056171231958,3.16869958089196e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN1,Tetraspanin-1,28916,-0.0156505319282695,0.00376067859286978,-0.0230214619702942,-0.0082796018862447,3.16905379488886e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK14,Kallikrein-14,29725,0.0126853472500153,0.00305221261704486,0.00670301052060738,0.0186676839794232,3.24610511593764e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR4,Toll-like receptor 4,24229,0.00784143151863193,0.00188723503676872,0.00414245084656524,0.0115404121906986,3.26426279760757e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0397799698979455,0.00960975142387011,0.02094485710716,0.0586150826887309,3.48990759006638e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPS,Calcyphosin,24845,0.026027247159417,0.00629635753741972,0.0136863863860744,0.0383681079327597,3.58142031558511e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15,Interleukin-15,29434,-0.00894085071459314,0.00217105701616086,-0.0131961224662684,-0.00468557896291786,3.82882591186071e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBA,Lysosomal acid glucosylceramidase,24195,0.0147554168966256,0.00358462077303111,0.00772956018148462,0.0217812736117666,3.86259820703681e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF9,Fibroblast growth factor 9,23970,0.0111782917286756,0.00271864449063836,0.00584974852702437,0.0165068349303268,3.94039486823418e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSAP,Gamma-secretase-activating protein,28797,0.0236379340398433,0.00575365690189032,0.0123607665121382,0.0349151015675483,3.99628290444508e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0145555063094929,0.00354336953499999,-0.0215005105980929,-0.00761050202089291,4.00739033556984e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0231863463077485,0.00564590398817183,-0.0342523181245653,-0.0121203744909317,4.02572125016339e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD55,Complement decay-accelerating factor,28490,0.00711058377799026,0.00174092916279357,0.00369836261891487,0.0105228049370656,4.43189982721441e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0100941012437659,0.00247167891328329,0.00524961057373069,0.0149385919138012,4.44274141870517e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OXT,Oxytocin-neurophysin 1,29694,0.0374044665357992,0.00919198418809144,0.01938817752714,0.0554207555444584,4.72869873787283e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0188186518187101,0.00463256865085826,0.00973881726302793,0.0278984863743923,4.87550327419307e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC4A1,Band 3 anion transport protein,24938,-0.0125624873465255,0.00310598331971128,-0.0186502146531596,-0.00647476003989138,5.25682788290824e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL12,Stromal cell-derived factor 1,28931,0.0106655416827493,0.00265296524437391,0.0054657298037764,0.0158653535617221,5.82876566004961e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00697909012622095,0.0017368574881431,-0.0103833308029814,-0.00357484944946048,5.88144212684711e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA10,Annexin A10,28774,-0.0218027419548044,0.00543804152996555,-0.0324613033535369,-0.011144180556072,6.1052501329632e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD58,Lymphocyte function-associated antigen 3,29409,0.00467028464761265,0.00116724573646279,0.00238248300414558,0.00695808629107971,6.31990209075445e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0106040667205871,0.00265455035904799,0.00540114801685299,0.0158069854243211,6.49700330864739e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCDH12,Protocadherin-12,24867,0.00675286239065777,0.00169734450399917,0.0034260671628194,0.0100796576184961,6.95519278711241e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0163219005740759,0.00412236915614151,0.00824205702803855,0.0244017441201133,7.53688776531204e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRND,Prion-like protein doppel,24845,-0.0135529871965111,0.00342491570406969,-0.0202658219764877,-0.00684015241653453,7.60525635795112e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,24445,0.0182752238329717,0.00462888086626937,0.00920261733508371,0.0273478303308597,7.89989009351293e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,-0.0149970875610345,0.00380577261012457,-0.0224564018768787,-0.00753777324519035,8.14601185399364e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,0.00878246038451299,0.0022312591515527,0.00440919244746971,0.0131557283215563,8.30062964506193e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,24229,0.0277490731474028,0.00705864871492588,0.013914121666148,0.0415840246286575,8.47523124738091e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.0160081812855621,0.00407248290572082,0.0080261147903493,0.0239902477807749,8.48866536969744e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF23,Fibroblast growth factor 23,29693,0.0147521125875842,0.00375838675209013,0.00738567455348752,0.0221185506216808,8.68826315986218e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNGR1,Interferon gamma receptor 1,29581,0.00546421804498954,0.00139215996798077,0.00273558450774723,0.00819285158223186,8.69286043993658e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB5,Integrin beta-5,29566,0.00976733322342309,0.00249554093816223,0.00487607298462512,0.0146585934622211,9.10153742438753e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0154439957731183,0.00395300335229068,0.00769610920262854,0.023191882343608,9.36997658414893e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.00967870690493057,0.00247886098204406,0.00482013938012422,0.0145372744297369,9.46712899008179e-05
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.010691494868369,0.00275003051114221,-0.0160815546702078,-0.00530143506653031,0.000101439187302268
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHPK,Sedoheptulokinase,24445,-0.0106898366526775,0.00275905090146389,-0.0160975764195467,-0.00528209688580828,0.000107139500537468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,24111,0.0113661671163867,0.00293367004293428,0.00561617383223547,0.0171161604005378,0.000107177046669017
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100P,Protein S100-P,28916,0.0137301179597037,0.00354748032506821,0.00677705652257,0.0206831793968374,0.00010890184500155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FRMD7,FERM domain-containing protein 7,24195,0.00862593443899374,0.00223090770567919,0.00425335533586252,0.012998513542125,0.000110670862738044
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSC,Dipeptidyl peptidase 1,29446,0.0110596000592621,0.00286985930595424,0.00543467581959179,0.0166845242989324,0.000116589147387251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLIC5,Chloride intracellular channel protein 5,24195,-0.00814919669376753,0.00211908787081749,-0.0123026089205698,-0.00399578446696524,0.000120558464691853
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALB1,Calbindin,29349,0.0111227639082398,0.00289347614875068,0.00545155065668845,0.0167939771597911,0.000121258985287944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,28797,0.0134285497751864,0.00349758291043267,0.00657328727073833,0.0202838122796344,0.000123609300589927
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.0180447964301535,0.00471076975883765,-0.0272779051574753,-0.00881168770283173,0.000128125387912835
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,24867,0.00765906046237588,0.00199970478620915,0.00373963908140594,0.0115784818433458,0.000128408027828131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.00940001617728121,0.00245557844790104,-0.0142129499351673,-0.00458708241939517,0.000129500881850719
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC51B,Organic solute transporter subunit beta,24111,-0.0194547504155418,0.00508800110349163,-0.0294272325783853,-0.00948226825269817,0.000131819863355167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,29409,-0.0116467787729778,0.0030540785760526,-0.0176327727820409,-0.0056607847639147,0.000137283202694808
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0150696619368206,0.00395359173538442,0.00732062213546714,0.0228187017381741,0.00013839341651362
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.00854510152620079,0.00224383728406624,0.00414718044943096,0.0129430226029706,0.000140296865435737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0155716501796486,0.00409499357409824,0.00754546277441606,0.0235978375848812,0.000143475735364872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNU13,NHP2-like protein 1,24111,0.0158234303095304,0.00416432652773648,0.00766135031516692,0.0239855103038939,0.000145193819420621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD109,CD109 antigen,29443,-0.00848613779956241,0.00223438108333874,-0.0128655247229063,-0.00410675087621848,0.000146172284690012
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.00836519869176338,0.00220714344307824,-0.0126911998401967,-0.00403919754333003,0.000150979708601072
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0243266328925509,0.0064410974734517,0.0117020818445856,0.0369511839405163,0.000159179118760763
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_DRA,,29322,-0.00901328153080913,0.00239233426786058,-0.0137022566958159,-0.00432430636580239,0.000165168352262155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MB,Myoglobin,29820,-0.0130833452783195,0.00347388089577179,-0.0198921518340322,-0.00627453872260683,0.000166066635407581
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,24240,0.0143074957025337,0.00380707300948385,0.00684563260394536,0.0217693588011221,0.00017158576178728
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0130793369279249,0.00348059415892443,0.00625737237643299,0.0199013014794168,0.000171759862725777
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPS10,40S ribosomal protein S10,24111,-0.010493336076402,0.00279318096318682,-0.0159679707642481,-0.00501870138855581,0.000172526430265152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPH,Hephaestin,24922,0.00657941247885307,0.0017538396179189,0.00314188682773204,0.0100169381299741,0.000176224869656316
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX9,Transcription factor SOX-9,24195,0.006815040842523,0.00181668683713609,0.00325433464173627,0.0103757470433097,0.000176290544700837
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANSC4,MANSC domain-containing protein 4,24111,0.0166332487257296,0.00443464042687256,0.00794135348905938,0.0253251439623998,0.000176715712583629
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,29434,-0.0152335880873923,0.00406864914046382,-0.0232081404027014,-0.00725903577208319,0.000181358067845046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCGB2A2,Mammaglobin-A,24111,-0.00787219881287819,0.00210266601922703,-0.0119934242105632,-0.0037509734151932,0.000181597499750273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC13A1,Solute carrier family 13 member 1,24793,0.0151679888053848,0.00405566290689387,0.0072188895078728,0.0231170881028968,0.000184469041454403
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0165893884653886,0.00443992485245491,0.00788713575457693,0.0252916411762002,0.000187083522242923
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTA2,"Actin, aortic smooth muscle",28916,-0.010772797145691,0.00288779571630838,-0.0164328767496554,-0.00511271754172659,0.000191498319543355
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00640357012887182,0.00172057985553282,0.00303123361202749,0.00977590664571616,0.000198298216152843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LCN15,Lipocalin-15,24867,-0.0153992174571002,0.00413885131808371,-0.0235113660405443,-0.00728706887365617,0.000199148087673913
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKCQ,Protein kinase C theta type,28931,0.0107397295608683,0.00288709973000123,0.00508101409006591,0.0163984450316707,0.000199676463936246
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.00738898726252337,0.00198815635827095,0.00349220080031232,0.0112857737247344,0.000202374542802386
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GM2A,Ganglioside GM2 activator,24421,0.00946126846732333,0.00255046899494745,0.00446234923722633,0.0144601876974203,0.000208031475554328
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0102654769035826,0.00276750080312555,-0.0156897784777087,-0.00484117532945657,0.000208305541114595
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0136821208851855,0.00368937075430254,0.00645095420675249,0.0209132875636185,0.000208860309516666
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MATN3,Matrilin-3,29169,-0.0078942265522087,0.00213031916822888,-0.0120696521219373,-0.00371880098248008,0.000211235347698559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SATB1,DNA-binding protein SATB1,24867,0.00730733969609508,0.00197251131583705,0.00344121751705447,0.0111734618751357,0.000212194090654603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,24793,0.0145901225507622,0.00393875904198127,0.00687015482847892,0.0223100902730455,0.000212482988514938
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL6,Interleukin-6,29349,-0.0180950103157397,0.00488594178118314,-0.0276714562068587,-0.00851856442462076,0.000213047835517165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSAB1,Tryptase alpha/beta-1,29753,0.0128309590591086,0.00346480721135073,0.00603993692486122,0.0196219811933561,0.000213261078070603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0105007444663783,0.00284154307277359,0.00493132004374209,0.0160701688890146,0.000219904328673511
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF3,Granulocyte colony-stimulating factor,28931,0.011764572198668,0.00320727708051112,0.00547830912086622,0.0180508352764698,0.000244810070025578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.00769432676534546,0.00209937339553925,-0.0118090986206024,-0.00357955491008853,0.000247812469250247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.00760906156824758,0.00207632457518443,0.00353946540088609,0.0116786577356091,0.000248178306380118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHISA5,Protein shisa-5,24938,-0.00614422340790176,0.00168096007688994,-0.00943890515860604,-0.00284954165719747,0.000257522380288852
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA1,Annexin A1,24281,0.0103865500073009,0.00284376581082197,0.00481276901808984,0.015960330996512,0.000260354436587995
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOC,Myocilin,29443,0.0110249191573437,0.00302424029457242,0.00509740817998172,0.0169524301347056,0.000267314367288821
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCN,Decorin,28916,-0.00552814430937411,0.00151695653781728,-0.00850137912349597,-0.00255490949525224,0.000268659146737389
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.00777307016558262,0.0021330410254795,0.0035923097556428,0.0119538305755224,0.000268758971371188
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROCR,Endothelial protein C receptor,24111,-0.00868419025467215,0.00238675960570837,-0.0133622390818606,-0.00400614142748375,0.000274818690181966
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.0143091176462982,0.00393873284053677,0.00658920127884615,0.0220290340137503,0.000280709568023208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADM,Pro-adrenomedullin,29725,0.00638524447547389,0.00175797600735734,0.00293961150105351,0.00983087744989427,0.000281535091238634
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0167403999234998,0.00462286447859164,0.0076795855454602,0.0258012143015394,0.000293812547012451
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDK2,Protein sidekick-2,24381,0.00932227053262482,0.00257613964671962,0.00427303682505437,0.0143715042401953,0.000296688324010487
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRIM26,Tripartite motif-containing protein 26,24016,0.0134922563250893,0.00373049898318213,0.00618047831805235,0.0208040343321263,0.000298944681035699
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM19,Probable RNA-binding protein 19,24111,-0.0115141271043461,0.00318707984804539,-0.0177608036065151,-0.00526745060217716,0.000303581167111182
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGR2,Anterior gradient protein 2 homolog,28553,-0.0241200657624772,0.00667899183712172,-0.0372108897632357,-0.0110292417617186,0.000305148994709347
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP12,Macrophage metalloelastase,29466,0.0126653712448566,0.00351464016228777,0.00577667652677256,0.0195540659629406,0.000314352210804004
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3D,Protein FAM3D,24805,-0.0202312102587324,0.00561748796911277,-0.0312414866781935,-0.00922093383927143,0.000317041898526541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PON3,Serum paraoxonase/lactonase 3,29581,-0.0067363092363317,0.00187387238417874,-0.010409099109322,-0.00306351936334138,0.000325093687285249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00706843453169751,0.00197065682007277,-0.0109309218990401,-0.00320594716435489,0.00033534934615478
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.0124488922669457,0.00347544302393113,0.00563702394004068,0.0192607605938507,0.000341697317923652
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPE,Carboxypeptidase E,29468,0.00914411767109199,0.00255755219549598,0.00413131536791988,0.0141569199742641,0.000350333081197948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300A,CMRF35-like molecule 8,24381,0.00712279627830056,0.00199289075132674,0.00321673040570014,0.011028862150901,0.000352109673660425
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTN,Neuroplastin,28797,0.0193071124362575,0.00540450632944453,0.0087142800305462,0.0298999448419687,0.000354288314245213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RB,Interleukin-17 receptor B,29034,-0.0126776860609454,0.00355079577659111,-0.019637245783064,-0.00571812633882686,0.000357041088348502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SULT1A1,Sulfotransferase 1A1,29694,-0.0302931488830926,0.0084952380455567,-0.0469438154523838,-0.0136424823138015,0.000363182939127591
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0146400376306812,0.00410660639018402,0.00659108910592049,0.0226889861554418,0.000364565130864853
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX5,Syntaxin-5,24229,0.00964784649914971,0.0027186617125336,0.00431926954258386,0.0149764234557156,0.00038779916580311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RLN2,Prorelaxin H2,24326,-0.0267671461624285,0.00754551427048815,-0.0415563541325852,-0.0119779381922717,0.000389748673775578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPJ,Centromere protein J,24445,0.0169254430573995,0.0047734814764432,0.00756941936357085,0.0262814667512282,0.000392269604244848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00605236026758539,0.00170788297947514,-0.00939981090735667,-0.00270490962781411,0.000395159453532383
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.00844417190826804,0.00238573503281086,0.00376813124395877,0.0131202125725773,0.000401728228192994
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE1,Ribonuclease pancreatic,24951,-0.00572933938831853,0.00161963146785587,-0.00890381706531603,-0.00255486171132103,0.000404768825964933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.00956728419498401,0.002723379283986,-0.0149051075915966,-0.00422946079837144,0.0004438474480501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0203087379463749,0.00578676250671467,0.00896668343321416,0.0316507924595357,0.000449737355483889
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPTX2,Neuronal pentraxin-2,24938,-0.00775973843306545,0.00221440671760424,-0.0120999755995698,-0.00341950126656115,0.000458773266268705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CENPF,Centromere protein F,24445,0.0126178222681921,0.00360294273391458,0.0055560545097195,0.0196795900266647,0.000462451337672342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRL6,Fc receptor-like protein 6,29434,-0.0157441993438475,0.00449700452434538,-0.0245583282115644,-0.00693007047613052,0.000464129926381228
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0101794599094911,0.00291684538245176,0.00446244295988566,0.0158964768590966,0.000484076863881672
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,29623,0.0189465773321028,0.00544331777641941,0.00827767449032081,0.0296154801738849,0.00050081798131827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB7,Integrin beta-7,29725,0.0105618807671036,0.00303470243227112,0.00461386399985222,0.016509897534355,0.00050144389111161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00686697678876152,0.00197696734955354,0.00299212078363658,0.0107418327938865,0.00051463475229267
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0109174165324278,0.00314713791883669,0.00474902621150784,0.0170858068533477,0.000523167083570549
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.00842833652910348,0.00242996911777255,0.00366559705826929,0.0131910759999377,0.000524295481413039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.00996882751686733,0.00289264053687661,-0.0156384029691455,-0.00429925206458917,0.000569166170616129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP2,Guanylate-binding protein 2,28931,0.0136704465373524,0.00397110945607993,0.00588707200343576,0.0214538210712691,0.000577231748961942
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.00906014296093343,0.00263712442458141,0.00389137908875387,0.014228906833113,0.000592045562446551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,24229,0.0147203555914988,0.00428755242575739,0.00631675283701434,0.0231239583459833,0.000597329787656627
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENO1,Alpha-enolase,29392,0.0178809643600516,0.00522004040738721,0.00764968516157262,0.0281122435585305,0.000614630904856886
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMS1,PMS1 protein homolog 1,24195,0.0115601656870421,0.00337519222657593,0.00494478892295328,0.0181755424511309,0.000615731242769296
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TERF1,Telomeric repeat-binding factor 1,24229,-0.00666888696176264,0.00195431780121397,-0.010499349852142,-0.00283842407138326,0.000645021241642623
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.00745537893287675,0.00219302685208978,-0.0117537115629727,-0.00315704630278079,0.000675941797302455
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA6C,Semaphorin-6C,24229,0.0058919402660803,0.00174357091740852,0.00247454126795961,0.00930933926420099,0.000728017995726397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0145634925392343,0.0043104310171876,0.00611504774554657,0.023011937332922,0.000729530869499101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATXN10,Ataxin-10,28774,0.0162420462447516,0.00481765231462578,0.00679944770808511,0.0256846447814182,0.000748961548067965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00660168431228024,0.00195812710667752,0.0027637551831923,0.0104396134413682,0.000748965272080099
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,-0.00599277554895038,0.00178470065432877,-0.00949078883143476,-0.00249476226646599,0.000786474100791396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN3,CCN family member 3,29795,0.00752229524760991,0.00224100261748949,0.00312993011733051,0.0119146603778893,0.000789872635251471
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PREB,Prolactin regulatory element-binding protein,28931,0.00643034127194601,0.00192208125037824,0.00266306202120465,0.0101976205226874,0.000822359983655308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00647482974157359,0.0019402072628409,0.00267202350640542,0.0102776359767418,0.000847591205947031
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0107154761977835,0.00321258203358126,0.00441881541196426,0.0170121369836028,0.000852829640618394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0134648427715989,0.00404306027843904,-0.0213892409173395,-0.00554044462585842,0.00086863605839447
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN2,Transcobalamin-2,29757,-0.0065934956079459,0.00198647308682972,-0.0104869828581322,-0.00270000835775964,0.000903851334910364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,-0.010699156345475,0.00322435587485687,-0.0170188938601945,-0.00437941883075554,0.000907015148604372
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00827263777209594,0.00250153608679262,0.00336962704198241,0.0131756485022095,0.00094410574126083
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0075269681974167,0.00227846610608848,0.00306117462948327,0.0119927617653501,0.000955919408344951
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX3,Syntaxin-3,24845,0.0083956515623256,0.00254988422861936,0.00339787847423164,0.0133934246504196,0.000994176989582197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NME1,Nucleoside diphosphate kinase A,24229,-0.00479748230577666,0.00145778925124644,-0.00765474923821968,-0.00194021537333363,0.000999995144009624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYO6,Unconventional myosin-VI,24867,0.00816423258947654,0.0024831422394356,0.00329727380018278,0.0130311913787703,0.00101090905356838
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYOM1,Myomesin-1,24101,0.0104216248727035,0.00317375196786633,0.00420107101568546,0.0166421787297215,0.00102602760405858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PODXL2,Podocalyxin-like protein 2,29566,0.00606761522320973,0.00184795176615118,0.00244562976155341,0.00968960068486605,0.00102672201639344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUP50,Nuclear pore complex protein Nup50,24111,-0.00734930177096215,0.00225088616967485,-0.0117610386635249,-0.00293756487839945,0.00109589556502532
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.00843729182061412,0.00258629528009391,0.00336815307163005,0.0135064305695982,0.00110661934106491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.0105868028615665,0.00325928402369226,-0.0169749995480033,-0.00419860617512964,0.00116296446112227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,-0.00759398779779864,0.00233815749716266,-0.0121767764922375,-0.00301119910335982,0.00116438344031232
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNC,Tenascin,29594,-0.0102553013307493,0.00315865297589862,-0.0164462611635106,-0.00406434149798801,0.00116867979025155
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UROS,Uroporphyrinogen-III synthase,24195,0.0147201584726103,0.00453708997230141,0.00582746212689951,0.023612854818321,0.00117856006356286
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK15,Kallikrein-15,24754,0.0111473936024233,0.00343736035524904,0.00441016730613521,0.0178846198987115,0.00118430848310975
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,-0.00609949925528836,0.00188278025132784,-0.00978974854789093,-0.00240924996268578,0.00119845275371561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.0117440917204661,0.00364810907306441,0.00459379793725986,0.0188943855036723,0.00128701793228046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMNB2,Lamin-B2,24845,0.00595620520941155,0.0018599223797344,0.00231075734513214,0.00960165307369097,0.00136461984552974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.00734334094261507,0.0022938391042108,0.0028474162983619,0.0118392655868682,0.00136937789640212
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARTN,Artemin,28931,0.00949590809337676,0.00296642523933377,0.00368171462428258,0.0153101015624709,0.00137038444247138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCC,Netrin receptor DCC,24195,0.00486475244401013,0.0015210937988829,0.00188340859819965,0.00784609628982062,0.00138469527800085
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EGFLAM,Pikachurin,24805,0.00653224421770631,0.0020467077654055,0.00252069699751153,0.0105437914379011,0.00141670302839704
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD160,CD160 antigen,29786,-0.00987946467168829,0.00310420238464267,-0.0159637013455879,-0.00379522799778865,0.00146104158650317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKAP12,A-kinase anchor protein 12,24381,0.00454403094147343,0.00143246368901247,0.00173640211100899,0.00735165977193787,0.00151487480074904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCN5,CCN family member 5,29443,0.00814702384944316,0.00257553349363884,0.00309897820191103,0.0131950694969753,0.00156183610351344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0116385230747895,0.00368642077370529,-0.0188639077912518,-0.0044131383583271,0.00159489299992402
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_E,,29434,0.00604592936147973,0.00192007359279288,0.00228258511960568,0.00980927360335378,0.00164105755774803
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RCC1,Regulator of chromosome condensation,24793,0.0107531646823228,0.00341939482674311,0.00405115082190629,0.0174551785427393,0.00166421389329121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDHR1,Cadherin-related family member 1,28774,0.00889295830622394,0.00283339986957314,0.00333949456186059,0.0144464220505873,0.00169918409064266
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LTO1,Protein LTO1 homolog,28931,0.00855727289065987,0.00272756922311795,0.00321123721334868,0.0139033085679711,0.00170667726704254
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ABO,Histo-blood group ABO system transferase,24951,0.0300629411071363,0.00958744364573163,0.0112715515615023,0.0488543306527703,0.00171668376191828
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,29218,-0.00751533497209502,0.0023998123465114,-0.0122189671712574,-0.00281170277293267,0.00174007753959706
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB39B,Ras-related protein Rab-39B,24111,0.0188083605234908,0.00601564542363801,0.00701769549316032,0.0305990255538213,0.00177066300529234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.00618166924484645,0.00198575965307998,0.00228958032480969,0.0100737581648832,0.00185376789852963
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TK1,"Thymidine kinase, cytosolic",24445,0.00944607917963304,0.00304232471934267,0.00348312272972141,0.0154090356295447,0.00190568358875794
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,24845,-0.00612424956879445,0.00197813386754757,-0.0100013919491877,-0.00224710718840121,0.00196386392366048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,-0.00910482370759336,0.00294158059369451,-0.0148703216712346,-0.00333932574395211,0.00196892719011837
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.00843471634030897,0.00273704853400876,0.0030701012136518,0.0137993314669661,0.00206027322448427
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0145518804732748,0.00473772521263294,0.0052659390565142,0.0238378218900353,0.00213222632953114
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR1,Folate receptor alpha,29383,-0.00587431088505115,0.00191284317894131,-0.00962348351577613,-0.00212513825432618,0.00213549444307101
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00647590843412959,0.00211023847405428,-0.010611975843276,-0.00233984102498319,0.00215155321647763
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APLP1,Amyloid-like protein 1,29478,-0.0103838331777866,0.00340487906105445,-0.0170573961374534,-0.00371027021811992,0.00229279324218387
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.0128913336305627,0.00422975432634331,0.00460101515092982,0.0211816521101956,0.00230755510250899
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,29375,-0.00746942848397791,0.00245175621813187,-0.0122748706715164,-0.00266398629643944,0.00231679782377651
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLGN,Calmegin,24195,0.00909683958034978,0.00298700381609792,0.00324231210079786,0.0149513670599017,0.00232564611217443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,29673,-0.00612315550286521,0.00201544624664652,-0.0100734301462924,-0.00217288085943803,0.00238270878653014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPON1,Spondin-1,29497,0.00657908064598142,0.00217312535104154,0.00231975495794001,0.0108384063340228,0.00246819852101854
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,29443,0.00876930233904523,0.00290251264314656,0.00308037755847797,0.0144582271196125,0.0025192494369448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,YY1,Transcriptional repressor protein YY1,24229,0.00558385371730206,0.00185992425755896,0.0019384021724865,0.00922930526211763,0.00268314533040906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0181764900264557,0.00607292923154207,0.00627354873263325,0.0300794313202782,0.00276498086121363
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0171589169362769,0.00577240122057799,-0.0284728233286098,-0.00584501054394409,0.00295593349140335
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.00739786504886715,0.00249116327058115,0.00251518503852809,0.0122805450592062,0.00298386640869666
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH7B,Myosin-7B,24016,-0.00877351024315751,0.00295601042563013,-0.0145672906773926,-0.00297972980892246,0.00300016582506793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNASE6,Ribonuclease K6,24828,-0.00605262980314716,0.00204059434620313,-0.0100521947217053,-0.00205306488458903,0.00301878595663558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FMR1,Synaptic functional regulator FMR1,28797,0.00694304754502083,0.00235211828255435,0.00233289571121429,0.0115531993788274,0.00316154118394513
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,24793,0.0102060738714079,0.00345920692879313,0.00342602829097339,0.0169861194518425,0.00317650770074236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,29216,-0.0113880003992752,0.00386445419299144,-0.0189623306175384,-0.00381367018101198,0.0032127354173065
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL11,Interleukin-11,28931,0.0121614741493227,0.00413683201387767,0.00405328340212243,0.0202696648965229,0.00328680017805937
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,24111,0.00781079220685759,0.00266116683436137,0.00259490521150929,0.0130266792022059,0.00333754336323625
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00709280994699539,0.00243437396517276,0.00232143697525679,0.011864182918734,0.0035760565404861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG1,Arginase-1,29216,0.00999197641660312,0.00343133028881915,0.0032665690505176,0.0167173837826887,0.00359413632506227
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAM,Integrin alpha-M,29443,-0.00609805158830081,0.00209478804925613,-0.0102038361648428,-0.00199226701175879,0.00360476161345607
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.00990310583386969,0.00340399099234639,0.00323128348887076,0.0165749281788686,0.00362614105795235
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD177,CD177 antigen,29413,-0.0245503083215761,0.00847925548939196,-0.0411696490807843,-0.00793096756236783,0.00379029619668878
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEF,Thyrotroph embryonic factor,24111,0.00825669142107936,0.00285452653279537,0.00266181941680043,0.0138515634253583,0.00382542568458739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00629089756059578,0.00217499053715165,0.00202791610777855,0.010553879013413,0.00382678216455926
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.00574011292135117,0.00198606406907868,0.00184742734595695,0.00963279849674539,0.00385290260342261
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,28774,0.00764310613991715,0.00264841263380388,0.00245221737766154,0.0128339949021728,0.00390561979491913
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTP1,Glutathione S-transferase P,28604,-0.0133271670548507,0.00462172207956126,-0.0223857423307908,-0.00426859177891061,0.00393459366380766
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD2,Sushi domain-containing protein 2,29443,-0.00544511382436084,0.00189127536897018,-0.0091520135475424,-0.00173821410117928,0.00399137414207541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,0.0060522899991889,0.00210877051195452,0.00191909979575804,0.0101854802026198,0.00410690793857299
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.00904417235282496,0.00315141529713059,-0.0152209463352009,-0.002867398370449,0.00410931559225234
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP2,Dipeptidase 2,29349,0.00557255170483299,0.00194182110092651,0.00176658234701703,0.00937852106264894,0.00411082825871954
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,METAP1,Methionine aminopeptidase 1,28774,0.00563048633912373,0.00198169393735175,0.0017463662219143,0.00951460645633316,0.00449687632206904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEDD9,Enhancer of filamentation 1,24229,0.00626171831012963,0.00221878409668869,0.00191290148061981,0.0106105351396395,0.00477432786485907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,24609,0.00597639981214998,0.0021177525416745,0.00182560483046796,0.010127194793832,0.00477562679126409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBC1D17,TBC1 domain family member 17,28774,0.0083266835973386,0.00295524585841717,0.00253440171484094,0.0141189654798363,0.00484179120679528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA4,Ephrin-A4,29169,0.00573417510103214,0.00203669027307974,0.00174226216579586,0.00972608803626843,0.00487434764173295
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0184280785093364,0.00656313079033128,-0.0312918148583857,-0.00556434216028707,0.00499184542240618
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPR101,Probable G-protein coupled receptor 101,24101,-0.011425798634917,0.00410090389114616,-0.0194635702615634,-0.00338802700827051,0.00533772683905766
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00724724274153632,0.00260191958673844,0.00214748035152897,0.0123470051315437,0.00535113720046953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DBH,Dopamine beta-hydroxylase,24919,0.0202017010939941,0.00726172681811066,0.0059687165304972,0.034434685657491,0.00540753747652846
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENOPH1,Enolase-phosphatase E1,24793,0.0101844306219306,0.00368278537853722,0.00296617127999766,0.0174026899638636,0.00568924476863491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00649035463418576,0.00235345550728507,0.00187758183990703,0.0111031274284645,0.0058235786743174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFB,Vascular endothelial growth factor B,24229,0.00530388873666911,0.00192457589242001,0.00153171998752589,0.00907605748581233,0.00585793036972822
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUSP29,Dual specificity phosphatase 29,24195,-0.0122549464996735,0.00444702911389471,-0.0209711235629071,-0.00353876943643985,0.00585997224396474
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VEGFD,Vascular endothelial growth factor D,29732,-0.00652359114653706,0.00236906936270434,-0.0111669670974376,-0.00188021519563655,0.00589703082781439
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PKLR,Pyruvate kinase PKLR,29491,-0.0117499456373171,0.00427201887344499,-0.0201231026292693,-0.0033767886453649,0.00595509902028989
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D1,DCN1-like protein 1,24101,-0.0136912128867986,0.00498509201303639,-0.0234619932323499,-0.00392043254124732,0.00602922300972949
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00747650572868131,0.00272303185044913,0.00213936330180102,0.0128136481555616,0.00604264497242931
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.0140263620280114,0.00512145839690464,-0.0240644204859445,-0.00398830357007826,0.00617123647056877
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.00763065145459423,0.00278620510561384,0.00216968944759109,0.0130916134615974,0.00617217512948516
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIL1,Nucleotide exchange factor SIL1,24240,0.0058546907789652,0.00214638453843892,0.00164777708362492,0.0100616044743055,0.00638237299945784
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.00638157417264066,0.00233986664977553,0.00179543553908062,0.0109677128062007,0.00638888642145038
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLIN3,Perilipin-3,29478,-0.00767161060552386,0.00281752184602084,-0.0131939534237247,-0.00214926778732302,0.00647649994575939
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17RA,Interleukin-17 receptor A,29443,0.00794165778752595,0.00291789233364731,0.00222258881357722,0.0136607267614747,0.00649832414927076
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,24845,0.00839632384015638,0.00308784551972737,0.00234414662149073,0.014448501058822,0.00654948411851238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SNX18,Sorting nexin-18,24805,0.00805846763734776,0.00296499209587696,0.00224708312942891,0.0138698521452666,0.00657489928084448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDRG1,Protein NDRG1,28774,0.012140488907174,0.004468465415326,0.00338229669313508,0.020898681121213,0.00659307945248446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP290,Centrosomal protein of 290 kDa,24445,0.00958088984696826,0.00352870646355624,0.00266462517839802,0.0164971545155385,0.00662966925450911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIF20B,Kinesin-like protein KIF20B,24101,0.0137935405066059,0.00508944247478549,0.00381823325602638,0.0237688477571855,0.00672849284080231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.0072460985208154,0.00267386616735731,-0.0124868762088357,-0.00200532083279508,0.00673367859703519
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL1,Interferon lambda-1,28774,-0.00813377525966125,0.00300287104367144,-0.0140194025052573,-0.00224814801406522,0.00675942396254552
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UNG,Uracil-DNA glycosylase,24793,0.00618714475180627,0.0022872928347332,0.0017040507957292,0.0106702387078833,0.00683494831780359
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAG,S-arrestin,24101,-0.00948950452375984,0.00351299511909377,-0.0163749749571836,-0.00260403409033604,0.00691261515519191
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00631826371480606,0.00234602233974087,0.00172005992891396,0.0109164675006982,0.00708147415790962
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0136949872550243,0.00510431110737624,0.00369053748456683,0.0236994370254817,0.00730098300032828
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALY,RNA-binding protein Raly,24793,0.00856892511872059,0.0031952841657419,0.00230616815386648,0.0148316820835747,0.00732886276974013
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.006717718096423,0.00250522754561888,0.00180747210701,0.011627964085836,0.00733388489461677
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOX2,Transcription factor SOX-2,24826,0.00424538622487795,0.00158461069749848,0.00113954925778094,0.00735122319197497,0.007386126590015
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00685894512174022,0.00256231632526243,0.00183680512422586,0.0118810851192546,0.00743673245893944
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP7,Dipeptidyl peptidase 2,29279,0.0106509435007412,0.00398459002037188,0.00284114706081233,0.0184607399406701,0.00752103749928327
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VIM,Vimentin,28916,0.0206505886277554,0.00772837223872631,0.00550297903985185,0.035798198215659,0.00754319323944394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD48,CD48 antigen,29536,-0.00526206118442623,0.00198284936674116,-0.00914844594323891,-0.00137567642561354,0.0079636530872078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0148300981196302,0.00559000955807964,0.00387367938579414,0.0257865168534663,0.00798311004091892
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.00880027852871517,0.00331855194628245,0.00229591671400157,0.0153046403434288,0.00800976746726709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0207231997935557,0.00781929820984895,0.00539737530225177,0.0360490242848596,0.00804728167109992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINA11,Serpin A11,29820,-0.00718466702341845,0.00271128190037936,-0.012498779548162,-0.00187055449867491,0.00805544784095238
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0242079453230231,0.00915937504259583,-0.0421603204065109,-0.00625557023953524,0.00822339208144737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPESP1,Sperm equatorial segment protein 1,24922,0.00531684106575442,0.00201670506520305,0.00136409913795644,0.00926958299355241,0.00838428784061735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPARCL1,SPARC-like protein 1,29489,0.00479634138984988,0.00181964416050521,0.00122983883525966,0.0083628439444401,0.00839663777442883
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2B,Sodium channel subunit beta-2,24195,-0.00507291826621023,0.00192628430856512,-0.00884843551099787,-0.0012974010214226,0.00845573374141307
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00542666384724911,0.00207607511218388,0.0013575566273687,0.00949577106712952,0.00895602314490984
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTTG1,Securin,24445,0.00717747026798558,0.00275123636049166,0.00178504700142193,0.0125698935345492,0.00909113329489107
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPM1B,Protein phosphatase 1B,24229,0.010853442948929,0.00416086325211555,0.00269815097478254,0.0190087349230755,0.00910066510995002
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRLF1,Cytokine receptor-like factor 1,29581,0.00445234727675285,0.00170760589867628,0.00110543971534734,0.00779925483815835,0.00912885787779541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLSPN,Claspin,28719,0.00596461380654851,0.00230171479718273,0.00145325280407036,0.0104759748090267,0.00956407204763503
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP164,Centrosomal protein of 164 kDa,28931,0.010824070537508,0.00417989449392572,0.00263147732941358,0.0190166637456024,0.0096147970866416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.00729574819194736,0.00282154107675398,0.00176552768150957,0.0128259687023852,0.0097220979186285
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,29594,0.00472390471131394,0.0018286464409689,0.0011397576870149,0.00830805173561298,0.00979135584762683
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.00997993152258778,0.00386941579920911,0.00239587655613792,0.0175639864890376,0.00990922118658725
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00635046228018002,0.0024625275615103,-0.0111770163007402,-0.00152390825961983,0.0099191934456383
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B4,Protein ATP1B4,24016,-0.00720883534873731,0.00280153150777949,-0.0126998371039851,-0.00171783359348952,0.0100829254735267
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00750645695310721,0.00291734139712224,-0.0132244460914668,-0.00178846781474762,0.0100865925034751
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.00618406376999915,0.00240365209299112,0.00147290566773655,0.0108952218722617,0.0100944826282701
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.00891557781707149,0.00347533043222339,0.00210393016991365,0.0157272254642293,0.0103119030878224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.00912216144509999,0.00357225120551236,0.00212054908229576,0.0161237738079042,0.0106661566264514
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGMA,Repulsive guidance molecule A,29694,-0.00530577822077025,0.00208324144270034,-0.0093889314484629,-0.00122262499307759,0.0108738996019872
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0114827136733055,0.00451180202576472,0.00263958170280662,0.0203258456438043,0.0109317193162906
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,24805,0.024819845386585,0.00979020707916114,0.00563103951142915,0.0440086512617408,0.0112453498265166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00566710577331843,0.0022453312136331,-0.0100679549520393,-0.00126625659459756,0.0116096298927017
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0105531424109724,0.00418279165508922,0.0023548707669975,0.0187514140549473,0.0116423555055801
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.00575845887536745,0.00228253220689275,-0.0102322220008772,-0.00128469574985766,0.0116475874798187
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QSOX1,Sulfhydryl oxidase 1,24502,0.00713004991739722,0.00283613283532819,0.00157122956015397,0.0126888702746405,0.0119432603465967
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00390252320336448,0.001553623603991,0.000857420939542126,0.00694762546718684,0.0120152861638656
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,-0.00644726659051923,0.00256841441491596,-0.0114813588437545,-0.00141317433728394,0.0120711039276431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGB2,Integrin beta-2,29274,0.00475774196631044,0.0019035143315471,0.00102685387647812,0.00848863005614277,0.0124440019925796
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GKN1,Gastrokine-1,28114,0.00464231165100673,0.00186261653969298,0.000991583233208488,0.00829304006880497,0.0126954358561874
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,-0.00559269126285826,0.00224957433508763,-0.01000185695963,-0.0011835255660865,0.0129202773675089
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.00428194476532198,0.00172427635937519,0.000902363100946595,0.00766152642969736,0.0130228446792096
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN2,Neuroligin-2,24101,-0.00783799927373622,0.00316195634965683,-0.0140354337190636,-0.00164056482840883,0.0131876551220189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0081102126765354,0.00327896409441133,0.00168344305148919,0.0145369823015816,0.0133898170208576
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GZMH,Granzyme H,28916,0.0125231400767681,0.00506553317545541,0.00259469505287546,0.0224515851006607,0.013433193603534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.00873188466118682,0.00353411340690747,0.00180502238364818,0.0156587469387255,0.0134890065579282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.0049490318181274,0.00200998989722971,-0.00888861201669763,-0.00100945161955717,0.0138137156257257
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRXN3,Neurexin-3,24195,0.00577927444028121,0.00234740152198493,0.00117836745719075,0.0103801814233717,0.0138238527570838
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLN,Mesothelin,29293,0.00911647300300098,0.00371019629558062,0.00184448826366297,0.016388457742339,0.0140105529894442
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRCAM,Neuronal cell adhesion molecule,29478,0.00460720880814695,0.00187591235802468,0.000930420586418571,0.00828399702987534,0.0140557109570991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.00796026274642749,0.00324294152634662,0.00160409735478813,0.0143164281380669,0.0141092728287958
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.0192772157783568,0.00786599046515214,-0.034694557090055,-0.00385987446665858,0.0142634843115559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.00457631298527362,0.0018678741423957,-0.00823734630436919,-0.000915279666178056,0.014290923882312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCF2,Neutrophil cytosol factor 2,29395,0.0134399304992449,0.00549240384999436,0.00267481895325593,0.0242050420452338,0.0144107663308194
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.00990465047762948,0.00404887466934627,0.00196885612571079,0.0178404448295482,0.0144401063354979
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OPTC,Opticin,29349,0.00730946444252655,0.00299265419698143,0.00144386221644294,0.0131750666686102,0.0145930511941981
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00578730027295461,0.00237346453378122,0.00113530978674342,0.0104392907591658,0.0147622647541578
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM3B,Protein FAM3B,29349,0.00575328414643745,0.0023614217279719,0.00112489755961252,0.0103816707332624,0.0148416327877072
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUMF1,Formylglycine-generating enzyme,24229,0.0107800177912883,0.00442592852238684,0.00210519788741008,0.0194548376951665,0.0148721772090195
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MENT,Protein MENT,24381,-0.00366882856974592,0.00150692955781522,-0.00662241050306374,-0.000715246636428094,0.014913806320636
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,0.00337866281787697,0.00139523020607539,0.000644011613969212,0.00611331402178474,0.0154604547244716
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,24805,0.00808606209895663,0.00334725513581877,0.00152544203275184,0.0146466821651614,0.0157109158731249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10,Interleukin-10,28931,-0.0130948444216714,0.00542292850247227,-0.023723784286517,-0.00246590455682575,0.0157535507128556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00535384604076922,0.00221994517450888,-0.00970493858280663,-0.00100275349873181,0.0158844493500971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,0.0078155033407825,0.00324390783576588,0.00145744398268138,0.0141735626988836,0.0159911309069647
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFRC,Transferrin receptor protein 1,29565,-0.00615020839849344,0.00255405815714703,-0.0111561623865016,-0.00114425441048526,0.0160456408285892
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.0196082257094542,0.00816731881486474,0.00360028083231931,0.0356161705865891,0.0163648869020646
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL21,C-C motif chemokine 21,29581,-0.0064298597127978,0.00268651928952349,-0.0116954375202638,-0.00116428190533177,0.0167001684693861
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NMI,N-myc-interactor,24706,0.0114507828731266,0.00478540648300465,0.00207138616643747,0.0208301795798157,0.0167252803811662
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAFB2,Scaffold attachment factor B2,24867,0.00435467364632327,0.00182339008064388,0.000780829088261265,0.00792851820438528,0.0169371942313406
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDI2,Protein DDI1 homolog 2,24381,0.0121449500527532,0.00509496886787016,0.00215881107172772,0.0221310890337787,0.0171465139682377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.0059574188562275,0.00249942226464059,0.00105855121753196,0.0108562864949231,0.0171557269755857
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,24101,0.00691597956862303,0.0029171099428876,0.00119844408056334,0.0126335150566827,0.0177558871653309
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.0036507936086904,0.00154305586682334,0.000626404109716641,0.00667518310766415,0.017990241947757
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMBN,Ameloblastin,28931,-0.00444098001428522,0.00189477334506582,-0.00815473577061423,-0.000727224257956214,0.0190948612230748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEPACAM2,HEPACAM family member 2,24845,-0.00654314994422196,0.00279187209198431,-0.0120152192445112,-0.00107108064393271,0.0191043120075272
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.0108529052551485,0.00466298983248932,-0.0199923653268276,-0.00171344518346944,0.0199489853284961
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A14,Protein S100-A14,24867,0.00814735695124669,0.00351340982293361,0.00126107369829681,0.0150336402041966,0.0204068150989452
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.010441566304417,0.00452378877714754,-0.0193081923076262,-0.00157494030120784,0.0209991771990221
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,28862,-0.00800480265321651,0.00347597376336817,-0.0148177112294181,-0.00119189407701489,0.0212918306000413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MPO,Myeloperoxidase,29443,0.00698866974771837,0.00303903697133002,0.00103215728391153,0.0129451822115252,0.0214759859988897
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ICAM4,Intercellular adhesion molecule 4,29434,-0.00800267316589079,0.00348308739208842,-0.0148295244543841,-0.00117582187739748,0.021592669049495
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBQLN3,Ubiquilin-3,24111,-0.00768705527391795,0.00335404922800907,-0.0142609917608157,-0.00111311878702018,0.0219215477877849
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00840432814489803,0.00370135085360898,-0.0156589758179716,-0.00114968047182442,0.0231792900387888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00649170445644415,0.00286040603163987,-0.0120981002784583,-0.000885308634430014,0.0232464626808612
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAT1,Diamine acetyltransferase 1,24111,-0.00758833679631559,0.00335894308782931,-0.014171865248461,-0.00100480834417016,0.0238833129393157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.00867635466719379,0.00384667779798132,0.0011368661831504,0.0162158431512372,0.0241080790278874
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGA4,Pepsin A-4,24951,0.0106489565734455,0.00472535793735227,0.00138725501623507,0.0199106581306559,0.0242314584085253
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0105534650291006,0.00468344464545648,0.00137391352400586,0.0197330165341953,0.0242455821434432
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,24938,-0.00490208904550971,0.00218260372273543,-0.00917999234207115,-0.000624185748948266,0.0247138728791169
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.00865446076945842,0.00385945738495271,0.00108992429495111,0.0162189972439657,0.0249428522312858
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,29662,0.00602099841213362,0.00269723754059257,0.000734412832572191,0.011307583991695,0.0256036815725905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUK1,Guanylate kinase,24111,-0.00591794653659768,0.00267182784235696,-0.0111547291076173,-0.000681163965578036,0.0267732899733945
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMBS,Porphobilinogen deaminase,29725,0.00631662769792693,0.00285192620054818,0.000726852344852497,0.0119064030510014,0.0267769812034102
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.00903895774191065,0.00408408110763799,-0.0170437567128811,-0.00103415877094019,0.0268920256255277
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSG1,Tryptase gamma,24229,0.00393213194471845,0.00178060168446584,0.000442152643165411,0.00742211124627149,0.0272315568954161
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRC1,Macrophage mannose receptor 1,24951,0.00414287865798058,0.00188164570481534,0.000454853076542514,0.00783090423941864,0.0276934021060635
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.00615347340800941,0.00280724780738566,0.000651267705533519,0.0116556791104853,0.028389103759733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSF,Cathepsin F,29566,0.0058032371569497,0.0026548867754935,0.000599659076982445,0.011006815236917,0.0288329425836704
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.00725053347657496,0.00332646521492842,-0.0137704052978347,-0.000730661655315252,0.0292929873874364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAMDC2,MAM domain-containing protein 2,24922,-0.00501433711941831,0.00230147110801715,-0.00952522049113192,-0.000503453747704707,0.0293593623985192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,28931,-0.00454441281461917,0.00209565739379101,-0.00865190130644955,-0.000436924322788793,0.0301295243067839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AOC3,Membrane primary amine oxidase,29594,-0.00432444082775567,0.00199958538964964,-0.00824362819146898,-0.000405253464042373,0.0305746536507192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.00475389757655114,0.00220906900057179,0.000424122335430437,0.00908367281767185,0.0314076383597313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LIF,Leukemia inhibitory factor,28774,0.00732231039868858,0.00340492115723595,0.000648664930506125,0.013995955866871,0.0315233571783374
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,-0.00528093988654262,0.00245805710473323,-0.0100987318118197,-0.000463147961265494,0.0316900195262192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHB6,Ephrin type-B receptor 6,29163,0.00454188135807142,0.00211408647767123,0.000398271861835819,0.00868549085430703,0.0316910332222737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00712706966653139,0.00332318382161727,0.000613629376161537,0.0136405099569012,0.0319907268543388
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,INSL5,Insulin-like peptide INSL5,24805,0.0138213036478022,0.00649100368467131,0.00109893642584647,0.026543670869758,0.0332391519801445
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,24195,-0.00883165909919242,0.00415233479294995,-0.0169702352933743,-0.000693082905010512,0.033437321953965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SH3GL3,Endophilin-A3,24307,0.0118220689533886,0.00556869591362051,0.000907424962692374,0.0227367129440848,0.0337680353520251
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DENND2B,DENN domain-containing protein 2B,24111,-0.0071539126391713,0.00338619768248451,-0.0137908600968409,-0.000516965181501652,0.0346394217310501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,24867,-0.00539326356254933,0.00255743364705651,-0.0104058335107801,-0.000380693614318571,0.0349668465416353
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00333287313349247,0.00158340848570502,-0.0064363537654743,-0.000229392501510638,0.0353124112877443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDAN1,Codanin-1,24845,0.00315297249536835,0.00150033005671488,0.000212325584207178,0.00609361940652952,0.0356054593042305
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,24240,0.00531106381713751,0.00252751307415211,0.000357138191799371,0.0102649894424756,0.0356249213288813
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00697988501636803,0.00332555567332702,0.000461795896647078,0.013497974136089,0.0358396504516749
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00588964797407506,0.00280934304068442,0.000383335614333588,0.0113959603338165,0.0360509807559767
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,24101,0.0165011137179013,0.00787684884450526,0.00106248998267103,0.0319397374531317,0.0361913949025026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.00983587475933903,0.0047097698666337,-0.0190670236979411,-0.000604725820736981,0.0367724028342991
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CORO6,Coronin-6,24101,-0.00518749989728424,0.00250035763406625,-0.0100882008600541,-0.000286798934514388,0.0380246467464135
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENG,Endoglin,29820,0.00236047386439611,0.00113983687698091,0.000126393585513522,0.00459455414327871,0.0383779035827948
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00720920135093188,0.00349039389289658,-0.0140503733810092,-0.000368029320854577,0.0388920582217574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.00326648298991478,0.00158547974365214,-0.00637402328747297,-0.000158942692356594,0.0393834810352985
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00391086971201204,0.00190102621679208,0.000184858327099567,0.0076368810969245,0.0396734587392048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GBP6,Guanylate-binding protein 6,24111,-0.00632199050191781,0.00307401763519314,-0.0123470650668964,-0.000296915936939258,0.0397365307288267
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00459567713975594,0.0022429634112723,-0.00899188542584965,-0.000199468853662226,0.0404796746467888
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO3,R-spondin-3,29725,0.00384487134360282,0.00187756140929671,0.00016485098138126,0.00752489170582437,0.0405883157851194
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.00864015721022408,0.00421992531420777,-0.0169112108260713,-0.000369103594376858,0.0406210612493538
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.00464341607040861,0.00227960213510214,-0.00911143625520881,-0.00017539588560841,0.0416647945217521
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC2,Plexin domain-containing protein 2,24845,0.00366153718614555,0.00179828476260621,0.000136899051437388,0.00718617532085372,0.0417481369691111
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACRV1,Acrosomal protein SP-10,24229,-0.0103938361570761,0.00511227199370558,-0.0204138892647391,-0.000373783049413195,0.0420518042373243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMIGO1,Amphoterin-induced protein 1,24195,0.00675633606825651,0.00334002589166659,0.000209885320589993,0.013302786815923,0.0431006878929189
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMEM132A,Transmembrane protein 132A,24240,0.00841869156692697,0.00416492117868639,0.000255446056701657,0.0165819370771523,0.043256305991704
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.00376605683241588,0.00186485261584062,-0.00742116795946349,-0.000110945705368264,0.0434466840766298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.00505651064384584,0.00250812272733217,-0.00997243118941689,-0.000140590098274785,0.043805414079507
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH23,Cadherin-23,24845,-0.0035471401798716,0.00176344261374491,-0.00700348770281162,-9.079265693158e-05,0.0442849283805186
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00658950002194217,0.00327874429128757,-0.0130158388328658,-0.000163161211018531,0.0444673316792802
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COMMD9,COMM domain-containing protein 9,24793,0.00525691962588553,0.00262126793605797,0.000119234471211919,0.0103946047805591,0.044921826951556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.00365121453418482,0.00182244543384409,7.92214838503925e-05,0.00722320758451924,0.045135922904571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMCN2,Hemicentin-2,24343,-0.00764140432612683,0.00383411340838069,-0.015156266606553,-0.000126542045700672,0.046272131751572
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.00513040273935611,0.00257739425327885,7.87100029295594e-05,0.0101820954757827,0.0465408998452262
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,-0.00511431148681867,0.00257783546132259,-0.010166868991011,-6.17539826263877e-05,0.047270119568127
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD70,CD70 antigen,29434,0.00561161793867906,0.00282994421606251,6.49272751965515e-05,0.0111583086021616,0.0473830863772208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD200,OX-2 membrane glycoprotein,29434,0.00346350948119694,0.00175669633076265,2.03846729021594e-05,0.00690663428949173,0.0486641868654784
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEB,Nebulin,24111,-0.00497628898862126,0.00252573462542717,-0.00992672885445851,-2.58491227840101e-05,0.0488229556815922
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PIGR,Polymeric immunoglobulin receptor,29115,-0.00471378608053351,0.00239542762804266,-0.00940882423149713,-1.87479295698876e-05,0.0490974790249999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD248,Endosialin,24938,0.0052558622494063,0.00267104861957708,2.06069550352178e-05,0.0104911175437774,0.0491119171689396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00709797075732772,0.00361577103447713,-0.0141848819849029,-1.10595297525507e-05,0.049650844203825
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.00529025045582596,0.00270179839589002,-5.27440011847784e-06,0.0105857753117704,0.0502358622408325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GH2,Growth hormone variant,28797,0.0214453134796876,0.0109577930359726,-3.19608708186717e-05,0.0429225878301938,0.0503473303148173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.00520733977324981,0.00266214489763204,-1.04642261089857e-05,0.0104251437726086,0.0504681445695413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00623533352318004,0.00318983535838178,-0.0124874108256083,1.67437792482602e-05,0.0506240254686139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,-0.00492489334383891,0.00252017515640979,-0.0098644366504021,1.4649962724279e-05,0.0506884713305585
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LPA,Apolipoprotein(a),24484,-0.0231748987292016,0.0118724918035059,-0.0464449826640732,9.51852056700481e-05,0.0509516470747078
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00364485434314856,0.00186989561992168,-2.01410718979416e-05,0.00730984975819506,0.0512796399007904
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.0049269275506369,0.00253042093973847,-3.26974912505107e-05,0.0098865525925243,0.0515369164759106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00963448312543976,0.00496133710422778,-0.0193587038497262,8.97375988466922e-05,0.0521593229302167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.0058867583397604,0.00303172420246161,-0.0118289377765852,5.5421097064347e-05,0.0521826979641676
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.0035222287317459,0.00181687287055546,-3.88420945428144e-05,0.00708329955803461,0.0525568770062001
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NEFL,Neurofilament light polypeptide,28674,0.00574167342645395,0.00296947131173806,-7.84903445526577e-05,0.0115618371974605,0.0531761530216416
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00756053486130684,0.00392198791475463,-0.000126561451612233,0.0152476311742259,0.0539004268762684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RSPO1,R-spondin-1,29218,-0.00446660603118769,0.00232342441050551,-0.00902051787577849,8.73058134031202e-05,0.054562188154557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.0033194157159625,0.00173079011988143,-7.29329190050903e-05,0.0067117643509301,0.0551382994587355
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD80,T-lymphocyte activation antigen CD80,24922,0.00435218335182343,0.00227058920641972,-9.81714927592234e-05,0.00880253819640609,0.0552793660260198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCP2,Non-specific lipid-transfer protein,28797,0.00966606179196518,0.00504387699470733,-0.00021993711766119,0.0195520607015916,0.0553247004383879
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MN1,Transcriptional activator MN1,24195,-0.00754128449649143,0.00393971197414601,-0.0152631199658176,0.000180550972834744,0.0556100323080544
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.0064203629974915,0.00335511675260402,-0.0129963918325954,0.00015566583761239,0.0556826787373864
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLNS1A,Methylosome subunit pICln,24195,-0.00426132217617464,0.00223046641894588,-0.00863303635730857,0.00011039200495928,0.0560797535279684
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP112,Centrosomal protein of 112 kDa,24111,0.00580866669896059,0.00305488894788139,-0.000178915638886931,0.0117962490368081,0.0572572347906835
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,24445,0.00672446632187416,0.00355112700399667,-0.000235742605959322,0.0136846752497076,0.058287973303764
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.00852203890733599,0.00450839902180275,-0.000314423175397399,0.0173585009900694,0.0587334606772865
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFD,Complement factor D,24966,0.00245753676340125,0.00130052911762925,-9.15003071520716e-05,0.00500657383395458,0.0588171987562528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,29434,0.00640876118945289,0.00339387259563161,-0.000243229097985053,0.0130607514768908,0.0589911063281079
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.0105539446721922,0.00559326890547295,-0.0215167517269192,0.00040886238253475,0.0591857005833792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCN1,Transcobalamin-1,24546,0.0042871819974939,0.00227216801211716,-0.000166267306255734,0.00874063130124354,0.0591957485189252
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",24111,0.00708009391259801,0.00375565765327758,-0.00028099508782605,0.0144411829130221,0.0594174453521257
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPP1,Osteopontin,29757,-0.00573785025097434,0.00305285740158056,-0.0117214507580722,0.000245750256123549,0.0601858085614291
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00331489988141818,0.00176752738706598,-0.000149453797231146,0.00677925356006751,0.0607436993027588
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCRLB,Fc receptor-like B,28797,-0.00758762723212211,0.00405361453448297,-0.0155327117197087,0.000357457255464509,0.0612419691019273
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI4,Protein-arginine deiminase type-4,28722,0.00879398864060769,0.00470551230676454,-0.000428815480650799,0.0180167927618662,0.0616511415527255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.00754946218940573,0.00404145838530334,-0.0154707206246003,0.000371796245788812,0.0617735155337408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.00494577573642866,0.00265084577109832,-0.0101414334477814,0.000249881974924047,0.0620905913807694
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSTN,Osteocrin,24195,-0.00519022433159692,0.00278222487778403,-0.0106433850920536,0.000262936428859785,0.0621242669151742
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.00843967988383446,0.00453162227364422,-0.00044229977250821,0.0173216595401771,0.0625589381239394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00437578001492291,0.00235603102544902,-0.000242040794957171,0.00899360082480299,0.063285121026862
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMPD3,AMP deaminase 3,24845,0.00868785636245898,0.00470854643223716,-0.000540894644725849,0.0179166073696438,0.0650312684967671
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,28774,0.006677682728551,0.00364527899101339,-0.000467064093835245,0.0138224295509372,0.0669809022669925
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNA1,Ephrin-A1,29390,0.00342439576016801,0.00187133116994007,-0.000243413332914518,0.00709220485325054,0.0672712771787124
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RALB,Ras-related protein Ral-B,24229,0.00358994020520114,0.00196813018042752,-0.000267594948436799,0.00744747535883908,0.0681589558016537
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00328967200636839,0.00180808234215939,-0.000254169384264019,0.0068335133970008,0.0688568057094876
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBLN2,Fibulin-2,24938,-0.00379012443751127,0.00208583745336287,-0.0078783658461025,0.000298116971079957,0.069217534989895
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.00318007456799391,0.0017504294629956,-0.000250767179477467,0.00661091631546529,0.0692671112849748
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STX1B,Syntaxin-1B,24195,0.00500942243491365,0.0027700633597323,-0.000419901750161645,0.010438746619989,0.0705544474016117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,29434,0.00560931684570786,0.00310461250234644,-0.000475723658891153,0.0116943573503069,0.0708085560683039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,0.0032987917347649,0.0018272696544287,-0.000282656787915352,0.00688024025744514,0.071036010660048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB118,Beta-defensin 118,24101,0.00689395661802691,0.00383230401457492,-0.000617359250539929,0.0144052724865938,0.0720459847351131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00729057746834904,0.00406292745312886,-0.00067276033978352,0.0152539152764816,0.0727595039530494
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPN1,Epsin-1,24445,0.00520544844753672,0.00290606106976377,-0.000490431249200273,0.0109013281442737,0.0732674054867491
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SBSN,Suprabasin,24905,-0.00409809409690659,0.00228934590403682,-0.00858521206881876,0.00038902387500557,0.0734544811168381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA3G,Semaphorin-3G,24381,0.00526357798734573,0.00294233875550019,-0.000503405973434642,0.0110305619481261,0.0736417958978346
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00562108498727985,0.00314977218855196,-0.0117946384768417,0.000552468502281997,0.0743386750109139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DEFB116,Beta-defensin 116,24101,-0.00914959509908078,0.00513579754352675,-0.0192157582843932,0.000916568086231655,0.0748379419982556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PI3,Elafin,29014,-0.00648016420826814,0.00364749256564335,-0.0136292496369291,0.000668921220392816,0.0756432512123131
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLAMF8,SLAM family member 8,28797,-0.0062703049504884,0.00354762380079114,-0.013223647600039,0.000683037699062222,0.0771607883956595
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.00346979994475879,0.00197409295442304,-0.00733902213542794,0.000399422245910365,0.0788163041712802
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,-0.00855959760637552,0.0048762405017739,-0.0181170289898524,0.000997833777101333,0.0792067535091541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,0.00249457484409832,0.00142151541883074,-0.000291595376809926,0.00528074506500656,0.0792921317199145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN7,Septin-7,24445,0.00614385592823495,0.00350507124806307,-0.000726083717968654,0.0130137955744386,0.0796407020037709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP1,Caspase-1,28774,0.00785938551269506,0.00449906101067316,-0.00095877406822434,0.0166775450936145,0.080666291925475
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL1A,Interleukin-1 alpha,28931,0.00644004889295089,0.00368854569571841,-0.000789500670657197,0.013669598456559,0.0808287269356437
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PXDNL,Peroxidasin-like protein,24793,0.00669356709208885,0.00384513153470228,-0.000842890715927616,0.0142300249001053,0.0817327819191989
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.0054220094122785,0.00312190311747591,-0.000696920697974291,0.0115409395225313,0.0824415884892276
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,0.00366050506042099,0.00210776505338114,-0.000470714444206036,0.00779172456504802,0.0824550244956988
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0106549693902652,0.00616584381624559,-0.00143008448957615,0.0227400232701066,0.083989709803535
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST6,Cystatin-M,28830,0.00556276246276407,0.00323056279674889,-0.000769140618863755,0.0118946655443919,0.0850952043859409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-0.00295863342237321,0.00172377337286507,-0.00633722923318875,0.000419962388442331,0.0861067080264069
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MTR,Methionine synthase,24111,0.00744960344600494,0.00434704274573652,-0.00107060033563865,0.0159698072276485,0.0865934731588391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD6,Programmed cell death protein 6,29478,-0.00792840063880436,0.00463793617379477,-0.0170187555394421,0.0011619542618334,0.0873749373696835
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRA3,GDNF family receptor alpha-3,29157,0.00318833106585129,0.00186739537801598,-0.000471763875060034,0.00684842600676261,0.0877643302898731
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00732323208817316,0.00429183506916751,-0.0157352288237415,0.00108876464739516,0.0879617425920477
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DRAXIN,Draxin,29218,0.00482018502083613,0.00284362638005646,-0.000753322684074528,0.0103936927257468,0.0900701847558203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPA33,Cell surface A33 antigen,29349,-0.0151274670484904,0.00894506922168232,-0.0326598027229878,0.00240486862600694,0.0908184976193691
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIMAP7,GTPase IMAP family member 7,24381,-0.00362458645009014,0.00214880888131092,-0.00783625185745955,0.000587078957279264,0.0916567974510917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNPO1,Transportin-1,24445,0.0039655022487142,0.0023545420169475,-0.000649400104502901,0.0085804046019313,0.0921572262886139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF12,Fibroblast growth factor 12,24229,0.00523605824041158,0.00311738515443939,-0.000874016662289629,0.0113461331431128,0.0930419390667108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRTN,Neurturin,28931,0.00550271355921671,0.0032767287713613,-0.000919674832651427,0.0119251019510849,0.0930982752816705
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A3,Protein S100-A3,24793,0.00493164909906082,0.00295093698688287,-0.00085218739522961,0.0107154855933513,0.0946919168834485
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD4,Sushi domain-containing protein 4,24793,-0.0046512766042838,0.00278371729798283,-0.0101073625083301,0.000804809299762547,0.0947566594588441
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.0065266109298972,0.00390619883073623,-0.0141827606381402,0.00112953877834581,0.0947674004886875
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00444475638257688,0.00266932801848608,-0.00967663929880959,0.00078712653365583,0.0959012723264048
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.00339845613443568,0.00204929531507651,-0.000618162683114287,0.00741507495198564,0.0972590748988732
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP7,Retinoid-binding protein 7,24805,-0.00662995057263279,0.00400040306665671,-0.0144707405832799,0.00121083943801436,0.09746731965312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDK1,Cyclin-dependent kinase 1,24016,0.00401537599004655,0.00243075395173426,-0.000748901755352594,0.0087796537354457,0.0985668834264428
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL28,C-C motif chemokine 28,29327,0.00644690356334208,0.00392277708155148,-0.00124173951649883,0.014135546643183,0.100299766507233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100A16,Protein S100-A16,28722,-0.00669058461970357,0.00407636096800512,-0.0146802521169936,0.00129908287758646,0.100743394209369
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYB5A,Cytochrome b5,24016,0.00790186352802576,0.00481576385652028,-0.00153703363075399,0.0173407606868055,0.100845220201947
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAST,Gastrin,24845,-0.0141877751170576,0.00865280095071473,-0.0311472649804585,0.00277171474634324,0.101085578114661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH3,Cadherin-3,29694,-0.00392539904615186,0.00239666818542706,-0.00862286868958891,0.00077207059728519,0.101462190837624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.00943689512388433,0.00576325668243569,-0.00185908797368961,0.0207328782214583,0.101555004539839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCG3,Secretogranin-3,29497,-0.00359131876491622,0.00220180810474073,-0.00790686265020805,0.000724225120375614,0.102884734253589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0184965180193387,0.0113931032615201,-0.00383396437324076,0.0408270004119181,0.104496893927611
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH1,Cadherin-1,28477,-0.00429791689240347,0.00265881659263991,-0.00950919741397769,0.000913363629170747,0.106002221387287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,0.00262338260509853,0.00163057012079343,-0.000572534831656598,0.00581930004185365,0.107654388206019
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,0.00325469077871444,0.00202588623373847,-0.000716046239412963,0.00722542779684185,0.108163735547246
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAPPA,Pappalysin-1,28931,0.00501616637000317,0.00312542707317691,-0.00110967069342356,0.0111420034334299,0.108514870421312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRR5,Proline-rich protein 5,24229,0.00508009266023937,0.00317331618306901,-0.00113960705857589,0.0112997923790546,0.109416946384504
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA10,Ephrin type-A receptor 10,28774,0.0069425132674443,0.0043367520250455,-0.00155752070164487,0.0154425472365335,0.109419914294208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,29786,-0.0062337669229195,0.00389983820462226,-0.0138774498039791,0.00140991595814014,0.109949453648774
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA3,Carbonic anhydrase 3,29761,-0.00629425645020338,0.00397363944713462,-0.0140825897665872,0.00149407686618048,0.113203687035015
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNG,Interferon gamma,28931,0.0119025338545544,0.0075356010855619,-0.00286724427314692,0.0266723119822557,0.114230774491436
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0130712491696014,0.00828157171177388,-0.00316063138547539,0.0293031297246782,0.114495369801244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.0150678562155542,0.00957096421452218,-0.0338269460760177,0.00369123364490925,0.115424354672007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.00479755758549006,0.00305165458949431,-0.00118368540991878,0.0107788005808989,0.115936584568615
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH4,Cadherin-4,24101,0.00502436959210526,0.00320116356552212,-0.0012499109963181,0.0112986501805286,0.116534187197569
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH15,Cadherin-15,29639,-0.00598654733041372,0.0038265812579902,-0.0134866465960745,0.00151355193524708,0.117719401224882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PYDC1,Pyrin domain-containing protein 1,24240,-0.00434928671492221,0.00278958286913599,-0.00981686913842876,0.00111829570858434,0.118981698800828
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.0052722763317904,0.00338443975727392,-0.0119057782560473,0.00136122559246649,0.11929407330855
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF830,Zinc finger protein 830,24793,-0.00817979373479923,0.00526581226565812,-0.0185007857754892,0.00214119830589069,0.120345771502544
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00625321487487515,0.00406375945747201,-0.0142181834115203,0.00171175366176999,0.123872160084014
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MERTK,Tyrosine-protein kinase Mer,29786,0.00259090501263767,0.00168517683327591,-0.000712041580583112,0.00589385160585845,0.124189436820105
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00296554071401167,0.00192952968893897,-0.000816337476308708,0.00674741890433204,0.124323203532593
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.00856990125135889,0.00561401223008082,-0.00243356271959952,0.0195733652223173,0.126893523370236
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.00577020534217597,0.00379790630837261,-0.0132141017065863,0.00167369102223434,0.128694645463664
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,H2AP,Huntingtin-interacting protein M,24016,-0.00517199523931795,0.00341475468365863,-0.0118649144192889,0.00152092394065296,0.129886321556632
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,S100G,Protein S100-G,24867,0.00466437589776267,0.00308714146176544,-0.00138642136729759,0.0107151731628229,0.130825500306994
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.00492164948751568,0.00326156251875176,-0.0113143120242691,0.00147101304923776,0.131313283103947
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OTOA,Otoancorin,24101,-0.00539095128696683,0.00357387502838923,-0.0123957463426097,0.00161384376867605,0.1314568397177
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNN,Tenascin-N,24938,0.00435553781662541,0.00288848505190891,-0.00130589288511605,0.0100169685183669,0.13159357659556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOBR,Apolipoprotein B receptor,24240,-0.00426341071930009,0.00282934359513993,-0.00980892416577435,0.00128210272717418,0.13186085098524
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3B,Sodium channel subunit beta-3,24101,0.00461696449087365,0.00306958275021287,-0.00139941769954358,0.0106333466812909,0.132568305723733
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00491430159531954,0.00327009017937965,-0.00149507515626457,0.0113236783469036,0.132902941039215
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,24229,0.00421942756376439,0.00281262514218375,-0.00129331771491575,0.00973217284244453,0.133582331955502
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC8,Histone deacetylase 8,24229,0.00611755731511774,0.00408539605603326,-0.00188981895470745,0.0141249335849429,0.13429681543468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF5,Fibroblast growth factor 5,28931,-0.00328282966694307,0.00219397546678349,-0.00758302158183871,0.00101736224795258,0.134588287392144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,-0.00829774435130998,0.00562833597790394,-0.0193292828680017,0.00273379416538174,0.140416861088168
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCNA,Proliferating cell nuclear antigen,24016,0.00618202630917019,0.0042185308846284,-0.00208629422470148,0.0144503468430419,0.142812561546058
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC12A2,Solute carrier family 12 member 2,24111,-0.00268848737085281,0.00183669189059199,-0.00628840347641312,0.000911428734707487,0.143270905257847
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.00363987345938278,0.00251276593099382,-0.0012851477653651,0.00856489468413066,0.147473116071218
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,24195,0.00349006679858335,0.00241287403347718,-0.00123916630703192,0.00821929990419863,0.148068036081922
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00347755483275938,0.00240711357633249,-0.00124038777685229,0.00819549744237106,0.148554992151294
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,-0.00570680733929211,0.00395092539100804,-0.0134506211056679,0.00203700642708366,0.14863268075955
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPSD1,Tryptase delta,24867,-0.00359055003859568,0.00248634377913005,-0.00846378384569058,0.00128268376849922,0.148721079741974
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTN4,Contactin-4,29443,0.00227767080124918,0.00159408585377858,-0.000846737472156835,0.00540207907465519,0.153064956678945
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOS,Proto-oncogene c-Fos,23970,-0.00336834342035899,0.00236539049417733,-0.00800450878894657,0.00126782194822858,0.154456148964256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.00486035573073377,0.00341754582041436,-0.00183803407727837,0.0115587455387459,0.154985653294077
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYL6B,Myosin light chain 6B,24195,-0.00867174592416067,0.00610622508688892,-0.020639947094463,0.00329645524614161,0.155577368159558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RYR1,Ryanodine receptor 1,24111,-0.00318233407433874,0.00227307559764571,-0.00763756224572434,0.00127289409704686,0.161522472824496
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVPL,Envoplakin,24445,0.00315050219203307,0.00225704670717877,-0.00127330935403732,0.00757431373810346,0.1627718812381
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAP1,Antigen peptide transporter 1,24445,-0.00557390408056019,0.00399398258301242,-0.0134021099432645,0.00225430178214415,0.162855060011636
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,29678,-0.00250530352919026,0.00179907683483807,-0.00603149412547288,0.00102088706709236,0.163766503532165
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.00531477130210453,0.00381944067664857,-0.00217133242412666,0.0128008750283357,0.164085200488795
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXNB2,Plexin-B2,29701,0.00219652051900309,0.00158001262814154,-0.00090030423215433,0.00529334527016051,0.164481080912458
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00296996102821741,0.0021374622781098,-0.00121946503687781,0.00715938709331262,0.164699689912108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DUOX2,Dual oxidase 2,28916,0.00657386923798873,0.00473211275589869,-0.0027010717635727,0.0158488102395502,0.164781475450222
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGM2,Phosphoglucomutase-2,24195,0.00554218366418251,0.00400446979940509,-0.00230657714265148,0.0133909444710165,0.166371422261787
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B2M,Beta-2-microglobulin,24966,-0.00285923289484345,0.00206769630051449,-0.00691191764385185,0.00119345185416495,0.166735243377038
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00498948128737172,0.00361445439374973,-0.0120738118991212,0.00209484932437775,0.167468641354845
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK3,Prostate-specific antigen,24938,-0.00812401386921367,0.00590697862230019,-0.019701691968922,0.0034536642304947,0.169043149101978
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20,Interleukin-20,28931,0.00445072279075665,0.00324665167106082,-0.00191271448452255,0.0108141600660358,0.170427525013687
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.00244248038158529,0.0017825158559807,-0.00105125069613689,0.00593621145930746,0.17062137428937
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00291158272796693,0.00212555020555219,-0.00707766113084923,0.00125449567491537,0.170761560134908
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MYH4,Myosin-4,24111,-0.0042574842937233,0.00311092761870922,-0.0103549024263934,0.00183993383894676,0.171150297645
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0094776786417318,0.00693018033616028,-0.00410547481714236,0.023060832100606,0.171449466897798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AZU1,Azurocidin,28534,0.00690441653248586,0.00506770655546828,-0.00302828831623197,0.0168371213812037,0.173071667528716
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC44A4,Choline transporter-like protein 4,24195,-0.00627196099735197,0.00461565633227707,-0.015318647408615,0.00277472541391108,0.174208421047325
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COPE,Coatomer subunit epsilon,28774,0.00425615235660545,0.00313958449171232,-0.0018974332471507,0.0104097379603616,0.175223771278953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPA2,Carboxypeptidase A2,29577,0.00583702444544631,0.00431688729190601,-0.00262407464668947,0.0142981235375821,0.176341731631313
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.0060254935999371,0.00446447380741673,-0.0147758622624739,0.00272487506259968,0.17713976858627
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL25,Interleukin-25,23913,0.00310751225707569,0.00230571465927931,-0.00141168847511177,0.00762671298926314,0.177753627511662
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,24016,0.00379443343122939,0.00281627100586652,-0.00172545774026898,0.00931432460272776,0.177888176877209
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00492074099296182,0.00366900853642148,-0.0121119977243479,0.00227051573842428,0.17988000609023
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.00691058904999969,0.00517824166184616,-0.00323876460721878,0.0170599427072182,0.182036295070423
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHP1,Calcineurin B homologous protein 1,24101,0.00648944823189873,0.00487307093927769,-0.00306177080908554,0.016040667272883,0.182972762710964
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00701911565440476,0.00529066934745594,-0.0173888275754184,0.00335059626660889,0.184621302482145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00354515240079978,0.00267512464945417,-0.00878839671372995,0.0016980919121304,0.18510775257224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.00397700382897791,0.00300258523178877,-0.00190806322532807,0.00986207088328389,0.185338702324902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GFRAL,GDNF family receptor alpha-like,24025,0.00550529902046589,0.00417195270524399,-0.00267172828181232,0.0136823263227441,0.186981966912181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00293176454937764,0.00222231916989552,-0.00728751012237285,0.00142398102361757,0.187100358310859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP73,Tumor protein p73,24195,0.00303522449559407,0.00230111986694113,-0.00147497044361054,0.00754541943479868,0.187174717858971
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD2,T-cell surface antigen CD2,24111,-0.00337196374322085,0.0025603661291541,-0.00839028135636288,0.00164635386992119,0.187856181939668
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,24016,0.00293348669706981,0.00222950979694139,-0.0014363525049353,0.00730332589907493,0.188269150459363
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA1,Apolipoprotein A-I,24966,0.0023984691111677,0.00182665052712241,-0.00118176592199222,0.00597870414432763,0.189180825027688
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBP1,Retinol-binding protein 1,24195,-0.00604908687963074,0.0046169896639106,-0.0150983866208955,0.00300021286163403,0.190147441961735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MUCL3,Mucin-like protein 3,24016,-0.00381765416931166,0.00292580376734655,-0.00955222955331089,0.00191692121468758,0.191965854006121
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.00485200837925383,0.00372180069274911,-0.00244272097853443,0.0121467377370421,0.192357432201255
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,29388,0.00414413610699632,0.00318886301113904,-0.00210603539483621,0.0103943076088288,0.193760155813447
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00233948830476863,0.00180333435629324,-0.00587402364310338,0.00119504703356613,0.194533706615472
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00402494861180532,0.003112523022505,-0.00207559651230448,0.0101254937359151,0.195970420246166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNPEP,Aspartyl aminopeptidase,24845,0.00499478119157298,0.00387277066692624,-0.00259584931560246,0.0125854116987484,0.197160675463008
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.0031055512203035,0.00241307084536402,-0.00162406763660998,0.00783517007721697,0.198116856919735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,24016,0.00463266468720457,0.00360405391928421,-0.00243128099459249,0.0116966103690016,0.19866360809685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0028519820550757,0.00222615306701766,-0.00151127795627892,0.00721524206643033,0.200159493913193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.00359021480289375,0.0028189602536711,-0.0019349472943016,0.00911537690008911,0.20281689138768
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTNNA1,Catenin alpha-1,24101,-0.00297218237483068,0.00233750165745844,-0.00755368562344922,0.00160932087378785,0.203555649448293
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HCG22,Protein PBMUCL2,24111,-0.00468117460917044,0.00369402293568324,-0.0119214595631096,0.00255911034476872,0.205085509034683
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,24805,0.00391974175451519,0.00309588111198672,-0.00214818522497877,0.00998766873400916,0.205483782323882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD33,Myeloid cell surface antigen CD33,29566,0.00663616075038427,0.00525084602520473,-0.003655497459017,0.0169278189597856,0.206302112588347
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,24195,0.00356021665259073,0.00282337859674059,-0.00197360539702082,0.00909403870220228,0.20732914913591
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC16A1,Monocarboxylate transporter 1,28774,0.00479914197666668,0.00382735591261834,-0.00270247561206526,0.0123007595653986,0.20988660955527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANXA5,Annexin A5,28650,-0.00252980820913653,0.00201783231577334,-0.00648475954805227,0.00142514312977921,0.209951962589997
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RELB,Transcription factor RelB,24229,0.0041144050013596,0.00328867501157694,-0.00233139802133119,0.0105602080240504,0.210916328329778
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,24793,0.00308153013125528,0.00247327026347537,-0.00176607958515644,0.007929139847667,0.212800611360087
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,0.00244971171244966,0.00196758194193081,-0.00140674889373472,0.00630617231863404,0.213130311516231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL18BP,Interleukin-18-binding protein,29594,-0.00253988897288102,0.0020444823848525,-0.00654707444719193,0.00146729650142989,0.214130601718468
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLMP,CXADR-like membrane protein,29725,0.00173451884068079,0.00140233689952544,-0.00101406148238906,0.00448309916375065,0.216142371902298
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SUSD5,Sushi domain-containing protein 5,24273,0.00281974663950441,0.00228182348104823,-0.00165262738335013,0.00729212066235895,0.216566197435681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,24867,0.00277634299327576,0.00224886115276534,-0.0016314248661443,0.00718411085269582,0.217007802525217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.00236894524753237,0.00191920733855022,-0.00139270113602605,0.0061305916310908,0.217087800906859
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEP350,Centrosome-associated protein 350,24016,0.00303909551932774,0.00246571453648735,-0.00179370497218748,0.00787189601084295,0.217758943002529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACTN4,Alpha-actinin-4,28931,0.00259046295255969,0.00212130553936767,-0.00156729590460093,0.00674822180972032,0.222033710350638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.00221005049775373,0.00181089412454802,-0.00575940298186786,0.0013393019863604,0.22231562784469
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIP1,Huntingtin-interacting protein 1,24111,0.00271475277318517,0.00222993000174563,-0.00165591003023626,0.0070854155766066,0.223457847246619
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,29116,0.00236960770636209,0.0019482644454421,-0.00144899060670444,0.00618820601942862,0.22389349276689
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00382743930755077,0.00315111115877197,-0.00234873856364229,0.0100036171787438,0.224518191149639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00462769305722374,0.00381360415598236,-0.0121023572029492,0.00284697108850168,0.224962194433828
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.00558933332648279,0.00462581955867365,-0.00347727300851756,0.0146559396614831,0.226947399074225
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOP56,Nucleolar protein 56,24111,0.00887405055990092,0.00739601162388821,-0.00562213222291997,0.0233702333427218,0.230212233329553
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.00669641130615516,0.00558617975866884,-0.00425250102083576,0.0176453236331461,0.230638426689042
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UPK3A,Uroplakin-3a,24101,0.00392080658269254,0.00327751186068928,-0.00250311666425846,0.0103447298296435,0.231600907823568
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NFASC,Neurofascin,29786,-0.00224119364119163,0.00187514651292859,-0.00591648080653167,0.0014340935241484,0.232014559213208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00330955675788792,0.00277652672325847,-0.00213243561969868,0.00875154913547452,0.233281853763276
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAP1A,Ras-related protein Rap-1A,24229,-0.00545924643359592,0.00461528795505213,-0.0145052108254981,0.00358671795830625,0.236875655499185
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOA4,Apolipoprotein A-IV,24966,0.00280859831854188,0.00237723705853401,-0.00185078631618478,0.00746798295326855,0.23743332854317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,0.00411432664911549,0.00349801420871055,-0.0027417811999572,0.0109704344981882,0.239530885484431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.00549994492200305,0.00468429780628211,-0.014681168622316,0.00368127877830988,0.240356773346262
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAPT,Microtubule-associated protein tau,28774,0.00407979919770841,0.00350650406747296,-0.0027929487745386,0.0109525471699554,0.24463846529848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCARB1,Scavenger receptor class B member 1,28774,0.00443151190893314,0.00381115178876626,-0.00303834559704872,0.011901369414915,0.244930462756637
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,-0.00210475892890353,0.00182509956211788,-0.00568195407065458,0.00147243621284751,0.248825459304621
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.00262843601740181,0.00228025053014577,-0.00709772705648753,0.0018408550216839,0.249044423437154
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00503590670695508,0.00436891138769147,-0.00352715961292019,0.0135989730268304,0.249057837875446
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCNE1,G1/S-specific cyclin-E1,24229,0.00703788291475639,0.00616036392130272,-0.00503643037099694,0.0191121962005097,0.253279989498582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.00424867795105023,0.00373353055101811,-0.00306904192894526,0.0115663978310457,0.255140728118582
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.00468914660653134,0.00414294578982722,-0.00343102714153002,0.0128093203545927,0.257713183923924
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ELAVL4,ELAV-like protein 4,24101,0.00636629264583474,0.00563316309558138,-0.00467470702150477,0.0174072923131743,0.258426269039763
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAG,Myelin-associated glycoprotein,24195,0.0035613875341155,0.00315734404361818,-0.00262700679137614,0.00974978185960714,0.259344024890648
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.00174184021370078,0.0015443834065516,-0.00128515126314035,0.00476883169054191,0.259390518024465
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.00444266539095058,0.00393948621168699,-0.00327872758395593,0.0121640583658571,0.259444402090729
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BOC,Brother of CDO,28916,0.00175006376059846,0.00155322431813922,-0.00129425590295441,0.00479438342415134,0.259866192956658
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CST7,Cystatin-F,29498,-0.0069312560860968,0.00615526476313021,-0.018995575021832,0.00513306284963841,0.260145256393536
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMA1,Proteasome subunit alpha type-1,28797,-0.00345244843365643,0.00306986919693325,-0.0094693920596456,0.00256449519233274,0.260757797255193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB44,Ras-related protein Rab-44,24793,0.00313140755793807,0.00279772287201924,-0.00235212927121963,0.00861494438709577,0.263035777145691
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0196280233054592,0.0175416852647341,-0.054009726424338,0.0147536798134197,0.263178533732983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TJP3,Tight junction protein ZO-3,24101,-0.00318477195747356,0.00285018305534856,-0.00877113074595674,0.00240158683100962,0.26383786731063
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LY6D,Lymphocyte antigen 6D,29283,0.00283727647682602,0.00254367411624238,-0.00214832479100904,0.00782287774466108,0.264677705381919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,-0.00380943531089529,0.00342331480814584,-0.0105191323348611,0.00290026171307055,0.265807319153527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00245990892824114,0.00221346099366404,-0.00187847461934038,0.00679829247582265,0.266431041888681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNIP4,Kv channel-interacting protein 4,28774,0.00375902231201432,0.0033842215643405,-0.00287405195409306,0.0103920965781217,0.266685487642633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SDC1,Syndecan-1,29478,0.00293443897405891,0.00266207291172052,-0.00228322393291331,0.00815210188103113,0.270334395429164
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00230920400017475,0.00209678593160345,-0.00641890442611752,0.00180049642576801,0.270772171409564
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.00190234326455291,0.00172814545238716,-0.00528950835123174,0.00148482182212592,0.270992560096064
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SSB,Lupus La protein,28774,0.00434649819119072,0.0039508368509935,-0.00339714203675655,0.012090138419138,0.271277630531686
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTSB,Cathepsin B,29480,0.00381481574753672,0.00347285246307112,-0.00299197508008267,0.0106216065751561,0.27200935391019
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00419961671899872,0.00382610999044587,-0.00329955886227519,0.0116987923002726,0.272381253312571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC1A4,Neutral amino acid transporter A,24195,-0.0037698372738626,0.00343742925452005,-0.0105071986127219,0.00296752406499671,0.272782382568608
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00271834107573475,0.0024843114417264,-0.00758759150151849,0.002150909350049,0.273876885679326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,28774,-0.00277423492617961,0.0025450991619761,-0.00776262928365276,0.00221415943129355,0.275708977705213
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LAMA1,Laminin subunit alpha-1,24111,-0.0038824923321774,0.00360148388480664,-0.0109414007463984,0.00317641608204361,0.281033060263702
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00309589754560562,0.00288844713913202,-0.00875725393830438,0.00256545884709315,0.283811290668041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMG4,Proteasome assembly chaperone 4,24229,-0.00399431683204265,0.00373509877264922,-0.0113151104264351,0.00332647676234982,0.284899861191144
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00349037010933643,0.00326792327665078,-0.00989549973157196,0.00291475951289909,0.285499776354805
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,-0.00422450269521578,0.0039636959942108,-0.011993346843869,0.00354434145343739,0.286525252230452
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLINT1,Clathrin interactor 1,24016,0.00338284276876004,0.00317931754899668,-0.00284861962727345,0.00961430516479354,0.287332436588634
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.00521942316481617,0.00490689608613025,-0.00439809316399911,0.0148369394936315,0.287478833716791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GLI2,Zinc finger protein GLI2,24229,-0.0023626033595604,0.00222197213462051,-0.00671766874341659,0.00199246202429579,0.287660529705911
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PROK1,Prokineticin-1,29434,-0.00432115126265193,0.00406516928179643,-0.0122888830549729,0.00364658052966908,0.287804474073112
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCIN,Adseverin,24101,-0.00518808439090051,0.0048886685001804,-0.0147698746512541,0.00439370586945307,0.288588341616085
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHH,Sonic hedgehog protein,24229,-0.00301711669489163,0.00286297055397039,-0.00862853898067359,0.00259430559089033,0.291966082891533
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL4,Interleukin-4,28931,0.00639658050324782,0.00608546118126393,-0.00553092341202948,0.0183240844185251,0.293209958244518
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00579359852674192,0.0055448584292049,-0.0166615210479835,0.00507432399449967,0.296098204849738
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0203700943228722,0.0195390084313619,-0.0179263622025972,0.0586665508483416,0.29717240634025
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDSN,Corneodesmosin,29676,0.00297535572143361,0.00287183492300594,-0.00265344072765804,0.00860415217052526,0.300188700491178
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,24793,0.0038099545659635,0.00370260844758646,-0.00344715799130596,0.011067067123233,0.303493466104012
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KDM3A,Lysine-specific demethylase 3A,24229,-0.00620787473830836,0.006035714567025,-0.0180378752896774,0.00562212581306064,0.30371387930674
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,-0.0028417115506324,0.0027688801195117,-0.00826871658487533,0.00258529348361053,0.304757015641004
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00478015961621156,0.00466727707288554,-0.0139280226790672,0.0043677034466441,0.3057577378448
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALLD,Palladin,24229,0.00271420985713617,0.00265890335327965,-0.00249724071529195,0.00792566042956429,0.307359168335737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DKKL1,Dickkopf-like protein 1,29349,-0.0057993983067006,0.0056936103006888,-0.0169588744960507,0.00536007788264945,0.308410742861039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.00656828452673174,0.00645500626602898,-0.00608352775468505,0.0192200968081485,0.308902316991583
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,STEAP4,Metalloreductase STEAP4,24101,0.0049730281328394,0.00492964894303969,-0.00468908379551839,0.0146351400611972,0.313080862133373
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00435961460422648,0.00432515841218776,-0.0128369250921145,0.00411769588366153,0.313480690399184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TCP11,T-complex protein 11 homolog,24445,-0.00392693357236274,0.00394815412359372,-0.0116653156546064,0.00381144850988094,0.319928438802527
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,24805,-0.00329536273106564,0.00332830478293902,-0.00981884010562613,0.00322811464349484,0.322133707597066
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300E,CMRF35-like molecule 2,29642,0.00266819186234836,0.00269700626792921,-0.0026179404227929,0.00795432414748961,0.322516563153148
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MKI67,Proliferation marker protein Ki-67,24229,0.00255160517759496,0.00259755328983458,-0.00253959927048082,0.00764280962567074,0.325956469719181
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,0.00507605741888645,0.00517250812078693,-0.00506205849785594,0.0152141733356288,0.326428412475843
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,24845,-0.00182256158527625,0.00186919000780455,-0.00548617400057316,0.00184105083002066,0.329542869368242
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASP4,Caspase-4,24445,-0.0109135024494058,0.0111956796845261,-0.032857034631077,0.0110300297322655,0.329671171837302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SOD3,Extracellular superoxide dismutase,24951,0.00385703943078885,0.00398040464395408,-0.00394455367136114,0.0116586325329388,0.332551161294561
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSCA,Prostate stem cell antigen,24805,0.0166038219598971,0.0172436147656454,-0.0171936629807678,0.050401306900562,0.335608693418986
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF7,Fibroblast growth factor 7,24016,-0.00504668518996782,0.0052929432723058,-0.0154208540036872,0.00532748362375154,0.340359431782432
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ACHE,Acetylcholinesterase,24381,-0.00209418933668178,0.00219700654501998,-0.00640032216492095,0.00221194349155739,0.340497579579331
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRP2BP,LRP2-binding protein,24195,-0.00522881787305403,0.00550223416285825,-0.0160131968322562,0.00555556108614813,0.34196520549163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G15,Phospholipase A2 group XV,29566,0.00166238619529554,0.00175647861485985,-0.00178031188982978,0.00510508428042085,0.343936427220163
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPB41L5,Band 4.1-like protein 5,24195,-0.00393881289519639,0.00418511872228088,-0.0121416455908669,0.00426401980047414,0.346638816230913
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA8,Carbonic anhydrase-related protein,24229,0.00170498291985448,0.00181367528171434,-0.00184982063230563,0.00525978647201458,0.347190694298417
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.00298107716441814,0.00318612123571859,-0.00922587478642657,0.00326372045759029,0.349465573727009
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RTKN2,Rhotekin-2,24111,-0.00321824273938922,0.00344998111607675,-0.00998020572689966,0.00354372024812122,0.350917566164638
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00244775978617232,0.00262422800688366,-0.00269572710731966,0.00759124667966429,0.350956221057318
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TP53BP1,TP53-binding protein 1,24229,-0.0054254504056988,0.00582036657574814,-0.0168333688941651,0.00598246808276755,0.351268686317247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD1,Glutamate decarboxylase 1,24016,0.00161643977798296,0.00173455879913868,-0.00178329546832886,0.00501617502429478,0.351396260147137
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00309779103357395,0.0033648241861503,-0.00969284643842853,0.00349726437128064,0.357246125298399
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.0030073499433605,0.00326808239474943,-0.00339809155034839,0.00941279143706939,0.357467793931857
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNL2,Interferon lambda-2,24101,-0.00378458721727767,0.00412001517880714,-0.0118598169677397,0.00429064253318434,0.358321488379514
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REG4,Regenerating islet-derived protein 4,29497,0.00300385659957322,0.00328901972645855,-0.00344262206428553,0.00945033526343198,0.36109306856341
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,0.00160297490120971,0.00175738018614388,-0.00184149026363229,0.00504744006605172,0.361704403856825
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCLN,Nicalin,28931,-0.00315858052937895,0.00346798878890504,-0.00995583855563283,0.00363867749687494,0.362418028055929
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00177709851363623,0.00195549583281479,-0.00205567331868076,0.00560987034595321,0.363478291893576
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXNL1,Thioredoxin-like protein 1,24069,0.00588097420486391,0.00652783607039583,-0.00691358449311191,0.0186755329028397,0.367646707469669
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,-0.00889941807961905,0.00993173660586852,-0.0283656218271213,0.0105667856678832,0.370228793823986
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,WNT9A,Protein Wnt-9a,28931,-0.00170871903747172,0.00191253007634273,-0.00545727798710348,0.00203983991216004,0.371632337445697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PMCH,Pro-MCH,24111,-0.00496907615564195,0.00557564475333677,-0.015897339872182,0.00595918756089811,0.37282486146222
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRSS8,Prostasin,29347,-0.00240794910210009,0.0027135477769762,-0.00772650274497345,0.00291060454077327,0.374881409807902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.00387673149118128,0.00438543883877541,-0.0124721916151811,0.00471872863281852,0.376704594523024
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CADPS,Calcium-dependent secretion activator 1,24195,-0.00252670133602117,0.00286773674947002,-0.00814746536498241,0.00309406269294007,0.378284063487415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00285159051119409,0.00324321447416931,-0.00920829088056593,0.00350510985817775,0.37927405176714
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRN1,Neuritin,24867,-0.00208691563033073,0.0023753737975775,-0.00674264827358263,0.00256881701292118,0.379646735398092
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF3,Fibroblast growth factor 3,24229,0.00173478792675208,0.00199940799728483,-0.00218405174792619,0.00565362760143034,0.385594131474142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCL15,C-C motif chemokine 15,29820,-0.00251797393217431,0.00291346075621911,-0.00822835701436376,0.00319240915001514,0.387454608664407
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",24111,-0.003601405517069,0.00418240277572429,-0.0117989149574886,0.00459610392335061,0.389199636700633
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,29443,0.00298838480367126,0.003472121476031,-0.00381697328934949,0.00979374289669201,0.389421435463046
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.00312465085297512,0.00364323934650761,-0.01026539997213,0.00401609826617979,0.391090011079889
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRING1,SREBP regulating gene protein,24016,0.00338174663547455,0.00396858968980984,-0.00439668915655275,0.0111601824275018,0.394151521382348
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00355300054995993,0.00417004620400413,-0.011726291109808,0.00462029000988817,0.394206430451317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CFC1,Cryptic protein,28797,0.00265052339381338,0.0031143893751532,-0.00345367978148688,0.00875472656911365,0.394744678286293
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSMB,Beta-microseminoprotein,29313,0.00391952943403935,0.0046068728575242,-0.00510994136670809,0.0129490002347868,0.394887172593172
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRG3,Proteoglycan 3,24938,0.00281909307974906,0.00331550642875195,-0.00367929952060476,0.00931748568010288,0.395180237544832
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TET2,Methylcytosine dioxygenase TET2,24421,-0.00566095392555692,0.00667654260320366,-0.0187469774278361,0.00742506957672225,0.396509199107219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EFNB2,Ephrin-B2,24195,-0.00325800505141797,0.00384360535709709,-0.0107914715513283,0.00427546144849232,0.39664522700898
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,24229,0.00113883770450186,0.00135735150212998,-0.0015215712396729,0.00379924664867662,0.401469408713049
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOH,Beta-2-glycoprotein 1,29443,-0.00197546844375035,0.00238006659749924,-0.00664039897484887,0.00268946208734817,0.406542388395559
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NRP2,Neuropilin-2,29443,-0.00157470776450303,0.00189763369435097,-0.00529406980543093,0.00214465427642487,0.4066433076424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.00190860960584015,0.00233105357208975,-0.00266025539545575,0.00647747460713605,0.412921246272551
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00277632793618877,0.00341757471356179,-0.00947477437476988,0.00392211850239235,0.416588594411907
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZPR1,Zinc finger protein ZPR1,24101,0.00521633849737181,0.00643199213041122,-0.00739036607823418,0.0178230430729778,0.417374319628282
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDNRB,Endothelin receptor type B,24229,0.00244990568770666,0.00304329198864867,-0.00351494661004474,0.00841475798545806,0.420817034097327
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,0.00344734174570651,0.00428408110272078,-0.00494945721562622,0.0118441407070392,0.42100715697233
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00335829141492603,0.00419477557638673,-0.00486346871479196,0.011580051544644,0.423377374044534
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00159114975260162,0.00201599205215382,-0.0055424941748231,0.00236019466961986,0.429965576571901
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK12,Kallikrein-12,28797,-0.0072104782874742,0.00917717441071964,-0.0251977401324847,0.0107767835575363,0.432051496172093
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL14,C-X-C motif chemokine 14,28931,0.00309581970502366,0.00394512440955117,-0.00463662413769663,0.0108282635477439,0.432623932853567
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,0.00219163832705864,0.00279821780650907,-0.00329286857369914,0.00767614522781641,0.433500441356015
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00196881240123495,0.00251489071402809,-0.00689799820073001,0.00296037339826011,0.433715814693741
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.00405976100390393,0.0052019723230709,-0.00613610474931504,0.0142556267571229,0.435145850853867
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL5,Interleukin-5,28931,0.00734417922294901,0.009422265911577,-0.0111234619637419,0.0258118204096399,0.435721430415773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PSME2,Proteasome activator complex subunit 2,29081,-0.00185567917544049,0.00239875956285932,-0.00655724791864475,0.00284588956776377,0.439173964846483
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TAGLN3,Transgelin-3,24016,-0.00311191785752312,0.00402862589080958,-0.0110080246035099,0.00478418888846365,0.439854705054176
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MBL2,Mannose-binding protein C,24610,0.00555144046193708,0.00718847746202292,-0.00853797536362785,0.019640856287502,0.439962364134365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BEX3,Protein BEX3,24016,-0.00242659966021583,0.00314798153067268,-0.00859664346033429,0.00374344413990263,0.440807558847603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HRAS,GTPase Hras,24421,0.00498638641627052,0.00655404450862054,-0.00785954082062574,0.0178323136531668,0.446777562950589
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NXPE4,NXPE family member 4,24111,-0.00170384081569457,0.00229123159422604,-0.00619465474037761,0.00278697310898847,0.457104359605262
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,-0.00180078246856336,0.00242267121741119,-0.00654921805468928,0.00294765311756257,0.457304482706454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00350241470867119,0.00471244845155456,-0.0127388136737181,0.00573398425637574,0.457352049771574
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SKIV2L,Helicase SKI2W,24111,-0.00197728420362543,0.00266786151948301,-0.00720629278181213,0.00325172437456126,0.458610027672004
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.0016000688819908,0.002181078983292,-0.00587498368924312,0.00267484592526153,0.463191500127541
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTLA,B- and T-lymphocyte attenuator,24016,0.00425455124162072,0.00581753584243101,-0.00714781900954405,0.0156569214927855,0.464583411195687
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RUVBL1,RuvB-like 1,28797,-0.00499191307895384,0.00685134201422817,-0.0184205434268411,0.00843671726893339,0.466250047946703
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RAB6B,Ras-related protein Rab-6B,28774,0.00230884752646926,0.00318483659389075,-0.00393343219755661,0.00855112725049513,0.468488557254548
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,29628,0.000968301517175777,0.00134086470879,-0.00165979331205262,0.00359639634640417,0.470209765164661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MSLNL,Mesothelin-like protein,24195,-0.00180819196792223,0.00250694181878578,-0.00672179793274236,0.00310541399689791,0.470747920265793
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00254789829604933,0.00353965045108298,-0.00438981658807332,0.00948561318017198,0.471645378849789
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDAC9,Histone deacetylase 9,24101,-0.00310286780517843,0.00431427815659104,-0.0115588529920969,0.00535311738174001,0.472019114157424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC123,Cell division cycle protein 123 homolog,24016,0.00303264956828796,0.00422499156280197,-0.00524833389480389,0.0113136330313798,0.472894806126961
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNNI3,"Troponin I, cardiac muscle",28916,-0.00400590786920049,0.00558384721395403,-0.0149502484085504,0.00693843267014941,0.473126944711377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00224476498462108,0.00313981570639784,-0.00390927379991869,0.00839880376916085,0.474655935282708
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLXDC1,Plexin domain-containing protein 1,28797,0.00156368862890604,0.00219679424365041,-0.00274202808864876,0.00586940534646084,0.476591445359562
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,24445,0.00369003936976424,0.00519525453229661,-0.00649265951353711,0.0138727382530656,0.477542791153929
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,-0.00373537543981538,0.00531659800047851,-0.0141559075207533,0.00668515664112249,0.482319651690575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP15,Matrix metalloproteinase-15,24922,0.00229026846833518,0.00326961667370517,-0.00411818021212696,0.00869871714879732,0.483640362105931
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF75D,Zinc finger protein 75D,24445,0.00280104664225219,0.00399958042403411,-0.00503813098885466,0.010640224273359,0.483724711971173
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00154100624069465,0.00220315368990985,-0.00277717499152865,0.00585918747291795,0.484274618502941
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPT1,Translationally-controlled tumor protein,28931,0.00302353093447688,0.00432814073820522,-0.00545962491240535,0.0115066867813591,0.48482328709323
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00262506343922986,0.00375837207684596,-0.00999147270984794,0.00474134583138823,0.484897825124394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBLN1,Cerebellin-1,24101,0.00443446067370043,0.00635738416895575,-0.00802601229745283,0.0168949336448537,0.485478445968647
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL2L15,Bcl-2-like protein 15,24229,-0.00260208383955168,0.00375416840474972,-0.00996025391286114,0.00475608623375777,0.488241791770429
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TYMP,Thymidine phosphorylase,29301,0.00304306411524715,0.00440307500894837,-0.00558696290229165,0.011673091132786,0.489494052774281
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDN1,Endothelin-1,24240,0.00133618551597132,0.00193927582503827,-0.0024647951011037,0.00513716613304633,0.490821924799235
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00186748630765904,0.0027408288946405,-0.00723951094115442,0.00350453832583635,0.495650213176891
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD300C,CMRF35-like molecule 6,29694,0.00155480069196633,0.00228875228847361,-0.00293115379344195,0.00604075517737461,0.496938905531678
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR1,Toll-like receptor 1,24229,-0.00117973450192003,0.00175678444092246,-0.00462303200612805,0.00226356300228798,0.501888981406394
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA11,Carbonic anhydrase-related protein 11,28797,0.0014151905468732,0.00211173958599676,-0.00272381904168045,0.00555420013542686,0.502765056075247
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CPLX2,Complexin-2,24016,-0.00136317798209202,0.00205148594201354,-0.00538409042843857,0.00265773446425453,0.506387469430396
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CGN,Cingulin,24195,-0.00175930174190732,0.00265573687406668,-0.006964546015078,0.00344594253126336,0.507687047393456
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEMA7A,Semaphorin-7A,29736,-0.00121063506999716,0.00183068682917271,-0.00479878125517567,0.00237751111518135,0.50842441270287
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,24111,-0.0032026488957501,0.00485534724133705,-0.0127191294887707,0.00631383169727051,0.509508680577184
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00140764214648075,0.00213614353826601,-0.00277919918852063,0.00559448348148214,0.509924833764182
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPGN,Epigen,24793,-0.00209579169102649,0.003189125461074,-0.00834647759473153,0.00415489421267855,0.511078903917828
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00409348668645677,0.00623417015745812,-0.0163124601950747,0.00812548682216115,0.51143097444129
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00145766511461468,0.00222862792075384,-0.00582577583929221,0.00291044561006286,0.513075783962224
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00318339840211122,0.00487808266033709,-0.0127444404163719,0.00637764361214947,0.514025482035871
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DPEP1,Dipeptidase 1,29163,0.00209768425764857,0.00321866299435955,-0.00421089521129614,0.00840626372659328,0.514583506268415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDIA2,Protein disulfide-isomerase A2,24016,0.00176270981057194,0.00271852432435574,-0.00356559786516531,0.00709101748630919,0.516728040034862
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.0033135756615557,0.00512662826398416,-0.0133617670589646,0.00673461573585326,0.5180614629363
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2A,Pancreatic alpha-amylase,28334,0.00204609387109708,0.00317401514240344,-0.00417497580801367,0.00826716355020783,0.519166392179174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,24195,-0.00215182171135681,0.00334353480615649,-0.00870514993142353,0.00440150650870991,0.519855947492196
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BSND,Barttin,24016,-0.00145092422490727,0.00225883695720063,-0.0058782446610205,0.00297639621120596,0.520663498950953
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00128302691834769,0.00200167477524427,-0.00520630947782646,0.00264025564113107,0.52154391090557
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX33,Testis-expressed protein 33,24445,-0.00166213441886623,0.00259359410762594,-0.00674557886981308,0.00342131003208061,0.521618730562895
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL17F,Interleukin-17F,28931,-0.00324667754541655,0.00508059018122815,-0.0132046343006237,0.00671127920979061,0.522804892071753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6L2,Seizure 6-like protein 2,29349,-0.00100735586698265,0.00158933990568397,-0.00412246208212322,0.00210775034815793,0.526203057205558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00216043723635256,0.00341351827774559,-0.0088509330607339,0.00453005858802879,0.526800815963355
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FBN2,Fibrillin-2,24195,0.00253504112401456,0.00402080445996768,-0.00534573561752209,0.0104158178655512,0.528385838155117
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00203884157308939,0.00325516234013367,-0.00841895975975139,0.0043412766135726,0.531097268334721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TUBB3,Tubulin beta-3 chain,24101,-0.00116061911175905,0.00187176316355793,-0.00482927491233258,0.00250803668881449,0.535219352346744
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,24101,0.00445611396785182,0.00720033606786326,-0.00965654472516018,0.0185687726608638,0.536004014200026
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,24805,0.00179176549246192,0.00289630833267881,-0.00388499883958855,0.00746852982451238,0.536160751552905
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.0023698372567921,0.00384743935991443,-0.00517114388864017,0.00991081840222438,0.537932111782669
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFA,Protransforming growth factor alpha,29434,0.00187981921121373,0.00309262234402659,-0.00418172058307838,0.00794135900550584,0.543298364816364
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC39A14,Zinc transporter ZIP14,28774,-0.00134994173639814,0.00222121250251459,-0.00570351824132674,0.00300363476853046,0.543358142771761
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN15,Tetraspanin-15,24111,-0.0020356991497943,0.00337086238168801,-0.00864258941790281,0.0045711911183142,0.545908839744264
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,0.00156130949305494,0.00259012245912002,-0.00351533052682029,0.00663794951293017,0.5466505866244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ENPEP,Glutamyl aminopeptidase,24111,0.00178483393796851,0.00296795110828076,-0.00403235023426177,0.00760201811019879,0.547599865272182
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,0.00168369077920447,0.00280772089808901,-0.00381944218104999,0.00718682373945893,0.548735263715039
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ZNF174,Zinc finger protein 174,24229,0.00149930133697334,0.00251851387224761,-0.00343698585263197,0.00643558852657866,0.551640550598349
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PADI2,Protein-arginine deiminase type-2,28931,-0.00222241072938897,0.00373945645319944,-0.00955174537765986,0.00510692391888192,0.55230687215337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,0.00117648990920221,0.00197986091487298,-0.00270403748394882,0.00505701730235325,0.552364643640086
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NCAM2,Neural cell adhesion molecule 2,29443,-0.00105610147900142,0.00178460383118539,-0.00455392498812477,0.00244172203012194,0.553999227154575
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.00175450645561748,0.00296507338380673,-0.0040570373766437,0.00756605028787866,0.554040510870567
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NECTIN2,Nectin-2,29433,-0.00116611796538801,0.00197294461709187,-0.00503308941488808,0.00270085348411206,0.554488387624743
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESR1,Estrogen receptor,24229,0.00226648823016864,0.0038354584893539,-0.005251010408965,0.00978398686930229,0.55457270931009
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00193717908853654,0.0033083816889067,-0.00842160719879366,0.00454724902172059,0.558192341400191
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PITHD1,PITH domain-containing protein 1,23970,-0.00308906584171231,0.00531729206894097,-0.0135109582968366,0.00733282661341198,0.561281517167222
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00181066419786719,0.00312068736825353,-0.00792721143964411,0.00430588304390974,0.561776257982404
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00157853483619827,0.00272986336778517,-0.00377199736466068,0.00692906703705721,0.563102816523424
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,-0.00122969769391171,0.00213739355512922,-0.00541898906196499,0.00295959367414156,0.56507617271615
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,0.00110343263181919,0.00192189925631522,-0.00266348991055865,0.00487035517419703,0.565880754689978
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00262645100982771,0.0046218822698838,-0.0116853402588,0.00643243823914455,0.569860764750319
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBZ,Hemoglobin subunit zeta,24922,0.00399381250999131,0.00703434606188403,-0.00979350577130138,0.017781130791284,0.570203815493522
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FOLR3,Folate receptor gamma,29461,-0.00703235926046101,0.0124201484876429,-0.0313758502962412,0.0173111317753192,0.571258248955197
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CBX2,Chromobox protein homolog 2,24111,0.00150983236024181,0.00268481340421868,-0.0037524019120268,0.00677206663251043,0.573875821284692
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DNLZ,DNL-type zinc finger protein,24101,0.00335461499104399,0.00600982118663399,-0.00842463453475863,0.0151338645168466,0.576720643121492
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DHODH,Dihydroorotate dehydrogenase,24111,0.00175274342700105,0.00315761689580691,-0.0044361856887805,0.0079416725427826,0.57884218314459
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTF,Ciliary neurotrophic factor,24101,0.00125773972546627,0.00227052049315823,-0.00319248044112386,0.00570795989205641,0.579622759277208
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NOS2,"Nitric oxide synthase, inducible",24111,-0.00145737594661296,0.00264315796865811,-0.00663796556518286,0.00372321367195694,0.581380522926431
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00142086818386431,0.00261018418811982,-0.00369509282485053,0.00653682919257915,0.586201881616415
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,29517,-0.0009536579121,0.00178147789621407,-0.00444535458867957,0.00253803876447957,0.592433734037844
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR2,TGF-beta receptor type-2,29566,-0.00116031841246999,0.00216961714099844,-0.00541276800882693,0.00309213118388695,0.592789902751443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN8,Tetraspanin-8,24805,0.00355218715907435,0.00665489708390525,-0.00949141112537994,0.0165957854435286,0.593505172517354
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00221667009105762,0.00416295618120363,-0.0103760642062167,0.0059427240241015,0.594401964267649
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FABP3,"Fatty acid-binding protein, heart",24922,0.00178323893411713,0.00336404009452557,-0.00481027965115299,0.00837675751938725,0.596055304115624
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALPP,"Alkaline phosphatase, placental type",29349,0.00362061220991532,0.00685929611501824,-0.00982360817552042,0.0170648325953511,0.597614247662603
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00152446904518601,0.00290232327520882,-0.00416408457422329,0.0072130226645953,0.599408490738262
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00230567929219091,0.004392671679603,-0.0109153157842128,0.00630395719983097,0.599662949821192
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TBR1,T-box brain protein 1,24195,0.00168429816463624,0.0032154931524374,-0.00461806841414107,0.00798666474341355,0.600417510550256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.0011115122208621,0.00212359068521976,-0.00305072552216864,0.00527374996389284,0.600691722986949
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,0.00111053276241903,0.00212597199368927,-0.00305637234521194,0.00527743787004999,0.601421219994118
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ULBP2,UL16-binding protein 2,29218,-0.00130559927796704,0.00253009519054985,-0.00626458585144475,0.00365338729551067,0.605838948606839
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,29349,-0.00106973903082655,0.00207365462604431,-0.0051341020978734,0.00299462403622031,0.605948146708434
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.000857328990228554,0.00168813746419474,-0.00416607842005024,0.00245142043959313,0.611559554808016
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00169637988428253,0.00334160749853352,-0.00485317081284317,0.00824593058140824,0.611700772568792
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HBQ1,Hemoglobin subunit theta-1,29725,-0.00201931761267059,0.00398312804210583,-0.00982624857519801,0.00578761334985684,0.612181182894992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL3,Interleukin-3,24016,0.00202646987733431,0.00403673228740746,-0.00588552540598431,0.00993846516065293,0.615666851367851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-0.00198356570264997,0.0039633449575549,-0.00975172181945758,0.00578459041415763,0.616743338759681
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ESPL1,Separin,24016,-0.0018466354028682,0.00369648891916287,-0.00909175368442743,0.00539848287869104,0.617386193311079
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN6,Prefoldin subunit 6,24195,0.00211719246362973,0.0043538886177515,-0.00641642922716321,0.0106508141544227,0.62677574965438
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANK2,Ankyrin-2,24111,0.00226300901313198,0.0048077483746183,-0.00716017780111989,0.0116861958273838,0.637858969626739
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARG2,"Arginase-2, mitochondrial",24793,-0.00134957802366561,0.00288039954821256,-0.00699516113816223,0.004296005090831,0.639403681982249
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ITGAX,Integrin alpha-X,24445,0.00166073854805131,0.00356080935957234,-0.00531844779671047,0.0086399248928131,0.640937979916034
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GJA8,Gap junction alpha-8 protein,24016,-0.00192043190752912,0.00414657231934355,-0.0100477136534425,0.00620684983838425,0.643270223692662
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF6,Fibroblast growth factor 6,24229,0.00125898988012237,0.00274244927574048,-0.00411621070032896,0.00663419046057371,0.64618443491827
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00176223420863613,0.00384544909598036,-0.00577484601948537,0.00929931443675762,0.646766312552219
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36G,Interleukin-36 gamma,24149,0.00206913495283848,0.00453233659647342,-0.00681424477624943,0.0109525146819264,0.648015021536418
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00134223779832596,0.00294979325305702,-0.00712383257431771,0.00443935697766579,0.649093387746077
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00261227053863779,0.00574671612422337,-0.00865129306484001,0.0138758341421156,0.649424439534769
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00215095720592146,0.00474428531493064,-0.00714784201134259,0.0114497564231855,0.650280246346558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00171512760745081,0.00378666919867286,-0.00913699923684962,0.00570674402194799,0.650597246464337
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.00103474460000357,0.00228940129485993,-0.0034524819379219,0.00552197113792903,0.651292673719243
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NLGN1,Neuroligin-1,24195,-0.00205457926278374,0.00455364935118559,-0.0109797319911075,0.00687057346554002,0.651853780127042
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TLR2,Toll-like receptor 2,24445,-0.000688137305391615,0.00153037222997485,-0.00368766687614231,0.00231139226535908,0.652964258643529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FGF20,Fibroblast growth factor 20,24229,0.00131121876951079,0.00292444830239473,-0.00442069990318288,0.00704313744220445,0.653894177220194
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DAND5,DAN domain family member 5,24229,0.00161503786045743,0.00362482567176403,-0.00548962045620007,0.00871969617711493,0.655926959240231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEPTIN8,Septin-8,24801,-0.00095179721689496,0.00213709459430569,-0.0051405026217341,0.00323690818794418,0.656056481750798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.00256341983722905,0.00584605800703646,-0.0088948538565624,0.0140216935310205,0.661037320351721
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL13,Interleukin-13,28931,-0.00139565284816047,0.00319337244684827,-0.00765466284398307,0.00486335714766213,0.662080753462804
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VCAN,Versican core protein,29694,-0.000868357033039675,0.00198942316885788,-0.00476762644400112,0.00303091237792177,0.662486720094436
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.00117932212701626,0.00271875540890485,-0.00650808272846977,0.00414943847443724,0.664457304744142
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LMOD2,Leiomodin-2,24101,-0.00182262970599558,0.00421479068981245,-0.010083619458028,0.00643836004603682,0.665428001929718
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ERVV_1,,24111,0.00132439212009995,0.00307528078403776,-0.00470315821661405,0.00735194245681395,0.666721422460113
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.000964197050276902,0.00224197490048705,-0.00343007375467771,0.00535846785523151,0.667150816236174
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHC1,SHC-transforming protein 1,24016,-0.00331260770581112,0.00777691386445441,-0.0185553588801418,0.0119301434685195,0.670145171916735
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00108977670908536,0.00257873075785018,-0.00396453557630099,0.0061440889944717,0.672589405230462
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TXK,Tyrosine-protein kinase TXK,24445,-0.0020917708101933,0.0049570750891624,-0.0118076379849516,0.007624096364565,0.67304564582139
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00134795472273954,0.00323863856956562,-0.00499977687360907,0.00769568631908814,0.677259831925106
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRD2,Bromodomain-containing protein 2,24101,0.000954496120097863,0.00230912726941198,-0.00357139332794961,0.00548038556814534,0.679348056079375
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MAGEA3,Melanoma-associated antigen 3,24445,-0.00233370670967884,0.00565992364403718,-0.0134271570519917,0.00875974363263403,0.680107603660007
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PALM3,Paralemmin-3,24111,0.00200452010045031,0.0049197436999388,-0.00763817755142974,0.0116472177523304,0.683685528335952
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PFDN4,Prefoldin subunit 4,24016,0.00144022862342395,0.00356827774854945,-0.00555359576373297,0.00843405301058088,0.686495697946454
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00204971774282128,0.00508509287923926,-0.0120164997861302,0.00791706430048766,0.686890163476776
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TG,Thyroglobulin,24793,-0.00298552418253343,0.00741952626682583,-0.0175277956655121,0.0115567473004452,0.68740238288032
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00110909107506481,0.00275824750630184,-0.0065152561874164,0.00429707403728679,0.687614052721509
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00115990763333685,0.00289117304789757,-0.00682660680721608,0.00450679154054238,0.688284312731193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,0.000544964567626903,0.00136119066111178,-0.00212296912815218,0.00321289826340598,0.688895864026312
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CAPN3,Calpain-3,24793,0.00100827508286345,0.00252124826074809,-0.00393337150820281,0.00594992167392971,0.689225467618409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.000565740564009233,0.00142535839525908,-0.00222796189069856,0.00335944301871703,0.691436437544356
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RRP15,RRP15-like protein,24101,-0.00237327612152148,0.00605758235160489,-0.0142461375306671,0.00949958528762411,0.695219786384699
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,F3,Tissue factor,29541,0.000699735443564586,0.00180925814448279,-0.00284641051962167,0.00424588140675084,0.698942096154033
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TPBGL,Trophoblast glycoprotein-like,24195,-0.00105352112214436,0.00274015155284995,-0.00642421816573026,0.00431717592144155,0.700629436668917
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NPHS2,Podocin,24229,-0.00263933732847183,0.00688015811404376,-0.0161244472319976,0.0108457725750539,0.701266598881753
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEZ6,Seizure protein 6 homolog,24195,0.000789528827465108,0.00207791290542197,-0.00328318046716196,0.00486223812209217,0.703976644251498
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK11,Kallikrein-11,29296,0.000761601658508208,0.00204324212520774,-0.00324315290689896,0.00476635622391538,0.709343353155274
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00275680069787367,0.00755119987551267,-0.0175571524538785,0.0120435510581312,0.715054039018232
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TOP1,DNA topoisomerase 1,24805,-0.00274472567562991,0.00752946977214053,-0.0175024864290254,0.0120130350777655,0.715464585859481
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHGB,Secretogranin-1,29590,0.000992792822329037,0.00272634203402444,-0.00435083756435886,0.00633642320901693,0.715749872626836
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDH22,Cadherin-22,24445,-0.000684997761813229,0.00190056751907561,-0.00441011009920142,0.00304011457557496,0.718538070104326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PDCL2,Phosducin-like protein 2,24016,0.00126033419481427,0.00353635872472692,-0.0056709289056505,0.00819159729527903,0.721549255325853
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,0.00214444800917871,0.00604150778510188,-0.00969690724962098,0.0139858032679784,0.722628302963342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCUN1D2,DCN1-like protein 2,24016,-0.00187835060855429,0.00534808261342443,-0.0123605925308662,0.0086038913137576,0.725426805800882
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.00146879493030382,0.00419289711129344,-0.00968687326843896,0.00674928340783132,0.726112487250201
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.00116457310454197,0.00336779098447665,-0.00543629722503225,0.0077654434341162,0.729497971870506
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLHL41,Kelch-like protein 41,24867,-0.00113244624975745,0.00330573341226679,-0.00761168373780036,0.00534679123828547,0.731924608604571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.00149333554812488,0.0043790632693127,-0.0100762995559778,0.00708962845972801,0.733093655709737
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00144957503545869,0.00425335273386945,-0.00688699632292544,0.00978614639384282,0.733251394177305
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C9orf40,Uncharacterized protein C9orf40,24805,-0.00181282940805367,0.00533117228036452,-0.0122619270775681,0.00863626826146078,0.733826801949538
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FH,"Fumarate hydratase, mitochondrial",24101,0.0018952445395405,0.00558722971369137,-0.00905572569929458,0.0128462147783756,0.734454446699803
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,0.000767975379343346,0.0022938824169219,-0.00372803415782357,0.00526398491651026,0.73778429205397
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,24195,0.000810317408528748,0.00243807544059286,-0.00396831045503325,0.00558894527209075,0.739620736172685
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00162885543116565,0.00490370364629299,-0.00798240371556861,0.0112401145778999,0.739764988155972
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00380793166720099,0.0114666274804039,-0.0262825215287927,0.0186666581943907,0.739825468412851
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.0013733453443721,0.00418556411596513,-0.00957705101166375,0.00683036032291955,0.742827286762043
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSPAN7,Tetraspanin-7,24101,-0.00203799870569941,0.00626766942141932,-0.0143226307716813,0.0102466333602825,0.745062404141328
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KEL,Kell blood group glycoprotein,28774,0.000765678259186685,0.00237818577634125,-0.00389556586244216,0.00542692238081553,0.747486112848646
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRDX2,Peroxiredoxin-2,24556,0.00131715437758547,0.00409546138503095,-0.00670994993707518,0.00934425869224612,0.747748493385919
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAGE2A,G antigen 2A,24016,0.00135713615254145,0.00423643626766201,-0.00694627893207609,0.00966055123715899,0.748706923041193
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,24445,-0.00114916457815025,0.00359144471152291,-0.00818839621273516,0.00589006705643466,0.748991695031571
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL36A,Interleukin-36 alpha,24229,-0.00121914047333984,0.00387829647498595,-0.0088206015643123,0.00638232061763261,0.753258331282317
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MORN4,MORN repeat-containing protein 4,24016,-0.00163653869784519,0.00523011584677844,-0.0118875657575309,0.00861448836184056,0.754354206574327
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SPRR1B,Cornifin-B,24445,-0.00173073371871109,0.00569187488758289,-0.0128868084983736,0.00942534106095138,0.761076439246709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.000834916879652911,0.00277362950822725,-0.00627123071577831,0.00460139695647249,0.763402123695443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.000650860311406232,0.00216865770689492,-0.00359970879410781,0.00490142941692027,0.764087242173374
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,24101,0.00151459592978501,0.00514101141616856,-0.00856178644590538,0.0115909783054754,0.768293981143754
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.0010647340632681,0.00362616427495113,-0.00817201604217232,0.00604254791563612,0.76904665403931
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,0.000731789986624592,0.00250319955611495,-0.0041744811433607,0.00563806111660988,0.770027753737304
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CASQ2,Calsequestrin-2,24111,0.000938730758194191,0.00325753463867919,-0.00544603713361701,0.0073234986500054,0.773217445019892
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HSP90B1,Endoplasmin,28626,0.00127978377498511,0.00444666673611,-0.00743568302779049,0.00999525057776072,0.773496225575098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,-0.000991462127838132,0.00344845456450575,-0.00775043307426941,0.00576750881859314,0.773724926220528
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FAM171A2,Protein FAM171A2,24867,0.00301265562300967,0.0105330460606535,-0.0176321146558712,0.0236574259018905,0.774865638884529
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.0014482255229343,0.00509359619082758,-0.0114316740569564,0.00853522301108775,0.776165391998365
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UMOD,Uromodulin,29750,-0.00101536468179887,0.00357168323662139,-0.0080158638255768,0.00598513446197906,0.776196381459311
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,24111,-0.00184362571660958,0.00653967186454697,-0.0146613825711216,0.0109741311379025,0.778011797574992
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PGR,Progesterone receptor,24229,0.00188995576526553,0.00678044472148689,-0.0113997158888488,0.0151796274193798,0.780449617855401
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TSLP,Thymic stromal lymphopoietin,28916,0.0011107869283887,0.00401077485594567,-0.00675033178926482,0.00897190564604222,0.78181993749041
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,24101,0.000737053117621643,0.00267225033191802,-0.00450055753293767,0.00597466376818096,0.782690690848983
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL24,Interleukin-24,28931,-0.00088481975179396,0.00323087277348131,-0.00721733038781732,0.0054476908842294,0.784191091625152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.000895530639130649,0.00327961389490797,-0.00732357387315027,0.00553251259488897,0.784809573345157
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,0.000884691272558857,0.00324554603656536,-0.00547657895910924,0.00724596150422696,0.785173606724207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRX,Cone-rod homeobox protein,28916,-0.00193913898854425,0.00711530674368642,-0.0158851402061696,0.0120068622290811,0.785215994272476
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EPHA4,Ephrin type-A receptor 4,24381,0.000504335393478381,0.00190338180049201,-0.00322629293548596,0.00423496372244272,0.79103630412145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IFNW1,Interferon omega-1,24111,-0.000628793693335507,0.00240175590358099,-0.00533623526435426,0.00407864787768324,0.793473383244628
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGLON5,IgLON family member 5,24016,-0.00162186757633801,0.00622066310659809,-0.0138143672652703,0.0105706321125942,0.794308658544198
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MMP13,Collagenase 3,28774,-0.000563830523376868,0.00217004419975014,-0.00481711715488715,0.00368945610813341,0.79500105613098
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD99,CD99 antigen,29443,0.000337302565500152,0.00130275183297489,-0.00221609102713063,0.00289069615813093,0.795702294898409
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,AMY2B,Alpha-amylase 2B,27585,0.000826062217745876,0.00325058370731969,-0.00554508184860072,0.00719720628409247,0.799399071009263
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCLRE1C,Protein artemis,24016,-0.000526503893909629,0.00207355654609454,-0.00459067472425493,0.00353766693643567,0.799564599530566
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,0.000575158729327735,0.00226782652369242,-0.00386978125710942,0.00502009871576489,0.799793848806663
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.00102196768242222,0.00403978189855858,-0.0068960048387526,0.00893994020359703,0.800288574926794
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RBM25,RNA-binding protein 25,24016,-0.000768911777373782,0.00309673854778147,-0.00683851933102545,0.00530069577627789,0.803906522809329
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HEBP1,Heme-binding protein 1,28916,-0.000875846086984872,0.00353231264867391,-0.00779917887838573,0.00604748670441599,0.804172846907501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RASA1,Ras GTPase-activating protein 1,28774,0.000533704225129198,0.00215617291234872,-0.00369239468307428,0.00475980313333268,0.804504601321344
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MLLT1,Protein ENL,24016,0.00113687882417868,0.0046109392786826,-0.00790056216203922,0.0101743198103966,0.805249926825749
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.000607219227600899,0.00246795355648272,-0.00422996974310523,0.00544440819830702,0.805651780671035
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.00106267284772509,0.0044044095807597,-0.00969531562601411,0.00756996993056393,0.809344199468072
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,28774,-0.000783403379043018,0.003267534107383,-0.00718777022951369,0.00562096347142766,0.81052291391342
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KLK1,Kallikrein-1,29199,-0.00195479904891018,0.00845001474134143,-0.0185168279419394,0.014607229844119,0.817054810961775
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,24111,-0.000573794010918995,0.00256134614272926,-0.00559403245066835,0.00444644442883036,0.82274326100625
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLA2G1B,Phospholipase A2,29787,-0.000634414319498516,0.00285390139498654,-0.00622806105367214,0.00495923241467511,0.824084048165499
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,24016,0.000818832998393052,0.0037129147806712,-0.0064584799717225,0.00809614596850861,0.825455273580773
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00104322467921736,0.00475471757649929,-0.010362471129156,0.00827602177072125,0.826333808763138
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.000686190912977876,0.00325849342384625,-0.00570045619776077,0.00707283802371653,0.833212632465308
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EVI2B,Protein EVI2B,24016,0.000557809103517816,0.00273885327708651,-0.00481034331957174,0.00592596152660737,0.838616864265061
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYTH3,Cytohesin-3,24016,-0.000987141492062462,0.00488869530194049,-0.0105689842838658,0.0085947012997409,0.839978397117235
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL33,Interleukin-33,28931,0.000512426613084274,0.00258304279965943,-0.0045503372742482,0.00557519050041675,0.842748376577798
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.000811942471571779,0.00418840107733439,-0.00902120858314719,0.00739732364000363,0.846291035269965
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,24229,0.000615099777350701,0.00321923524058234,-0.00569460129419069,0.00692480084889209,0.848472231353999
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD8,Frizzled-8,24101,0.000531438501465889,0.00292831582907589,-0.00520806052352286,0.00627093752645464,0.85599028144933
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CHIT1,Chitotriosidase-1,29579,-0.00180081678716224,0.0100951284497994,-0.0215872685487691,0.0179856349744446,0.858422061005791
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD5L,CD5 antigen-like,24833,0.00055951387472781,0.00314419377195872,-0.00560310591831128,0.0067221336677669,0.858762548191558
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.000625733892119031,0.00361320807229097,-0.00645615392957128,0.00770762171380934,0.862511721317207
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,24195,0.000879613641408272,0.00516556163042965,-0.00924488715423384,0.0110041144370504,0.864788043979203
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,0.000969041631114159,0.00575115614305307,-0.0103032244092699,0.0122413076714982,0.866195212116902
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CA6,Carbonic anhydrase 6,29372,-0.000692125056212677,0.00418366716447845,-0.00889211269859045,0.00750786258616509,0.86860273144894
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SEL1L,Protein sel-1 homolog 1,24240,-0.000346132501402802,0.00212183873756235,-0.00450493642702502,0.00381267142421941,0.870418572692009
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.000614922512361568,0.0037789143380416,-0.00802159461492311,0.00679174959019998,0.870736602400848
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.000371457077383624,0.00229109550555008,-0.00411909011349454,0.00486200426826179,0.871203992816231
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,0.000541882282947923,0.0033531048483,-0.00603020321972009,0.00711396778561593,0.871617372305177
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.000431242675123543,0.00268047299226778,-0.00568496973996838,0.0048224843897213,0.872186824923709
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OMP,Olfactory marker protein,24101,-0.000523608028540485,0.00328483811397127,-0.00696189073192417,0.0059146746748432,0.873353916250302
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,GAD2,Glutamate decarboxylase 2,24229,0.000491067789055469,0.00308593747137227,-0.00555736965483419,0.00653950523294513,0.873567126520661
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2,Interleukin-2,28931,0.000328121345586081,0.00209306153773791,-0.00377427926838021,0.00443052195955238,0.87543019054916
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,REST,RE1-silencing transcription factor,24016,-0.000348173909943224,0.00233720335315248,-0.00492909248212208,0.00423274466223563,0.881578311599746
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.000437460473352931,0.00295415767646943,-0.00622760951923302,0.00535268857252716,0.882278513996932
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.000394957257887824,0.00274428625968057,-0.00577375832686174,0.00498384381108609,0.885564967401719
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD82,CD82 antigen,24445,-0.000392189555667701,0.0027662490222025,-0.0058140376391846,0.0050296585278492,0.887257587004707
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OLFM4,Olfactomedin-4,23498,0.00113833253421652,0.00819944744814629,-0.0149325844641502,0.0172092495325833,0.8895853646329
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,0.000447231607799676,0.00329412232609358,-0.00600924815134374,0.00690371136694309,0.892006977712639
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SERPINB5,Serpin B5,28916,-0.000425848379356562,0.00322665166586675,-0.00675008564445539,0.00589838888574227,0.895002281763217
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HMMR,Hyaluronan mediated motility receptor,23975,-0.000423683062086549,0.00322948812437502,-0.00675347978586159,0.00590611366168849,0.895624512024449
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,0.000666403638101949,0.0052032754956851,-0.00953201633344085,0.0108648236096448,0.898091578170542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.000981803235020222,0.00767689432980961,-0.0140649096514066,0.0160285161214471,0.8982365216167
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,24101,0.000492946049119778,0.00392809173436635,-0.00720611375023826,0.00819200584847782,0.900134710130352
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,NENF,Neudesin,24793,-0.000907044063829971,0.00730352561732273,-0.0152219542737825,0.0134078661461226,0.901163763847789
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRC1,Protein regulator of cytokinesis 1,24793,0.000359649628865152,0.00301845806026544,-0.00555652816925511,0.00627582742698542,0.905157392348501
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CRYBB2,Beta-crystallin B2,24845,0.000519638832643534,0.00459879070959944,-0.00849399095817137,0.00953326862345844,0.910035695345326
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IKZF2,Zinc finger protein Helios,28797,-0.000656071609459361,0.00605016820569339,-0.0125144012926184,0.0112022580736997,0.913648560195278
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,KHDC3L,KH domain-containing protein 3,24016,0.00048648108897314,0.00450517277674755,-0.00834365755345206,0.00931661973139834,0.9140102530466
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL21R,Interleukin-21 receptor,24229,0.000394975794760746,0.00366538192234883,-0.00678917277304297,0.00757912436256446,0.914188213045099
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,APOD,Apolipoprotein D,23787,-0.000309370373587504,0.00289541232116042,-0.00598437852306193,0.00536563777588692,0.914910096448697
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SHD,SH2 domain-containing adapter protein D,24059,-0.000586221444940864,0.00568069240961428,-0.0117203785677849,0.0105479356779031,0.91780873460143
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,24016,0.000167011543376272,0.00169493588695679,-0.00315506279505904,0.00348908588181158,0.921507818809422
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,0.0004190073084081,0.00457342237362567,-0.00854490054389822,0.00938291516071442,0.927002388133408
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.000207194679820686,0.00235236731920579,-0.00481783462546403,0.00440344526582266,0.929814443729166
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HK2,Hexokinase-2,28916,0.000153736108305688,0.00181991080732071,-0.00341328907404291,0.00372076129065428,0.932679738419838
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ALMS1,Alstrom syndrome protein 1,24445,-0.000243845151239031,0.00297124663739126,-0.00606748856052591,0.00557979825804785,0.934593075757443
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BTNL10,Butyrophilin-like protein 10,24016,0.000214917140168093,0.00272607773095077,-0.00512819521249541,0.00555802949283159,0.937162537161015
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TEX101,Testis-expressed protein 101,24195,-0.000265356837590711,0.00336987796401984,-0.0068703176470696,0.00633960397188818,0.937237095312392
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TGFBR1,TGF-beta receptor type-1,24229,-0.000111790772542484,0.00144427882134674,-0.0029425772623821,0.00271899571729713,0.938304001964981
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,24101,-0.000308074228536377,0.00399477084590598,-0.00813782508651211,0.00752167662943935,0.938529220885244
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,RGS8,Regulator of G-protein signaling 8,28931,0.000328211241395071,0.00432155557457462,-0.00814203768477118,0.00879846016756132,0.939461410334788
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL9,Interleukin-9,24445,0.000284711647577158,0.00377628018537295,-0.00711679751575382,0.00768622081090813,0.939901264679548
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,24195,-0.000505255388439164,0.00686308882480136,-0.0139569094850498,0.0129463987081715,0.941313969710402
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL1A1,Collagen alpha-1(I) chain,29820,-0.000120988507951518,0.00165588146810466,-0.00336651618543665,0.00312453916953361,0.94175414888514
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,28967,-0.000209974151221928,0.00290390388123192,-0.00590162575843648,0.00548167745599263,0.942357662392145
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.000271923566340566,0.00417979219541177,-0.00846431626934763,0.0079204691366665,0.948129380511292
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,ISM2,Isthmin-2,24938,0.000188747916944152,0.00292136925251318,-0.00553713581798168,0.00591463165186998,0.948485517742393
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,JUN,Transcription factor AP-1,28931,0.000213600026157703,0.00332332801892986,-0.00630012289094483,0.00672732294326023,0.948753352587587
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL31,Interleukin-31,24229,0.00023887080189699,0.00379048821315677,-0.00719048609589028,0.00766822769968426,0.949752309585391
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,0.000141446994681827,0.00247380718402367,-0.00470721508600457,0.00499010907536822,0.954403990522152
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,HLA_A,,24867,-0.000121235246226002,0.00217331666871784,-0.00438093591691296,0.00413846542446096,0.955514714844413
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CXCL9,C-X-C motif chemokine 9,29581,-0.000228193110012769,0.00439793047204695,-0.00884813683522479,0.00839175061519925,0.958619501567283
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CD7,T-cell antigen CD7,24177,0.000143098212913279,0.00290598311596934,-0.00555262869438663,0.00583882512021319,0.960726356171711
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,0.000114552037185039,0.00242847447889023,-0.00464525794143982,0.0048743620158099,0.962377822376556
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.000203390568403118,0.00488551305235838,-0.00977899615102554,0.00937221501421931,0.966792910872377
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,28931,9.7368000025951e-05,0.00249630489808623,-0.00479538960022306,0.00499012560027496,0.968886790464265
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,24405,0.000131961956361363,0.00351652803435468,-0.00676043299097382,0.00702435690369654,0.970065752385352
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,EXOSC10,Exosome component 10,24111,0.000144529643944988,0.0040428626626268,-0.00777948117480354,0.00806854046269352,0.971482529670817
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,24445,0.000136376053211536,0.00445653824173997,-0.0085984389005988,0.00887119100702188,0.975587721437967
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,FZD10,Frizzled-10,24195,-9.02794423088069e-05,0.00400750649175603,-0.00794499216615063,0.00776443328153301,0.98202729397442
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,24016,8.72494286920591e-05,0.0042236557103285,-0.00819111576355179,0.00836561462093591,0.983519183176599
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,PCARE,Photoreceptor cilium actin regulator,24101,0.000102478004227209,0.00563623588522451,-0.0109445443308128,0.0111495003392673,0.985493817963108
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,CDC25A,M-phase inducer phosphatase 1,24016,-4.5550049718577e-05,0.00269794098413722,-0.00533351437862753,0.00524241427919037,0.986529884639329
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,BLVRB,Flavin reductase,29443,-5.77044161153844e-05,0.00431007139044453,-0.00850544434138665,0.00839003550915588,0.98931811286607
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,IGFL4,Insulin growth factor-like family member 4,24229,-6.52831516685378e-05,0.00501740804791579,-0.00989940292558348,0.00976883662224641,0.989618860812542
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,29820,1.17713376059764e-05,0.00231643402389304,-0.00452843934922438,0.00455198202443634,0.995945470823644
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,28916,8.14289977728652e-06,0.00323631830540676,-0.00633504097881996,0.00635132677837454,0.997992462315256
NMR metabolomics,X23502.Concentration of Medium VLDL Particles,DLGAP5,Disks large-associated protein 5,24867,5.43875150972077e-06,0.00343942209764963,-0.00673582855988356,0.006746706062903,0.99873831990477
